NorthStar Healthcare Income (NHHS) 10-K 23 Mar 21 2020 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2020	Mar. 18, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2020
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Transition Report	false
Entity File Number	000-55190
Entity Registrant Name	NorthStar Healthcare Income, Inc.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	27-3663988
Entity Address, Address Line One	590 Madison Avenue, 34th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	547-2600
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		190,837,789
ICFR Auditor Attestation Flag	false
Entity Central Index Key	0001503707
Amendment Flag	false
Document Fiscal Period Focus	FY
Entity Public Float			$ 0
Documents Incorporated by Reference	Certain portions of the definitive proxy statement related to the registrant’s 2021 Annual Meeting of Stockholders to be filed hereafter are incorporated by reference into Part III (Items 10, 11, 12, 13 and 14) of this Annual Report on Form 10-K

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents		$ 65,995	$ 41,884
Restricted cash		27,575	16,936
Operating real estate, net		1,483,930	1,700,218
Investments in unconsolidated ventures		229,173	268,894
Real estate debt investments, net		55,864	55,468
Assets held for sale		5,000	1,649
Receivables, net		14,735	13,314
Goodwill and intangible assets, net		26,483	28,355
Other assets		9,681	14,489
Total assets	[1]	1,918,436	2,141,207
Liabilities
Mortgage and other notes payable, net		1,416,871	1,431,922
Line of credit - related party		35,000	0
Due to related party		8,318	5,780
Escrow deposits payable		3,851	3,292
Accounts payable and accrued expenses		38,393	28,135
Other liabilities		3,941	4,574
Total liabilities	[1]	1,506,374	1,473,703
Commitments and contingencies (Note 14)
NorthStar Healthcare Income, Inc. Stockholders’ Equity
Preferred stock, $0.01 par value, 50,000,000 shares authorized, no shares issued and outstanding as of December 31, 2020 and December 31, 2019		0	0
Common stock, $0.01 par value, 400,000,000 shares authorized, 190,409,341 and 189,111,561 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively		1,904	1,891
Additional paid-in capital		1,710,023	1,702,260
Retained earnings (accumulated deficit)		(1,302,755)	(1,041,297)
Accumulated other comprehensive income (loss)		467	(470)
Total NorthStar Healthcare Income, Inc. stockholders’ equity		409,639	662,384
Non-controlling interests		2,423	5,120
Total equity		412,062	667,504
Total liabilities and equity		$ 1,918,436	$ 2,141,207
[1]	Represents the consolidated assets and liabilities of NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Operating Partnership is a consolidated variable interest entity (“VIE”), of which the Company is the sole general partner and owns approximately 99.99%. As of December 31, 2020, the Operating Partnership includes $0.5 billion and $0.5 billion of assets and liabilities, respectively, of certain VIEs that are consolidated by the Operating Partnership. Refer to Note 2, “Summary of Significant Accounting Policies.”

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)		$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)		50,000,000	50,000,000
Preferred stock, shares issued (in shares)		0	0
Preferred stock, shares outstanding (in shares)		0	0
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01
Common stock, shares authorized (in shares)		400,000,000	400,000,000
Common stock, shares issued (in shares)		190,409,341	189,111,561
Common stock, shares outstanding (in shares)		190,409,341	189,111,561
Assets	[1]	$ 1,918,436	$ 2,141,207
Liabilities	[1]	$ 1,506,374	$ 1,473,703
Primary Beneficiary
Ownership interest in operating partnership		99.99%
Primary Beneficiary | Northstar Healthcare Income Operating Partnership, LP
Ownership interest in operating partnership		99.99%
Assets		$ 500,000
Liabilities		$ 500,000
[1]	Represents the consolidated assets and liabilities of NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Operating Partnership is a consolidated variable interest entity (“VIE”), of which the Company is the sole general partner and owns approximately 99.99%. As of December 31, 2020, the Operating Partnership includes $0.5 billion and $0.5 billion of assets and liabilities, respectively, of certain VIEs that are consolidated by the Operating Partnership. Refer to Note 2, “Summary of Significant Accounting Policies.”

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Property and other revenues
Resident fee income	$ 118,126	$ 130,135	$ 129,855
Rental income	157,024	161,084	159,481
Other revenue	198	1,959	4,935
Total property and other revenues	275,348	293,178	294,271
Net interest income
Interest income on debt investments	7,674	7,703	7,706
Interest income on mortgage loans held in a securitized trust	0	0	5,149
Interest expense on mortgage obligations issued by a securitization trust	0	0	(3,824)
Net interest income	7,674	7,703	9,031
Expenses
Real estate properties - operating expenses	184,178	181,214	188,761
Interest expense	65,991	68,896	70,196
Other expenses related to securitization trust	0	0	811
Transaction costs	65	122	888
Asset management and other fees - related party	17,170	19,789	23,478
General and administrative expenses	16,505	12,761	14,390
Depreciation and amortization	65,006	70,989	107,133
Impairment loss	165,968	27,554	36,277
Total expenses	514,883	381,325	441,934
Other income (loss)
Other income	1,840	0	0
Realized gain (loss) on investments and other	302	6,314	20,243
Income (loss) before equity in earnings (losses) of unconsolidated ventures and income tax expense	(229,719)	(74,130)	(118,389)
Equity in earnings (losses) of unconsolidated ventures	(34,466)	(3,545)	(33,517)
Income tax expense	(53)	(75)	(114)
Net income (loss)	(264,238)	(77,750)	(152,020)
Net (income) loss attributable to non-controlling interests	2,780	790	442
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders	$ (261,458)	$ (76,960)	$ (151,578)
Net income (loss) per share of common stock, basic/diluted (in dollars per share)	$ (1.38)	$ (0.41)	$ (0.81)
Weighted average number of shares of common stock outstanding, basic/diluted (in shares)	189,573,204	189,054,270	187,501,302
Distributions declared per share of common stock (in dollars per share)	$ 0	$ 0.03	$ 0.34

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (264,238)	$ (77,750)	$ (152,020)
Other comprehensive income (loss)
Foreign currency translation adjustments related to investment in unconsolidated venture	937	1,814	(1,968)
Total other comprehensive income (loss)	937	1,814	(1,968)
Comprehensive income (loss)	(263,301)	(75,936)	(153,988)
Comprehensive (income) loss attributable to non-controlling interests	2,780	790	442
Comprehensive income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders	$ (260,521)	$ (75,146)	$ (153,546)

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Total Company’s Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2017			186,709,000
Beginning Balance at Dec. 31, 2017	$ 944,799	$ 938,501	$ 1,867	$ 1,681,040	$ (744,090)	$ (316)	$ 6,298
Increase (Decrease) in Stockholder's Equity
Share-based payment of advisor asset management fees (in shares)			1,078,000
Share-based payment of advisor asset management fees	9,030	9,030	$ 11	9,019
Issuance and amortization of equity-based compensation (in shares)			21,000
Issuance and amortization of equity-based compensation	174	174		174
Non-controlling interests - contributions	484						484
Non-controlling interests - distributions	(641)						(641)
Shares redeemed for cash (in shares)			(3,275,000)
Shares redeemed for cash	(25,907)	(25,907)	$ (33)	(25,874)
Distributions declared	(63,256)	(63,256)			(63,256)
Proceeds from distribution reinvestment plan (in shares)			3,962,000
Proceeds from distribution reinvestment plan	33,679	33,679	$ 40	33,639
Other comprehensive income (loss)	(1,968)	(1,968)				(1,968)
Net income (loss)	(152,020)	(151,578)			(151,578)		(442)
Ending Balance (in shares) at Dec. 31, 2018			188,495,000
Ending Balance at Dec. 31, 2018	744,374	738,675	$ 1,885	1,697,998	(958,924)	(2,284)	5,699
Increase (Decrease) in Stockholder's Equity
Share-based payment of advisor asset management fees (in shares)			1,408,000
Share-based payment of advisor asset management fees	9,899	9,899	$ 14	9,885
Issuance and amortization of equity-based compensation (in shares)			35,000
Issuance and amortization of equity-based compensation	239	239		239
Non-controlling interests - contributions	505						505
Non-controlling interests - distributions	(294)						(294)
Shares redeemed for cash (in shares)			(1,514,000)
Shares redeemed for cash	(10,746)	(10,746)	$ (15)	(10,731)
Distributions declared	(5,413)	(5,413)			(5,413)
Proceeds from distribution reinvestment plan (in shares)			687,000
Proceeds from distribution reinvestment plan	4,876	4,876	$ 7	4,869
Other comprehensive income (loss)	1,814	1,814				1,814
Net income (loss)	$ (77,750)	(76,960)			(76,960)		(790)
Ending Balance (in shares) at Dec. 31, 2019	189,111,561		189,111,000
Ending Balance at Dec. 31, 2019	$ 667,504	662,384	$ 1,891	1,702,260	(1,041,297)	(470)	5,120
Increase (Decrease) in Stockholder's Equity
Share-based payment of advisor asset management fees (in shares)	1,600,000		1,600,000
Share-based payment of advisor asset management fees	$ 9,685	9,685	$ 16	9,669
Issuance and amortization of equity-based compensation (in shares)			29,000
Issuance and amortization of equity-based compensation	169	169		169
Non-controlling interests - contributions	234						234
Non-controlling interests - distributions	(151)						(151)
Shares redeemed for cash (in shares)			(331,000)
Shares redeemed for cash	(2,078)	(2,078)	$ (3)	(2,075)
Other comprehensive income (loss)	937	937				937
Net income (loss)	$ (264,238)	(261,458)			(261,458)		(2,780)
Ending Balance (in shares) at Dec. 31, 2020	190,409,341		190,409,000
Ending Balance at Dec. 31, 2020	$ 412,062	$ 409,639	$ 1,904	$ 1,710,023	$ (1,302,755)	$ 467	$ 2,423

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ (264,238)	$ (77,750)	$ (152,020)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Equity in (earnings) losses of unconsolidated ventures	34,466	3,545	33,517
Depreciation and amortization	65,006	70,989	107,133
Impairment loss	165,968	27,554	36,277
Capitalized interest for mortgage and other notes payable	222	193	0
Amortization of below market debt	3,090	3,015	2,932
Straight-line rental income, net and amortization of lease inducements	441	(467)	440
Amortization of discount/accretion of premium on investments	(125)	(113)	(101)
Amortization of deferred financing costs	1,887	1,850	1,946
Amortization of equity-based compensation	169	239	174
Realized (gain) loss on investments and other	(302)	(6,314)	(20,243)
Allowance for uncollectible accounts	2,371	801	3,172
Issuance of common stock as payment for asset management fees	9,685	9,899	9,030
Changes in assets and liabilities:
Receivables	(4,233)	691	1,219
Other assets	4,859	(629)	645
Due to related party	2,853	204	4,766
Escrow deposits payable	559	(1,087)	563
Accounts payable and accrued expenses	8,479	(6,647)	(2,205)
Other liabilities	(139)	(675)	741
Net cash provided by operating activities	31,018	25,298	27,986
Cash flows from investing activities:
Capital expenditures for operating real estate	(15,214)	(22,323)	(31,212)
Sale of operating real estate	927	19,618	11,784
Sale of healthcare-related securities	0	0	35,771
Repayment of real estate debt investment	0	818	0
Investment in unconsolidated ventures	0	(39,801)	(4,470)
Sale of ownership interest in unconsolidated ventures	0	0	47,813
Distributions from unconsolidated ventures	5,923	35,922	12,672
Other assets	(51)	1,479	1,590
Net cash (used in) provided by investing activities	(8,415)	(4,287)	73,948
Cash flows from financing activities:
Borrowings from mortgage notes	0	12,800	0
Repayment of mortgage notes	(20,250)	(51,734)	(25,979)
Borrowings from line of credit - related party	35,000	0	0
Payment of deferred financing costs	0	(708)	(283)
Debt extinguishment costs	0	0	(97)
Payments under finance leases	(608)	(585)	(610)
Shares redeemed for cash	(2,078)	(10,746)	(25,907)
Distributions paid on common stock	0	(10,813)	(68,560)
Proceeds from distribution reinvestment plan	0	4,876	33,679
Contributions from non-controlling interests	234	505	484
Distributions to non-controlling interests	(151)	(294)	(641)
Net cash provided by (used in) financing activities	12,147	(56,699)	(87,914)
Net increase (decrease) in cash, cash equivalents and restricted cash	34,750	(35,688)	14,020
Cash, cash equivalents and restricted cash-beginning of period	58,820	94,508	80,488
Cash, cash equivalents and restricted cash-end of period	93,570	58,820	94,508
Supplemental disclosure of cash flow information:
Cash paid for interest	53,140	64,163	64,568
Cash paid for income taxes	10	28	187
Supplemental disclosure of non-cash investing and financing activities:
Accrued distribution payable	0	0	5,400
Accrued capital expenditures	1,779	2,378	1,456
Assets acquired under finance leases	112	0	2,108
Reclassification of assets held for sale	5,000	0	2,183
Deconsolidation of securitization trust (VIE asset/liability)	$ 0	$ 0	$ 512,772

Business and Organization

Business and Organization	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Organization	Business and Organization NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes. Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Company’s sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of December 31, 2020 and December 31, 2019. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of December 31, 2020, the Company’s limited partnership interest in the Operating Partnership was 99.99%. The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue. The Company is externally managed and has no employees. The Company is sponsored by Colony Capital, Inc. (NYSE: CLNY) (“Colony Capital” or the “Sponsor”), a leading global investment management firm. Colony Capital manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds and non-traded and traded REITs. The Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), is a subsidiary of Colony Capital and manages its day-to-day operations pursuant to an advisory agreement. From inception through December 31, 2020, the Company raised total gross proceeds from the sale of shares of common stock totaling $2.0 billion (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). Impact of COVID-19 At the time of preparation of this Annual Report on Form 10-K, the world continues to face a global pandemic, the coronavirus 2019 (“COVID-19”). Efforts to address the pandemic continue to significantly impact economic and financial markets globally and across all facets of industries, including real estate. Specifically, the Company's healthcare real estate business and investments have experienced a myriad of challenges, including, but not limited to, declines in resident occupancy and operating cash flows, increases in cost burden faced by operators, lease concessions sought by tenants, and a stressed market affecting real estate values in general. Most of these COVID-19 effects on the Company's business significantly impacted results of operations beginning with the three months ended June 30, 2020, and continued throughout the remainder of the year 2020. At this time, the Company anticipates these effects to be sustained and continue in future periods. While the Company itself has the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue to permeate in an economic downturn environment. The effects of COVID-19 may also lead to heightened risk of litigation at the investment and corporate level, with an ensuing increase in litigation and related costs. If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the Company's financial condition and results of operations. At this time, as the extent and

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Accounting The accompanying consolidated financial statements and related notes of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Reclassifications Certain prior period amounts have been reclassified on the consolidated statements of cash flows from the supplemental disclosure of non-cash investing and financing activities to adjustments to reconcile net income (loss) to net cash provided by operating activities to conform to current period presentation. Principles of Consolidation The consolidated financial statements include the accounts of the Company, the Operating Partnership and their consolidated subsidiaries. The Company consolidates entities in which it has a controlling financial interest by first considering if an entity meets the definition of a variable interest entity (“VIE”) for which the Company is deemed to be the primary beneficiary or if the Company has the power to control an entity through majority voting interest or other arrangements. All significant intercompany balances are eliminated in consolidation. Variable Interest Entities A VIE is an entity that lacks one or more of the characteristics of a voting interest entity. A VIE is defined as an entity in which equity investors do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. The determination of whether an entity is a VIE includes both a qualitative and quantitative analysis. The Company bases its qualitative analysis on its review of the design of the entity, its organizational structure including decision-making ability and relevant financial agreements and the quantitative analysis on the forecasted cash flow of the entity. The Company reassesses its initial evaluation of an entity as a VIE upon the occurrence of certain reconsideration events. A VIE must be consolidated only by its primary beneficiary, which is defined as the party who, along with its affiliates and agents, has both the: (i) power to direct the activities that most significantly impact the VIE’s economic performance; and (ii) obligation to absorb the losses of the VIE or the right to receive the benefits from the VIE, which could be significant to the VIE. The Company determines whether it is the primary beneficiary of a VIE by considering qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE’s economic performance and which party controls such activities; the amount and characteristics of its investment; the obligation or likelihood for the Company or other interests to provide financial support; consideration of the VIE’s purpose and design, including the risks the VIE was designed to create and pass through to its variable interest holders and the similarity with and significance to the business activities of the Company and the other interests. The Company reassesses its determination of whether it is the primary beneficiary of a VIE each reporting period. Judgments related to these determinations include estimates about the current and future fair value and performance of investments held by these VIEs and general market conditions. The Company evaluates its investments and financings, including investments in unconsolidated ventures and securitization financing transactions to determine whether each investment or financing is a VIE. The Company analyzes new investments and financings, as well as reconsideration events for existing investments and financings, which vary depending on type of investment or financing. As of December 31, 2020, the Company has identified certain consolidated and unconsolidated VIEs. Assets of each of the VIEs, other than the Operating Partnership, may only be used to settle obligations of the respective VIE. Creditors of each of the VIEs have no recourse to the general credit of the Company. Consolidated VIEs The most significant consolidated VIEs are the Operating Partnership and certain properties that have non-controlling interests. These entities are VIEs because the non-controlling interests do not have substantive kick-out or participating rights. The Operating Partnership consolidates certain properties that have non-controlling interests. Included in operating real estate, net on the Company’s consolidated balance sheets as of December 31, 2020 is $494.3 million related to such consolidated VIEs. Included in mortgage and other notes payable, net on the Company’s consolidated balance sheet as of December 31, 2020 is $459.4 million, collateralized by the real estate assets of the related consolidated VIEs. Investing VIEs The Company’s investment in a securitization financing entity (“Investing VIE”) consisted of subordinate first-loss certificates in a securitization trust, generally referred to as Class B certificates, which represents interests in such VIE. Investing VIEs are structured as pass through entities that receive principal and interest payments from the underlying debt collateral assets and distribute those payments to the securitization trust’s certificate holders, including the Class B certificates. A securitization trust will name a directing certificate holder, who is generally afforded the unilateral right to terminate and appoint a replacement for the special servicer, and as such may qualify as the primary beneficiary of the trust. The Company held Class B certificates in an Investing VIE for which the Company had determined it was the primary beneficiary because it had the power to direct the activities that most significantly impacted the economic performance of the securitization trust. As a result, all of the assets, liabilities (obligations to the certificate holders of the securitization trust, less the Company’s retained interest from the Class B certificates of the securitization), income and expense of the entire Investing VIE were presented in the consolidated financial statements of the Company as required by U.S. GAAP. The Company’s Class B certificates, which represented the retained interest and related interest income, were eliminated in consolidation. Regardless of the presentation, the Company’s consolidated financial statements of operations ultimately reflect the net income attributable to its retained interest in the Class B certificates. In March 2018, the Company sold the Class B certificates of its consolidated Investing VIE, relinquishing its rights as directing certificate holder. As a result, the Company was no longer deemed the primary beneficiary of the securitization trust and, accordingly, did not present the assets or liabilities of the securitization trust on its consolidated balance sheets as of December 31, 2019 and December 31, 2018. The Company has presented the income and expenses of the securitization trust on its consolidated statements of operations for the periods that the Company owned the Class B certificates and was considered the primary beneficiary in 2018. Unconsolidated VIEs As of December 31, 2020, the Company identified unconsolidated VIEs related to its real estate equity investments with a carrying value of $229.2 million. The Company’s maximum exposure to loss as of December 31, 2020 would not exceed the carrying value of its investment in the VIEs and its investment in a mezzanine loan to a subsidiary of one of the VIEs. Based on management’s analysis, the Company determined that it is not the primary beneficiary of these VIEs and, accordingly, they are not consolidated in the Company’s financial statements as of December 31, 2020. The Company did not provide financial support to its unconsolidated VIEs during the year ended December 31, 2020. As of December 31, 2020, there were no explicit arrangements or implicit variable interests that could require the Company to provide financial support to its unconsolidated VIEs. Voting Interest Entities A voting interest entity is an entity in which the total equity investment at risk is sufficient to enable it to finance its activities independently and the equity holders have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the losses of the entity and the right to receive the residual returns of the entity. The usual condition for a controlling financial interest in a voting interest entity is ownership of a majority voting interest. If the Company has a majority voting interest in a voting interest entity, the entity will generally be consolidated. The Company does not consolidate a voting interest entity if there are substantive participating rights by other parties and/or kick-out rights by a single party or through a simple majority vote. The Company performs on-going reassessments of whether entities previously evaluated under the voting interest framework have become VIEs, based on certain events, and therefore subject to the VIE consolidation framework. Investments in Unconsolidated Ventures A non-controlling, unconsolidated ownership interest in an entity may be accounted for using the equity method or the Company may elect the fair value option. The Company will account for an investment under the equity method of accounting if it has the ability to exercise significant influence over the operating and financial policies of an entity, but does not have a controlling financial interest. Under the equity method, the investment is adjusted each period for capital contributions and distributions and its share of the entity’s net income (loss). Capital contributions, distributions and net income (loss) of such entities are recorded in accordance with the terms of the governing documents. An allocation of net income (loss) may differ from the stated ownership percentage interest in such entity as a result of preferred returns and allocation formulas, if any, as described in such governing documents. Equity method investments are recognized using a cost accumulation model, in which the investment is recognized based on the cost to the investor, which includes acquisition fees. The Company records as an expense certain acquisition costs and fees associated with consolidated investments deemed to be business combinations and capitalizes these costs for investments deemed to be acquisitions of an asset, including an equity method investment. Non-controlling Interests A non-controlling interest in a consolidated subsidiary is defined as the portion of the equity (net assets) in a subsidiary not attributable, directly or indirectly, to the Company. A non-controlling interest is required to be presented as a separate component of equity on the consolidated balance sheets and presented separately as net income (loss) and comprehensive income (loss) attributable to controlling and non-controlling interests. An allocation to a non-controlling interest may differ from the stated ownership percentage interest in such entity as a result of a preferred return and allocation formula, if any, as described in such governing documents. Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material. Comprehensive Income (Loss) The Company reports consolidated comprehensive income (loss) in separate statements following the consolidated statements of operations. Comprehensive income (loss) is defined as the change in equity resulting from net income (loss) and other comprehensive income (loss) (“OCI”). The only component of OCI for the Company is foreign currency translation adjustments related to its investment in an unconsolidated venture. Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. The Company may elect to apply the fair value option for certain investments due to the nature of the instrument. Any change in fair value for assets and liabilities for which the election is made is recognized in earnings. Cash, Cash Equivalents and Restricted Cash The Company considers all highly-liquid investments with an original maturity date of three months or less to be cash equivalents. Cash, including amounts restricted, may at times exceed the Federal Deposit Insurance Corporation deposit insurance limit of $250,000 per institution. The Company mitigates credit risk by placing cash and cash equivalents with major financial institutions. To date, the Company has not experienced any losses on cash and cash equivalents. Restricted cash consists of amounts related to operating real estate (escrows for taxes, insurance, capital expenditures, security deposits received from tenants and payments required under certain lease agreements) and other escrows required by lenders of the Company’s borrowings. The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported on the consolidated balance sheets to the total of such amounts as reported on the consolidated statements of cash flows (dollars in thousands): Year Ended December 31, 2020 2019 2018 Cash and cash equivalents $ 65,995 $ 41,884 $ 73,811 Restricted cash 27,575 16,936 20,697 Total cash, cash equivalents and restricted cash $ 93,570 $ 58,820 $ 94,508 Operating Real Estate Operating real estate is carried at historical cost less accumulated depreciation. Major replacements and betterments which improve or extend the life of the asset are capitalized and depreciated over their useful life. Ordinary repairs and maintenance are expensed as incurred. Operating real estate is depreciated using the straight-line method over the estimated useful life of the assets, summarized as follows: Category: Term: Building 30 to 50 years Building improvements Lesser of the useful life or remaining life of the building Land improvements 9 to 15 years Tenant improvements Lesser of the useful life or remaining term of the lease Furniture, fixtures and equipment 5 to 14 years Construction costs incurred in connection with the Company’s investments are capitalized and included in operating real estate, net on the consolidated balance sheets. Construction in progress is not depreciated until the asset is available for its intended use. Lessee Accounting A leasing arrangement, a right to control the use of an identified asset for a period of time in exchange for consideration, is classified by the lessee either as a finance lease, which represents a financed purchase of the leased asset, or as an operating lease. For leases with terms greater than 12 months, a lease asset and a lease liability are recognized on the balance sheet at commencement date based on the present value of lease payments over the lease term. Lease renewal or termination options are included in the lease asset and lease liability only if it is reasonably certain that the option to extend would be exercised or the option to terminate would not be exercised. As the implicit rate in most leases are not readily determinable, the Company’s incremental borrowing rate for each lease at commencement date is used to determine the present value of lease payments. Consideration is given to the Company’s recent debt financing transactions, as well as publicly available data for instruments with similar characteristics, adjusted for the respective lease term, when estimating incremental borrowing rates. Lease expense is recognized over the lease term based on an effective interest method for finance leases and on a straight-line basis for operating leases. Right of Use (“ROU”) - Finance Assets The Company has entered into finance leases for equipment totaling $3.5 million, which is included in furniture, fixtures, and equipment within operating real estate, net on the Company’s consolidated balance sheets. The leased equipment is amortized on a straight-line basis. For the years ended December 31, 2020 and 2019, payments for finance leases totaled $0.7 million, respectively. The following table presents the future minimum lease payments under finance leases and the present value of the minimum lease payments, which are included in other liabilities on the Company’s consolidated balance sheets (dollars in thousands): Years Ending December 31: 2021 $ 670 2022 577 2023 155 2024 59 2025 17 Thereafter 9 Total minimum lease payments $ 1,487 Less: Amount representing interest $ (112) Present value of minimum lease payments $ 1,375 The weighted average interest rate related to the finance lease obligations is 6.2% with a weighted average lease term of 2.4 years. As of December 31, 2020, there were no leases that had yet to commence which would create significant rights and obligations to the Company as lessee. Assets Held For Sale The Company classifies certain long-lived assets as held for sale once the criteria, as defined by U.S. GAAP, have been met and are expected to sell within one year. Long-lived assets to be disposed of are reported at the lower of their carrying amount or fair value minus cost to sell, with any write-down recorded to impairment loss on the consolidated statements of operations. Depreciation and amortization is not recorded for assets classified as held for sale. As of December 31, 2020, the Company classified two operating real estate properties within the Kansas City portfolio as held for sale, as presented on its consolidated balance sheets As of December 31, 2019, the Company had one net lease property classified as held for sale, which was sold in July 2020. Real Estate Debt Investments Real estate debt investments are generally intended to be held to maturity and, accordingly, are carried at cost, net of unamortized loan fees, premium, discount and unfunded commitments. Debt investments where the Company does not have the intent to hold the loan for the foreseeable future or until its expected payoff are classified as held for sale and recorded at the lower of cost or estimated fair value. Refer to “—Credit Losses on Real Estate Debt Investments and Receivables” for additional information on estimated credit loses for real estate debt investments. Goodwill, Intangible Assets and Deferred Costs Deferred Costs Deferred costs primarily include deferred financing costs and deferred lease costs. Deferred financing costs represent commitment fees, legal and other third-party costs associated with obtaining financing. These costs are recorded against the carrying value of such financing and are amortized to interest expense over the term of the financing using the effective interest method. Unamortized deferred financing costs are expensed to realized gain (loss) on investments and other, when the associated borrowing is repaid before maturity. Costs incurred in seeking financing transactions which do not close are expensed in the period in which it is determined that the financing will not occur. Deferred lease costs consist of fees incurred to initiate and renew operating leases, which are amortized on a straight-line basis over the remaining lease term and are recorded to depreciation and amortization in the consolidated statements of operations. Identified Intangibles The Company records acquired identified intangibles, such as the value of in-place leases, goodwill and other intangibles, based on estimated fair value at the acquisition date. The value allocated to the identified intangibles is amortized over the remaining lease term. In-place leases are amortized into depreciation and amortization expense. Impairment analysis for identified intangible assets is performed in connection with the impairment assessment of the related operating real estate. An impairment establishes a new basis for the identified intangible asset and any impairment loss recognized is not subject to subsequent reversal. Refer to “—Credit Losses and Impairment on Investments - Operating Real Estate” for additional information. Goodwill represents the excess of the purchase price over the fair value of net tangible and intangible assets acquired in a business combination and is not amortized. The Company performs an annual impairment test for goodwill and evaluates the recoverability whenever events or changes in circumstances indicate that the carrying value of goodwill may not be fully recoverable. In making such assessment, qualitative factors are used to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the estimated fair value of the reporting unit is less than its carrying value, then an impairment charge is recorded. During the year ended December 31, 2020, the Company tested its goodwill for impairment. The accounting guidance under ASC 350-20 requires that any assets in the reporting unit of goodwill that are subject to impairment testing be evaluated prior to testing the goodwill of the reporting unit for impairment. As a result of impairment recorded on the operating real estate of the reporting unit during the year ended December 31, 2020, the Company concluded that the fair value of its goodwill reporting unit remains greater than its carrying value and goodwill was not impaired as of December 31, 2020. The Company utilized future net cash flows expected to be generated by the properties in a discounted cash flow analysis using terminal capitalization rates ranging from 6.50% to 7.75% and discount rates ranging from 7.75% to 9.25%. The Company concluded that the fair value of the goodwill reporting unit was less than 10% in excess of its carrying value as of December 31, 2020. If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the performance of the Company's operating real estate. At this time, as the extent and duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact with any meaningful precision. Identified intangible assets are recorded in deferred costs and intangible assets, net on the consolidated balance sheets. The following table presents deferred costs and intangible assets, net (dollars in thousands): December 31, 2020 December 31, 2019 Goodwill and intangible assets, net: In-place lease value, net $ 4,635 $ 6,437 Goodwill 21,387 21,387 Certificate of need intangible assets 380 380 Subtotal intangible assets 26,402 28,204 Deferred costs, net 81 151 Total $ 26,483 $ 28,355 The Company recorded $1.9 million and $8.3 million of amortization expense for in-place leases and deferred costs for the year ended December 31, 2020 and 2019, respectively. In-place lease value, net includes a gross asset amount of $130.0 million for in-place leases related to the Company’s direct investment - net lease properties, of which $125.4 million has been amortized as of December 31, 2020. All other in-place leases related to the Company’s direct investment - operating properties have been fully amortized as of December 31, 2020. The following table presents future amortization of in-place lease value and deferred costs (dollars in thousands): Years Ending December 31: 2021 $ 1,871 2022 593 2023 337 2024 337 2025 337 Thereafter 1,241 Total $ 4,716 Acquisition Fees and Expenses The total of all acquisition fees and expenses for an investment, including acquisition fees to the Advisor, cannot exceed, in the aggregate, 6.0% of the contract purchase price of such investment unless such excess is approved by a majority of the Company’s directors, including a majority of its independent directors. Effective January 1, 2018, the Advisor no longer receives an acquisition fee in connection with the Company’s acquisitions of real estate properties or debt investments. For the year ended December 31, 2020, the Company did not incur any acquisition fees or expenses to the Advisor or third parties. The Company records as an expense for certain acquisition costs and fees associated with transactions deemed to be business combinations in which it consolidates the asset and capitalizes these costs for transactions deemed to be acquisitions of an asset, including an equity investment. Other Assets The following table presents a summary of other assets (dollars in thousands): December 31, 2020 December 31, 2019 Other assets: Healthcare facility regulatory reserve deposit (1) $ — $ 6,000 Remainder interest in condominium units (2) 2,327 2,327 Prepaid expenses 3,798 3,841 Lease / rent inducements, net 2,246 1,636 Utility deposits 447 317 Other 863 368 Total $ 9,681 $ 14,489 _______________________________________ (1) As of December 31, 2020, the Company is in possession of the regulatory reserve deposit and, accordingly, the amount totaling $6.0 million has been reclassified to restricted cash. (2) Represents future interests in property subject to life estates. Revenue Recognition Operating Real Estate Rental income from operating real estate is derived from leasing of space to healthcare operators, including rent received from the Company’s net lease properties and rent, ancillary service fees and other related revenue earned from ILF residents. Rental revenue recognition commences when the operator takes legal possession of the leased space and the leased space is substantially ready for its intended use. The leases are for fixed terms of varying length and generally provide for rentals and expense reimbursements to be paid in monthly installments. Rental income from leases is recognized on a straight-line basis over the term of the respective leases. ILF resident agreements are generally short-term in nature and may allow for termination with 30 days’ notice. The excess of rents recognized over amounts contractually due pursuant to the underlying leases are included in receivables, net on the consolidated balance sheets. The Company amortizes any operator inducements as a reduction of revenue utilizing the straight-line method over the term of the lease. The Company also generates operating income from operating healthcare properties. Revenue related to operating healthcare properties includes resident room and care charges, ancillary fees and other resident service charges. Rent is charged and revenue is recognized when such services are provided, generally defined per the resident agreement as of the date upon which a resident occupies a room or uses the services. Resident agreements are generally short-term in nature and may allow for termination with 30 days’ notice. Income derived from our ALFs, MCFs and CCRCs is recorded in resident fee income in the consolidated statements of operations. Lease income from operators and residents is recognized at lease commencement only to the extent collection is expected to be probable in consideration of operators’ and residents’ creditworthiness. This assessment is based on several qualitative and quantitative factors, including and as appropriate, the payment history, ability to satisfy its lease obligations, the value of the underlying collateral or deposit, if any, and current economic conditions. If collection is assessed to not be probable thereafter, lease income recognized is limited to lease payments collected, with the reversal of any income recognized to date in excess of amounts received. If collection is subsequently reassessed to be probable, lease income is adjusted to reflect the amount of income that would have been recognized had collection always been assessed as probable. For the year ended December 31, 2020, the operator of the Smyrna (formerly Peregrine) portfolio failed to remit rental payments and accordingly no rental income was recognized. Further, the Company continues to monitor the operator for the Arbors portfolio, which is currently in lease default as a result of the operators’ failure to remit rent timely and satisfy other conditions under its lease. As of December 31, 2020, the Company expects rent collection to be probable for the Arbors portfolio. For the years ended December 31, 2020 and 2019, total property and other revenues includes variable lease revenues of $14.4 million and $16.2 million, respectively. Variable lease income includes ancillary services provided to operator/residents, as well as non-recurring services and fees at the Company’s operating facilities. In addition, during the year ended December 31, 2020, the Company recognized $1.8 million in grant income received from the Provider Relief Fund administered by the U.S Department of Health & Human Services (“DHHS”). The grant income is classified as other income in the consolidated statements of operations. Lease Concessions Related to COVID-19 As a result of the COVID-19 crisis, the Company continues to engage with affected operators on a case-by-case basis to evaluate and respond to the current environment and assess the potential for flexible payment terms. For lease concessions resulting directly from the impact of COVID-19 that do not result in a substantial increase in the rights of the lessor or the obligations of the lessee, for example, where total payments required by the modified contract will be substantially the same as or less than the original contract, the Company made a policy election to account for the concessions as though the enforceable rights and obligations for those concessions existed in the lease contracts, under a relief provided by the Financial Accounting Standards Board (“FASB”). Under the relief, the concessions will not be treated as lease modifications that are accounted for over the remaining term of the respective leases, as the Company believes this would not accurately reflect the temporary economic effect of the concessions. Instead, (i) rent deferrals that meet the criteria will be treated as if no changes were made to the lease contract, with continued recognition of lease income and receivable under the original terms of the contract; and (ii) rent forgiveness that meets the criteria will be accounted for as variable lease payments in the affected periods. Effective June 1, 2020, the Company granted a lease concession to the operator of its Fountains net lease portfolio. The concession allowed the operator to defer a portion of contractual rent payments for a 90-day period, with full contractual rent to be repaid over the 12 months following the concession period. The lease concession provided the operator relief consistent with the debt forbearance received from the lender of the properties in the portfolio. The amount of the deferred rental payments under the lease concession totaled $3.9 million. The lease concession period ended on August 31, 2020 and the operator has resumed remitting contractual rent payments, including amounts related to deferred rent granted under the lease concession. As there were no substantive changes to the original lease or changes in total cash flows, the concession was not treated as a lease modification and the Company continues to recognize lease income and receivables under the original terms of the lease. Real Estate Debt Investments Interest income is recognized on an accrual basis and any related premium, discount, origination costs and fees are amortized over the life of the investment using the effective interest method. The amortization is reflected as an adjustment to interest income in the consolidated statements of operations. The amortization of a premium or accretion of a discount is discontinued if such investment is reclassified to held for sale. Income recognition is suspended for an investment at the earlier of the date at which payments become 90-days past due or when, in the opinion of the Company, a full recovery of income and principal becomes doubtful. When the ultimate collectability of the principal of an investment is in doubt, all payments are applied to principal under the cost recovery method. When the ultimate collectability of the principal

Operating Real Estate

Operating Real Estate	12 Months Ended
	Dec. 31, 2020
Real Estate [Abstract]
Operating Real Estate	Operating Real Estate The following table presents operating real estate, net (dollars in thousands): December 31, 2020 December 31, 2019 Land $ 234,706 $ 236,036 Land improvements 23,797 23,287 Buildings and improvements 1,389,706 1,551,113 Tenant improvements 16,172 14,642 Construction in progress 2,535 4,956 Furniture, fixtures and equipment 108,055 100,998 Subtotal $ 1,774,971 $ 1,931,032 Less: Accumulated depreciation (291,041) (230,814) Operating real estate, net $ 1,483,930 $ 1,700,218 For the years ended December 31, 2020, 2019 and 2018 depreciation expense was, $63.1 million, $62.8 million and $60.0 million, respectively. Within the table above, buildings and improvements have been reduced by accumulated impairment losses of $213.9 million and $58.0 million as of December 31, 2020 and December 31, 2019, respectively. Impairment loss, as presented on the consolidated statements of operations, totaled $166.0 million and $27.6 million for the years ended December 31, 2020 and 2019, respectively. Refer to Note 2, “Summary of Significant Accounting Policies” for further discussion. Future Minimum Rental Income Minimum rental amounts due under leases are generally either subject to scheduled fixed increases or adjustments. The following table presents approximate future minimum rental income under noncancelable operating leases to be received over the next five years and thereafter as of December 31, 2020 (dollars in thousands): Years Ending December 31: (1) 2021 $ 34,183 2022 14,659 2023 10,919 2024 11,192 2025 11,472 Thereafter 45,604 Total $ 128,029 _______________________________________ (1) Excludes rental income from residents at ILFs that are subject to short-term leases.

Investments in Unconsolidated V

Investments in Unconsolidated Ventures	12 Months Ended
	Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Investments in Unconsolidated Ventures	Investments in Unconsolidated Ventures All investments in unconsolidated ventures are accounted for under the equity method. The following tables present the Company’s investments in unconsolidated ventures (dollars in thousands): Carrying Value Portfolio Acquisition Date Ownership December 31, 2020 December 31, 2019 (1) Eclipse May-2014 5.6 % $ 5,624 $ 9,483 Envoy (2) Sep-2014 11.4 % 2 399 Diversified US/UK Dec-2014 14.3 % 89,651 125,597 Espresso (3) Jul-2015 36.7 % — — Trilogy (4) Dec-2015 23.2 % 133,896 133,361 Subtotal $ 229,173 $ 268,840 Operator Platform (5) Jul-2017 20.0 % — 54 Total $ 229,173 $ 268,894 _______________________________________ (1) Includes $1.3 million, $13.4 million, $7.6 million and $9.8 million of capitalized acquisition costs for the Company’s investments in the Eclipse, Diversified US/UK (formerly Griffin-American), Espresso and Trilogy joint ventures, respectively. (2) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. The Company’s carrying value for its investment in the Envoy joint venture represents additional proceeds to be received upon satisfaction of certain conditions under the sale. (3) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero in the fourth quarter of 2018. The Company has recorded the excess equity in losses related to its unconsolidated venture as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture. (4) In October 2018, the Company sold 20.0% of its ownership interest in the Trilogy joint venture, which generated gross proceeds of $48.0 million and reduced the Company’s ownership interest in the joint venture from approximately 29% to 23%. (5) Represents investment in Solstice Senior Living, LLC (“Solstice”), the manager of the Winterfell portfolio. Solstice is a joint venture between affiliates of Integral Senior Living, LLC (“ISL”), a management company of ILF, ALF and MCF founded in 2000, which owns 80.0%, and the Company, which owns 20.0%. As a result of losses recorded by the joint venture, the Company’s carrying value of its Solstice unconsolidated investment was reduced to zero in the third quarter of 2020. Year Ended December 31, 2020 Year Ended December 31, 2019 Portfolio Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Eclipse $ (3,774) $ (4,769) $ 86 $ 435 $ (987) $ 2,717 Envoy (7) — 390 20 (892) 4,339 (4) Diversified US/UK (Formerly Griffin-American) (35,396) (47,177) 1,487 (4,540) (16,359) 23,061 Espresso 270 (9,415) — (2,426) (8,530) — Trilogy (2) 4,495 (13,617) 3,960 3,003 (13,797) 5,805 Subtotal $ (34,412) $ (74,978) $ 5,923 $ (3,508) $ (40,565) $ 35,922 Operator Platform (3) (54) — — (37) — — Total $ (34,466) $ (74,978) $ 5,923 $ (3,545) $ (40,565) $ 35,922 _______________________________________ (1) Represents the net amount of the Company’s proportionate share of select revenues and expenses, including: straight-line rental income (expense), (above)/below market lease and in-place lease amortization, (above)/below market debt and deferred financing costs amortization, depreciation and amortization expense, acquisition fees and transaction costs, loan loss reserves, liability extinguishment gains, debt extinguishment losses, impairment, as well as unrealized and realized gain (loss) from sales of real estate and investments. (2) The Trilogy joint venture received and recognized federal COVID-19 provider relief funds totaling $53.9 million, of which the Company’s proportionate share totaled $12.5 million, and is included in equity in earnings for the year ended December 31, 2020. (3) Represents the Company’s investment in Solstice. During the year ended December 31, 2020, the Company's unconsolidated investment in Solstice was reduced to zero. As such, the Company did not recognize its proportionate share of losses from the joint venture of approximately $3,000 for the year ended December 31, 2020. (4) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. Summarized Financial Data The combined balance sheets as of December 31, 2020 and 2019 and combined statements of operations for the years ended December 31, 2020, 2019 and 2018 for the Company’s unconsolidated ventures are as follows (dollars in thousands): December 31, 2020 December 31, 2019 Year Ended December 31, 2020 2019 2018 Assets Operating real estate, net $ 4,500,319 $ 4,821,757 Total revenues $ 1,562,284 $ 1,575,758 $ 1,514,098 Other assets 1,261,678 1,199,552 Net income (loss) $ (294,501) $ (17,689) $ (150,170) Total assets $ 5,761,997 $ 6,021,309 Liabilities and equity Total liabilities $ 4,626,761 $ 4,578,905 Equity 1,135,236 1,442,404 Total liabilities and equity $ 5,761,997 $ 6,021,309

Real Estate Debt Investments

Real Estate Debt Investments	12 Months Ended
	Dec. 31, 2020
Real Estate [Abstract]
Real Estate Debt Investments	Real Estate Debt Investments The following table presents the Company’s one debt investment (dollars in thousands): Carrying Value (1) Asset Type: Principal Amount December 31, 2020 December 31, 2019 Fixed Rate Final Maturity Date Mezzanine loan (1) $ 74,182 $ 55,864 $ 55,468 10.0 % Jan 2022 _______________________________________ (1) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero in the fourth quarter of 2018. The Company has recorded the excess equity in losses related to its unconsolidated investment as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture. As of December 31, 2020 and December 31, 2019, the cumulative excess equity in losses included in the mezzanine loan carrying value were $18.3 million and $18.6 million, respectively. The Company evaluates its debt investment at least quarterly based on: (i) whether the borrower is currently paying contractual debt service in accordance with its contractual terms; and (ii) whether the Company believes the borrower will be able to perform under its contractual terms in the future, as well as the Company’s expectations as to the ultimate recovery of principal. The Company considers historical credit loss information, current conditions, the effects of expectations of changes in future macroeconomic conditions as well as reasonable and supportable forecasts. As of December 31, 2020, the Company’s debt investment was performing in accordance with the contractual terms of its governing documents. The Company continues to assess the collectability of principal and interest and expects to receive full payment of contractual interest and recover the principal outstanding. As of December 31, 2020, contractual debt service has been paid in accordance with contractual terms. Effective December 31, 2020, the Company executed an amended and restated loan agreement with the borrower of our debt investment. The terms set forth under the amended loan agreement include: • a partial principal repayment totaling $5.0 million upon execution, which was received in January 2021, as well as the remittance of modification fees upon certain milestones; • a fixed interest rate of 14.0%, effective February 2021, as well as the accrual of additional payment-in-kind, interest based on outstanding principal balance thresholds; • periodic principal repayments from the borrower’s available cash flow; and • an extension of the loan’s maturity through January 2022. For the year ended December 31, 2020, the mezzanine loan represented 100.0% of the Company’s interest income on debt investments as presented on the consolidated statements of operations.

Borrowings

Borrowings	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Borrowings	Borrowings The following table presents the Company’s mortgage and other notes payable (dollars in thousands): December 31, 2020 December 31, 2019 Recourse vs. Non-Recourse Final Maturity (1) Contractual Interest Rate (2) Principal Amount (3) Carrying Value (3) Principal (3) Carrying (3) Mortgage notes payable, net Watermark Aqua Portfolio Denver, CO Non-recourse Feb 2021 LIBOR + 2.92% $ 20,189 $ 20,183 $ 20,547 $ 20,500 Frisco, TX Non-recourse Mar 2021 LIBOR + 3.04% 18,770 18,764 19,170 19,127 Milford, OH Non-recourse Sep 2026 LIBOR + 2.68% 18,760 18,423 18,760 18,357 Rochester Portfolio Rochester, NY Non-recourse Feb 2025 4.25% 19,907 19,830 20,228 20,131 Rochester, NY (4) Non-recourse Aug 2027 LIBOR + 2.34% 101,224 100,378 101,224 100,267 Rochester, NY Non-recourse Aug 2021 LIBOR + 2.90% 12,800 12,584 12,800 12,232 Arbors Portfolio (5) Various locations Non-recourse Feb 2025 3.99% 87,302 86,521 89,026 88,020 Watermark Fountains Portfolio (6) Various locations Non-recourse Jun 2022 3.92% 386,607 385,606 392,269 390,508 Various locations Non-recourse Jun 2022 5.56% 73,439 73,180 74,208 73,750 Winterfell Portfolio (7) Various locations Non-recourse Jun 2025 4.17% 622,045 607,526 632,024 614,415 Avamere Portfolio (8) Various locations Non-recourse Feb 2027 4.66% 70,427 69,962 71,464 70,922 Subtotal mortgage notes payable, net $ 1,431,470 $ 1,412,957 $ 1,451,720 $ 1,428,229 Other notes payable Oak Cottage Santa Barbara, CA Non-recourse Feb 2022 6.00% 3,914 3,914 3,693 3,693 Subtotal other notes payable, net $ 3,914 $ 3,914 $ 3,693 $ 3,693 Total mortgage and other notes payable, net $ 1,435,384 $ 1,416,871 $ 1,455,413 $ 1,431,922 _______________________________________ (1) Refer to Note 15, “Subsequent Events” for additional information regarding the final maturity dates for two of the mortgage notes payable in the Watermark Aqua Portfolio. (2) Floating rate borrowings are comprised of $171.7 million principal amount at one-month LIBOR. (3) The difference between principal amount and carrying value of mortgage notes payable is attributable to deferred financing costs, net for all borrowings, other than the Winterfell portfolio which is attributable to below market debt intangibles. (4) Comprised of seven individual mortgage notes payable secured by seven healthcare real estate properties, cross-collateralized and subject to cross-default. (5) Comprised of four individual mortgage notes payable secured by four healthcare real estate properties, cross-collateralized and subject to cross-default. (6) Includes $386.6 million principal amount of fixed rate borrowings, secured by 14 healthcare real estate properties, cross-collateralized and subject to cross-default, as well as a supplemental financing totaling $73.4 million of principal, secured by seven healthcare real estate properties, cross-collateralized and subject to cross-default. (7) Comprised of 32 individual mortgage notes payable secured by 32 healthcare real estate properties, cross-collateralized and subject to cross-default. (8) Comprised of five individual mortgage notes payable secured by five healthcare real estate properties, cross-collateralized and subject to cross-default. The following table presents future scheduled principal payments on mortgage and other notes payable based on final maturity (dollars in thousands): Years Ending December 31: 2021 $ 79,696 2022 467,008 2023 19,696 2024 20,406 2025 670,302 Thereafter 178,276 Total $ 1,435,384 As of December 31, 2020, the operator for the Arbors portfolio failed to remit rent timely and comply with other contractual terms of its lease agreement, which resulted in a default under the operator’s lease, which in turn, resulted in a default under the mortgage notes collateralized by the properties. The Company is currently in discussions with the operator regarding the lease default. In response to the operational challenges resulting from the COVID-19 pandemic, the Company entered into forbearance agreements effective May 1, 2020 to defer up to 90 days of contractual debt service for borrowings on properties within the Aqua, Rochester, Arbors, Winterfell and Fountains portfolios. The aggregate outstanding principal amount of these borrowings totaled $1.3 billion as of December 31, 2020. The deferred debt service must be repaid over the 12 months following the forbearance period with no additional interest or penalties incurred by the Company, subject to satisfaction of certain conditions. The deferral of payments ended on August 1, 2020 and the Company has resumed remitting debt service, together with the deferred debt service, on these mortgage notes payable. As a result, these borrowings remain in technical default and are subject to the terms of the forbearance agreements until all deferred debt service is repaid. The Company entered into an additional forbearance agreement effective July 1, 2020 to defer up to 90 days of interest and 120 days of contractual principal payments for a mortgage note payable on a property within the Rochester portfolio. The forbearance agreement also temporarily waives financial covenants under the mortgage note, which the property has failed to maintain as of December 31, 2020. The outstanding principal amount of the mortgage note payable was $19.9 million as of December 31, 2020. The deferred debt service must be repaid over the 12 months following the forbearance period with no additional interest or penalties incurred by the Company, subject to satisfaction of certain conditions. The deferral of payments ended on December 31, 2020 and the Company has resumed remitting debt service, together with the deferred debt service, on this mortgage note payable. As a result, this borrowing remains in technical default and is subject to the terms of the forbearance agreements until all deferred debt service is repaid. Line of Credit - Related Party The following table presents the Company’s borrowings under the Sponsor line of credit as of December 31, 2020 (dollars in thousands): Capacity Principal Outstanding Contractual Interest Rate Maturity Date Sponsor Line of Credit $ 35,000 $ 35,000 LIBOR + 3.50% Dec 2022 In October 2017, the Company obtained a revolving line of credit from an affiliate of Colony Capital, the Sponsor, for up to $15.0 million at an interest rate of 3.5% plus LIBOR (the “Sponsor Line”). The Sponsor Line had an initial one year term, with an extension option of six months. In November 2017, the borrowing capacity under the Sponsor Line was increased to $35.0 million. In March 2018, the Sponsor Line maturity date was extended through December 2020, and in May 2019, the maturity date was further extended through December 2021. In July 2020, the maturity date was extended through December 2022. In April 2020, the Company borrowed $35.0 million under the Sponsor Line to improve its liquidity position as a result of the COVID-19 pandemic. Interest expense on the Company’s consolidated statements of operations includes $0.9 million related to the Sponsor Line for the year ended December 31, 2020.

Related Party Arrangements

Related Party Arrangements	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Arrangements	Related Party Arrangements Advisor Subject to certain restrictions and limitations, the Advisor is responsible for managing the Company’s affairs on a day-to-day basis and for identifying, acquiring, originating and asset managing investments on behalf of the Company. The Advisor may delegate certain of its obligations to affiliated entities, which may be organized under the laws of the United States or foreign jurisdictions. References to the Advisor include the Advisor and any such affiliated entities. For such services, to the extent permitted by law and regulations, the Advisor receives fees and reimbursements from the Company. Pursuant to the advisory agreement, the Advisor may defer or waive fees in its discretion. Below is a description and table of the fees and reimbursements incurred to the Advisor. In June 2020, the advisory agreement was renewed for an additional one-year term commencing on June 30, 2020, with terms identical to those in effect through June 30, 2020, but for the elimination of disposition fees. Fees to Advisor Asset Management Fee Effective January 1, 2018, the Advisor receives a monthly asset management fee equal to one-twelfth of 1.5% of the Company’s most recently published aggregate estimated net asset value, as may be subsequently adjusted for any special distribution declared by the board of directors in connection with a sale, transfer or other disposition of a substantial portion of the Company’s assets, with $2.5 million per calendar quarter of such fee paid in shares of the Company’s common stock at a price per share equal to the most recently published net asset value per share. The Advisor has also agreed that all shares of the Company’s common stock issued to it in consideration of the asset management fee will be subordinate in the Company’s share repurchase program (the “Share Repurchase Program”) to shares of the Company’s common stock held by third party stockholders for a period of two years, unless the advisory agreement is earlier terminated. Incentive Fee The Advisor is entitled to receive distributions equal to 15.0% of net cash flows of the Company, whether from continuing operations, repayment of loans, disposition of assets or otherwise, but only after stockholders have received, in the aggregate, cumulative distributions equal to their invested capital plus a 6.75% cumulative, non-compounded annual pre-tax return on such invested capital. From inception through December 31, 2020, the Advisor has not received any incentive fees from the Company. Acquisition Fee Effective January 1, 2018, the Advisor no longer receives an acquisition fee in connection with the Company’s acquisitions of real estate properties or debt investments. Disposition Fee For substantial assistance in connection with the sale of investments and based on the services provided, as determined by the Company’s independent directors, the Advisor could have received a disposition fee of 2.0% of the contract sales price of each property sold and 1.0% of the contract sales price of each debt investment sold. The Company did not pay a disposition fee upon the maturity, prepayment, workout, modification or extension of a debt investment unless there was a corresponding fee paid by the borrower, in which case the disposition fee was the lesser of: (i) 1.0% of the principal amount of the debt investment prior to such transaction; or (ii) the amount of the fee paid by the borrower in connection with such transaction. If the Company took ownership of a property as a result of a workout or foreclosure of a debt investment, the Company paid a disposition fee upon the sale of such property. A disposition fee from the sale of an investment was generally expensed and included in asset management and other fees - related party in the Company’s consolidated statements of operations. A disposition fee for a debt investment incurred in a transaction other than a sale was included in debt investments, net on the consolidated balance sheets and was amortized to interest income over the life of the investment using the effective interest method. Effective June 30, 2020, the Advisor no longer has the potential to receive a disposition fee in connection with the sale of real estate properties or debt investments. Reimbursements to Advisor Operating Costs The Advisor is entitled to receive reimbursement for direct and indirect operating costs incurred by the Advisor in connection with administrative services provided to the Company. The Advisor allocates, in good faith, indirect costs to the Company related to the Advisor’s and its affiliates’ employees, occupancy and other general and administrative costs and expenses in accordance with the terms of, and subject to the limitations contained in, the advisory agreement with the Advisor. The indirect costs include the Company’s allocable share of the Advisor’s compensation and benefit costs associated with dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company’s affairs, based upon the percentage of time devoted by such personnel to the Company’s affairs. The indirect costs also include rental and occupancy, technology, office supplies, travel and entertainment and other general and administrative costs and expenses. However, there is no reimbursement for personnel costs related to executive officers (although there may be reimbursement for certain executive officers of the Advisor) and other personnel involved in activities for which the Advisor receives an acquisition fee or a disposition fee. The Advisor allocates these costs to the Company relative to its and its affiliates’ other managed companies in good faith and has reviewed the allocation with the Company’s board of directors, including its independent directors. The Advisor updates the board of directors on a quarterly basis of any material changes to the expense allocation and provides a detailed review to the board of directors, at least annually, and as otherwise requested by the board of directors. The Company reimburses the Advisor quarterly for operating costs (including the asset management fee) based on a calculation for the four preceding fiscal quarters not to exceed the greater of: (i) 2.0% of its average invested assets; or (ii) 25.0% of its net income determined without reduction for any additions to reserves for depreciation, loan losses or other similar non-cash reserves and excluding any gain from the sale of assets for that period. Notwithstanding the above, the Company may reimburse the Advisor for expenses in excess of this limitation if a majority of the Company’s independent directors determines that such excess expenses are justified based on unusual and non-recurring factors. The Company calculates the expense reimbursement quarterly based upon the trailing twelve-month period. Summary of Fees and Reimbursements The following tables present the fees and reimbursements incurred and paid to the Advisor (dollars in thousands): Type of Fee or Reimbursement Due to Related Party as of December 31, 2019 Year Ended December 31, 2020 Due to Related Party as of December 31, 2020 Financial Statement Location Incurred Paid Fees to Advisor Entities (1) Asset management (2) Asset management and other fees-related party $ 1,477 $ 17,170 $ (17,724) (2) $ 923 Reimbursements to Advisor Entities Operating costs (3) General and administrative expenses 4,303 14,682 (11,590) 7,395 Total $ 5,780 $ 31,852 $ (29,314) $ 8,318 _______________________________________ (1) Effective June 30, 2020, our Advisor no longer has the potential to receive a disposition fee in connection with the sale of real estate properties or debt investments. The Company did not incur any disposition fees during the year ended December 31, 2020, nor were any such fees outstanding as of December 31, 2020. (2) Includes $9.7 million paid in shares of the Company’s common stock and a $0.3 million gain recognized on the settlement of the share-based payment. (3) As of December 31, 2020, the Advisor did not have any unreimbursed operating costs which remained eligible to be allocated to the Company. Type of Fee or Reimbursement Due to Related Party as of December 31, 2018 Year Ended December 31, 2019 Due to Related Party as of December 31, 2019 Financial Statement Location Incurred Paid Fees to Advisor Entities (1) Asset management (2) Asset management and other fees-related party $ 1,665 $ 19,789 $ (19,977) (2) $ 1,477 Reimbursements to Advisor Entities Operating costs (3) General and administrative expenses 4,010 11,892 (11,599) 4,303 Total $ 5,675 $ 31,681 $ (31,576) $ 5,780 _______________________________________ (1) The Company did not incur any disposition fees during the year ended December 31, 2019, nor were any such fees outstanding as of December 31, 2019. (2) Includes $9.9 million paid in shares of the Company’s common stock and a $0.1 million gain recognized on the settlement of the share-based payment. (3) As of December 31, 2019, the Advisor did not have any unreimbursed operating costs which remained eligible to be allocated to the Company. Pursuant to the advisory agreement, for the year ended December 31, 2020, the Company issued 1.6 million shares totaling $9.7 million, based on the estimated value per share on the date of each issuance, to an affiliate of the Advisor as part of its asset management fee. As of December 31, 2020, the Advisor, the Sponsor and their affiliates owned a total of 4.7 million shares or $18.3 million of the Company’s common stock based on the Company’s most recent estimated value per share. As of December 31, 2020, the Advisor, the Sponsor and their affiliates owned 2.1% of the total outstanding shares of the Company’s common stock. Investments in Joint Ventures Solstice, the manager of the Winterfell portfolio, is a joint venture between affiliates of ISL, which owns 80.0%, and the Company, which owns 20.0%. For the year ended December 31, 2020, the Company recognized property management fee expense of $5.0 million paid to Solstice related to the Winterfell portfolio. The below table indicates the Company’s investments for which Colony Capital is also an equity partner in the joint venture. Each investment was approved by the Company’s board of directors, including all of its independent directors. Refer to Note 4, “Investments in Unconsolidated Ventures” for further discussion of these investments: Portfolio Partner(s) Acquisition Date Ownership Eclipse Colony Capital/Formation Capital, LLC May 2014 5.6% Diversified US/UK (Formerly Griffin-American) Colony Capital December 2014 14.3% In connection with the acquisition of the Diversified US/UK (formerly Griffin-American) portfolio by NorthStar Realty Finance Corp. (“NorthStar Realty”), now a subsidiary of Colony Capital, and the Company, the Sponsor acquired a 43.0%, as adjusted, ownership interest in American Healthcare Investors, LLC (“AHI”). In December 2015, the Company, through a joint venture with Griffin-American Healthcare REIT III, Inc., a REIT sponsored and advised by AHI, acquired a 29.0% interest in the Trilogy portfolio, a $1.2 billion healthcare portfolio and contributed $201.7 million for its interest. The purchase was approved by the Company’s board of directors, including all of its independent directors. In October 2018, the Company sold 20.0% of its ownership interest in the Trilogy joint venture, which generated gross proceeds of $48.0 million and reduced its ownership interest in the joint venture from approximately 29% to 23%. The Company sold the ownership interest to a wholly-owned subsidiary of the operating partnership of Griffin-American Healthcare REIT IV, Inc., a REIT sponsored by AHI. Mezzanine Loan In July 2015, the Company originated a $75.0 million mezzanine loan to a subsidiary of the Espresso joint venture, of which the Company owns a minority interest. Refer to Note 5, “Real Estate Debt Investments” for further discussion. Line of Credit - Related Party The Company has the Sponsor Line, which provides up to $35.0 million at an interest rate of 3.5% plus LIBOR. Refer to Note 6, “Borrowings” for further discussion.

Equity-Based Compensation

Equity-Based Compensation	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Equity-Based Compensation	Equity-Based Compensation The Company adopted a long-term incentive plan, as amended (the “Plan”), which it may use to attract and retain qualified officers, directors, employees and consultants, as well as an independent directors compensation plan, which is a component of the Plan. Under the Plan, 2.0 million shares of restricted common stock were eligible to be issued. Pursuant to the Plan, as of December 31, 2020, the Company’s independent directors were granted a total of 159,932 shares of restricted common stock for an aggregate $1.3 million, based on the share price on the date of each grant. The restricted stock granted prior to 2015 generally vested quarterly over four years and the restricted stock granted in and subsequent to 2015 generally vests quarterly over two years. However, the stock will become fully vested on the earlier occurrence of: (i) the termination of the independent director’s service as a director due to his or her death or disability; or (ii) a change in control of the Company. The Company recognized equity-based compensation expense of $0.2 million, for the years ended December 31, 2020, 2019 and 2018, respectively. Equity-based compensation expense is related to the issuance of restricted stock to the independent directors

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The Company stopped accepting subscriptions for its Offering on December 17, 2015 and all of the shares initially registered for its Offering were issued on or before January 19, 2016. The Company issued 173.4 million shares of common stock generating gross proceeds of $1.7 billion, excluding proceeds from the DRP. Distribution Reinvestment Plan The Company adopted the DRP through which common stockholders may elect to reinvest an amount equal to the distributions declared on their shares in additional shares of the Company’s common stock in lieu of receiving cash distributions. The purchase price under the Company’s Initial DRP was $9.50. In connection with its determination of the offering price for shares of the Company’s common stock in the follow-on offering, the board of directors determined that distributions may be reinvested in shares of the Company’s common stock at a price of $9.69 per share, which was approximately 95% of the offering price of $10.20 per share established for purposes of the follow-on offering. In April 2016, the board of directors determined that distributions may be reinvested in shares of the Company’s common stock at a price equal to the most recent estimated value per share of the shares of common stock. The following table presents the price at which dividends were invested based on when the price became effective: Effective Date Estimated Value per Share Valuation Date April 2016 $ 8.63 12/31/2015 December 2016 9.10 6/30/2016 December 2017 8.50 6/30/2017 December 2018 7.10 6/30/2018 December 2019 6.25 6/30/2019 December 2020 3.89 6/30/2020 No selling commissions or dealer manager fees were paid on shares issued pursuant to the DRP. The board of directors of the Company may amend, suspend or terminate the DRP for any reason upon ten-days’ notice to participants, except that the Company may not amend the DRP to eliminate a participant’s ability to withdraw from the DRP. For the year ended December 31, 2020, the Company has not issued shares of common stock pursuant to the DRP. From inception through December 31, 2020, the Company issued 25.7 million shares of common stock, generating gross offering proceeds of $232.6 million pursuant to the DRP. Distributions From inception through December 31, 2017, distributions to stockholders were declared quarterly by the board of directors of the Company and paid monthly based on a daily amount of $0.00184932 per share, equivalent to an annualized distribution amount of $0.675 per share of the Company’s common stock. During the year ended December 31, 2018, the Company’s board of directors approved daily cash distributions of $0.000924658 per share of common stock, equivalent to an annualized distribution amount of $0.3375 per share. The Company’s board of directors approved daily cash distributions of $0.000924658 per share of common stock for the month ending January 31, 2019. Effective February 1, 2019, the Company’s board of directors determined to suspend distributions in order to preserve capital and liquidity. Distributions were generally paid to stockholders on the first business day of the month following the month for which the distribution was accrued. No distributions were declared during the year ended December 31, 2020. The following table presents distributions declared for the years ended December 31, 2019 and 2018 (dollars in thousands): Distributions (1) Period Cash DRP Total 2019 First Quarter $ 2,991 $ 2,422 $ 5,413 Second Quarter — — — Third Quarter — — — Fourth Quarter — — — Total $ 2,991 $ 2,422 $ 5,413 2018 First Quarter $ 7,684 $ 7,876 $ 15,560 Second Quarter 8,028 7,722 15,750 Third Quarter 8,374 7,567 15,941 Fourth Quarter 8,653 7,352 16,005 Total $ 32,739 $ 30,517 $ 63,256 _______________________________________ (1) Represents distributions declared for the period, even though such distributions are actually paid to stockholders in the month following such period. In order to continue to qualify as a REIT, the Company must distribute annually dividends equal to at least 90% of its REIT taxable income (with certain adjustments). For the year ended December 31, 2020, the Company generated net operating losses for tax purposes. The Company did not have positive REIT taxable income for its taxable year ending December 31, 2019, therefore, it was not required to make distributions to its stockholders in 2019 to qualify as a REIT. The Company’s most recently filed tax return is for the year ended December 31, 2019 and includes a net operating loss carry-forward of $86.0 million. Share Repurchase Program The Company adopted the Share Repurchase Program that enabled stockholders to sell their shares to the Company in limited circumstances. The Company is not obligated to repurchase shares under the Share Repurchase Program. The Company may amend, suspend or terminate the Share Repurchase Program at its discretion at any time, subject to certain notice requirements. In October 2018, the Company’s board of directors approved an amended and restated Share Repurchase Program, under which the Company only repurchased shares in connection with the death or qualifying disability of a stockholder at a price equal to the lesser of the price paid for the shares, as adjusted for any stock dividends, combinations, splits, recapitalizations or any similar transactions, or the most recently published estimated value per share. The amended and restated Share Repurchase Program became effective October 29, 2018. In April 2020, the Company’s board of directors determined to suspend all repurchases under the Share Repurchase Program effective April 30, 2020 in order to preserve capital and liquidity. For the year ended December 31, 2020, the Company repurchased 0.3 million shares of common stock for $2.1 million at an average price of $6.29 per share. For the year ended December 31, 2019, the Company repurchased 1.5 million shares of common stock for $10.7 million at an average price of $7.10 per share pursuant to the Share Repurchase Program.

Non-controlling Interests

Non-controlling Interests	12 Months Ended
	Dec. 31, 2020
Noncontrolling Interest [Abstract]
Non-controlling Interests	Non-controlling Interests Operating Partnership Non-controlling interests include the aggregate limited partnership interests in the Operating Partnership held by limited partners, other than the Company. Income (loss) attributable to the non-controlling interests is based on the limited partners’ ownership percentage of the Operating Partnership. Income (loss) allocated to the Operating Partnership non-controlling interests for the years ended December 31, 2020, 2019 and 2018 was de minimis. Other

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Fair Value Measurement The fair value of financial instruments is categorized based on the priority of the inputs to the valuation technique and categorized into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. Financial assets and liabilities recorded at fair value on the consolidated balance sheets are categorized based on the inputs to the valuation techniques as follows: Level 1. Quoted prices for identical assets or liabilities in an active market. Level 2. Financial assets and liabilities whose values are based on the following: a) Quoted prices for similar assets or liabilities in active markets. b) Quoted prices for identical or similar assets or liabilities in non-active markets. c) Pricing models whose inputs are observable for substantially the full term of the asset or liability. d) Pricing models whose inputs are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability. Level 3. Prices or valuation techniques based on inputs that are both unobservable and significant to the overall fair value measurement. Fair Value of Financial Instruments U.S. GAAP requires disclosure of fair value about all financial instruments. The following disclosure of estimated fair value of financial instruments was determined by the Company using available market information and appropriate valuation methodologies. Considerable judgment is necessary to interpret market data and develop estimated fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize on disposition of the financial instruments. The use of different market assumptions and/or estimation methodologies may have a material effect on estimated fair value. The following table presents the principal amount, carrying value and fair value of certain financial assets and liabilities (dollars in thousands): December 31, 2020 December 31, 2019 Principal Amount Carrying Value Fair Value Principal Amount Carrying Value Fair Value Financial assets: (1) Real estate debt investments, net $ 74,182 $ 55,864 $ 74,182 $ 74,182 $ 55,468 $ 74,182 Financial liabilities: (1) Mortgage and other notes payable, net $ 1,435,384 $ 1,416,871 $ 1,354,832 $ 1,455,413 $ 1,431,922 $ 1,450,876 Line of credit - related party 35,000 35,000 35,000 — — — _______________________________________ (1) The fair value of other financial instruments not included in this table is estimated to approximate their carrying value. Disclosure about fair value of financial instruments is based on pertinent information available to management as of the reporting date. Although management is not aware of any factors that would significantly affect fair value, such amounts have not been comprehensively revalued for purposes of these consolidated financial statements since that date and current estimates of fair value may differ significantly from the amounts presented herein. Real Estate Debt Investments, Net The Company’s real estate debt investment’s fair value was determined by comparing the current yield to the estimated yield for newly originated loans with similar credit risk or the market yield at which a third party might expect to purchase such investment; or based on discounted cash flow projections of principal and interest expected to be collected, which includes consideration of the financial standing of the borrower or sponsor as well as operating results of the underlying collateral. As of the reporting date, the Company believes that principal amount approximates fair value. The fair value measurement of the Company’s real estate debt investment is generally based on unobservable inputs, and as such, are classified as Level 3 of the fair value hierarchy. Mortgage and Other Notes Payable, Net and Line of Credit - Related Party The Company primarily uses rates currently available with similar terms and remaining maturities to estimate fair value. These measurements are determined using comparable U.S. Treasury and LIBOR rates as of the end of the reporting period. These fair value measurements are based on observable inputs, and as such, are classified as Level 2 of the fair value hierarchy. Nonrecurring Fair Values The Company measures fair value of certain assets on a nonrecurring basis when events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Adjustments to fair value generally result from the application of lower of amortized cost or fair value accounting for assets held for sale or otherwise, write-down of asset values due to impairment. The following table summarizes the fair value, measured at the time of impairment, of Level 3 assets which have been measured at fair value on a nonrecurring basis during the periods presented and the associated impairment losses (dollars in thousands): Year Ended December 31, 2020 2019 2018 Fair Value Impairment Losses Fair Value Impairment Losses Fair Value Impairment Losses Operating real estate, net $ 234,650 $ 164,215 $ 58,804 $ 27,021 $ 47,955 $ 31,000 Assets held for sale 5,000 1,753 1,649 533 2,183 2,494 Operating Real Estate, Net Operating real estate that is impaired is carried at fair value at the time of impairment. Impairment was driven by various factors that impacted undiscounted future net cash flows, including declines in operating performance, market growth assumptions, and expected margins to be generated by the properties. Fair value of impaired operating real estate was estimated based upon various approaches including discounted cash flow analysis using terminal capitalization rates ranging from 6.00% to 7.75% and discount rates ranging from 7.0% to 8.75%, third party appraisals, offer prices or broker opinions of value. Assets Held For Sale

Quarterly Financial Information

Quarterly Financial Information (Unaudited)	12 Months Ended
	Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information (Unaudited)	Quarterly Financial Information (Unaudited) The following tables present select quarterly information for the years ended December 31, 2020 and 2019 (dollars in thousands, except per share data): Three Months Ended December 31, September 30, June 30, March 31, 2020 2020 2020 2020 Property and other revenues $ 66,841 $ 67,755 $ 69,308 $ 72,891 Net interest income 1,936 1,927 1,906 1,905 Real estate properties - operating expenses 46,648 46,501 45,328 45,701 Impairment loss 74,531 — 91,437 — Expenses 165,333 86,782 176,432 86,336 Equity in earnings (losses) of unconsolidated ventures 2,333 (1,043) (34,763) (993) Net income (loss) (93,538) (18,158) (139,995) (12,547) Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders (91,709) (17,987) (139,281) (12,481) Net income (loss) per share of common stock, basic/diluted (1) $ (0.48) $ (0.09) $ (0.74) $ (0.07) _______________________________________ (1) The total for the year may differ from the sum of the quarters as a result of weighting. Three Months Ended December 31, September 30, June 30, March 31, 2019 2019 2019 2019 Property and other revenues $ 72,907 $ 72,778 $ 74,972 $ 72,521 Net interest income 1,932 1,946 1,923 1,902 Real estate properties - operating expenses 46,001 45,359 44,636 45,218 Impairment loss 17,408 — 10,146 — Expenses 106,235 86,571 95,420 93,099 Equity in earnings (losses) of unconsolidated ventures 4,121 (3,037) (4,405) (224) Net income (loss) (26,924) (14,697) (17,460) (18,669) Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders (26,573) (14,624) (17,146) (18,617) Net income (loss) per share of common stock, basic/diluted (1) $ (0.13) $ (0.08) $ (0.09) $ (0.10) _______________________________________ (1) The total for the year may differ from the sum of the quarters as a result of weighting.

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Segment Reporting	Segment Reporting The Company conducts its business through the following five segments, which are based on how management reviews and manages its business. • Direct Investments - Net Lease - Healthcare properties operated under net leases with an operator. • Direct Investments - Operating - Healthcare properties operated pursuant to management agreements with healthcare managers. • Unconsolidated Investments - Healthcare joint ventures, including properties operated under net leases with operators or pursuant to management agreements with healthcare managers, in which the Company owns a minority interest. • Debt and Securities Investments - Mortgage loans or mezzanine loans to owners of healthcare real estate and commercial mortgage backed securities backed primarily by loans secured by healthcare properties. • Corporate - The corporate segment includes corporate level asset management and other fees - related party and general and administrative expenses. The Company primarily generates rental and resident fee income from its direct investments and interest income on real estate debt and securities investments. The following table presents the operators and managers of the Company’s properties, excluding properties owned through unconsolidated joint ventures (dollars in thousands): Year Ended December 31, 2020 Operator / Manager Properties Under Management Units Under Management (1) Property and Other Revenues (2) % of Total Property and Other Revenues Watermark Retirement Communities 30 5,265 $ 138,708 50.3 % Solstice Senior Living (3) 32 4,000 101,054 36.7 % Avamere Health Services 5 453 17,367 6.3 % Arcadia Management 4 572 10,615 3.9 % Integral Senior Living (4) 1 44 7,405 2.7 % Senior Lifestyle Corporation (5) 1 63 — — % Other (6) — — 199 0.1 % Total 73 10,397 $ 275,348 100.0 % ______________________________________ (1) Represents rooms for ALFs and ILFs and beds for MCFs and SNFs, based on predominant type. (2) Includes rental income received from the Company’s net lease properties as well as rental income, ancillary service fees and other related revenue earned from ILF residents and resident fee income derived from the Company’s ALFs, MCFs and CCRCs, which includes resident room and care charges, ancillary fees and other resident service charges. (3) Solstice is a joint venture of which affiliates of ISL own 80%. (4) Property count and units excludes two ISL properties designated as held for sale as of December 31, 2020. (5) Operator has failed to remit rental payments during the year ended December 31, 2020. (6) Consists primarily of interest income earned on corporate-level cash accounts. The following tables present segment reporting (dollars in thousands): Direct Investments Year Ended December 31, 2020 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total Property and other revenues $ 32,899 $ 242,250 $ — $ — $ 199 $ 275,348 Interest income on debt investments — — — 7,674 — 7,674 Real estate properties - operating expenses (13) (184,165) — — — (184,178) Interest expense (11,832) (53,210) — — (949) (65,991) Transaction costs (58) (7) — — — (65) Asset management and other fees - related party — — — — (17,170) (17,170) General and administrative expenses (804) (296) — (19) (15,386) (16,505) Depreciation and amortization (14,940) (50,066) — — — (65,006) Impairment loss (722) (165,246) — — — (165,968) Other income — 1,840 — — — 1,840 Realized gain (loss) on investments and other — (13) — — 315 302 Equity in earnings (losses) of unconsolidated ventures — — (34,466) — — (34,466) Income tax expense — (53) — — — (53) Net income (loss) $ 4,530 $ (208,966) $ (34,466) $ 7,655 $ (32,991) $ (264,238) Direct Investments Year Ended December 31, 2019 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total Property and other revenues $ 33,424 $ 259,033 $ — $ 35 $ 686 $ 293,178 Interest income on debt investments — — — 7,703 — 7,703 Real estate properties - operating expenses (11) (181,203) — — — (181,214) Interest expense (12,434) (56,360) — — (102) (68,896) Transaction costs — (122) — — — (122) Asset management and other fees - related party — — — — (19,789) (19,789) General and administrative expenses (268) (42) — (38) (12,413) (12,761) Depreciation and amortization (14,329) (56,660) — — — (70,989) Impairment loss (4,132) (23,422) — — — (27,554) Realized gain (loss) on investments and other 5,872 719 — — (277) 6,314 Equity in earnings (losses) of unconsolidated ventures — — (3,545) — — (3,545) Income tax benefit (expense) — (75) — — — (75) Net income (loss) $ 8,122 $ (58,132) $ (3,545) $ 7,700 $ (31,895) $ (77,750) _______________________________________ (1) Includes unallocated asset management fee-related party and general and administrative expenses. Direct Investments Year Ended December 31, 2018 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Subtotal Investing VIE (2) Total Property and other revenues $ 34,276 $ 258,779 $ — $ 375 $ 841 $ 294,271 $ — $ 294,271 Net interest income — — — 8,534 (314) (3) 8,220 811 9,031 Real estate properties - operating expenses (1,346) (187,415) — — — (188,761) — (188,761) Interest expense (13,326) (56,595) — — (275) (70,196) — (70,196) Other expenses related to securitization trust — — — — — — (811) (811) Transaction costs (60) (828) — — — (888) — (888) Asset management and other fees - related party — — — — (23,478) (23,478) — (23,478) General and administrative expenses (183) (856) (2) (46) (13,303) (14,390) — (14,390) Depreciation and amortization (13,694) (93,439) — — — (107,133) — (107,133) Impairment loss (5,094) (31,183) — — — (36,277) — (36,277) Unrealized gain (loss) on mortgage loans held in securitization trust, net — — — (314) 314 (3) — — — Realized gain (loss) on investments and other — 2,525 14,086 3,495 137 20,243 — 20,243 Equity in earnings (losses) of unconsolidated ventures — — (33,517) — — (33,517) — (33,517) Income tax benefit (expense) — (114) — — — (114) — (114) Net income (loss) $ 573 $ (109,126) $ (19,433) $ 12,044 $ (36,078) $ (152,020) $ — $ (152,020) _______________________________________ (1) Includes unallocated asset management fee-related party and general and administrative expenses. (2) Investing VIEs are not considered to be a segment that the Company conducts its business through, however U.S. GAAP requires the Company, as the primary beneficiary, to present the assets and liabilities of the securitization trust on its consolidated balance sheets and recognize the related interest income and interest expense, as net interest income on the consolidated statements of operations. Though U.S. GAAP requires this presentation, the Company views its investment in the securitization trust as a net investment in debt and securities. (3) Represents income earned from the healthcare-related securities purchased at a discount, recognized using the effective interest method had the transaction been recorded as an available for sale security, at amortized cost. During the year ended December 31, 2018, $0.3 million was attributable to discount accretion income and was eliminated in consolidation in the corporate segment. The following table presents total assets by segment (dollars in thousands): Direct Investments Total Assets: Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total December 31, 2020 $ 348,688 $ 1,223,045 $ 229,170 $ 56,502 $ 61,031 $ 1,918,436 December 31, 2019 365,789 1,420,023 268,892 56,099 30,404 2,141,207 ______________________________________

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of December 31, 2020, the Company believes there are no material contingencies that would affect its results of operations, cash flows or financial position. Litigation and Claims The Company may be involved in various litigation matters arising in the ordinary course of its business. Although the Company is unable to predict with certainty the eventual outcome of any litigation, any current legal proceedings are not expected to have a material adverse effect on its financial position or results of operations. The Company’s tenants, operators and managers may be involved in various litigation matters arising in the ordinary course of their business. The unfavorable resolution of any such actions, investigations or claims could, individually or in the aggregate, materially adversely affect such tenants’, operators’ or managers’ liquidity, financial condition or results of operations and their ability to satisfy their respective obligations to the Company, which, in turn, could have a material adverse effect on the Company. Environmental Matters The Company follows a policy of monitoring its properties for the presence of hazardous or toxic substances. While there can be no assurance that a material environmental liability does not exist at its properties, the Company is not currently aware of any environmental liability with respect to its properties that would have a material effect on its consolidated financial position, results of operations or cash flows. Further, the Company is not aware of any material environmental liability or any unasserted claim or assessment with respect to an environmental liability that it believes would require additional disclosure or the recording of a loss contingency. General Uninsured Losses The Company obtains various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental and terrorism related losses. The Company attempts to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically insurable. Other

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsThe following is a discussion of material events which have occurred subsequent to December 31, 2020 through the issuance of the consolidated financial statements. Borrowings In January 2021, the Company refinanced an existing $18.7 million mortgage note payable, collateralized by a property within the Aqua portfolio, with a $26.0 million mortgage note payable. The new mortgage note carries a fixed interest rate of 3.0% through February 2024 and has initial maturity date of February 2026. In January 2021, the Company extended the maturity date of a mortgage note payable for a property within the Aqua portfolio from February 2021 to April 2021. The outstanding principal amount of the mortgage note payable was $20.2 million as of December 31, 2020. Real Estate Debt Investments From January 1, 2021 through March 18, 2021 , we have received principal repayments on our mezzanine loan debt investment which total $24.9 million. The borrower funded these principal repayments through net proceeds generated from the sale of underlying collateral and available operating cash flow. COIVD-19 Provider Relief Funding

Schedule III - Real Estate and

Schedule III - Real Estate and Accumulated Depreciation	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
Schedule III - Real Estate and Accumulated Depreciation	SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION December 31, 2020 (Dollars in Thousands) Column A Column B Column C Initial Cost Column D Capitalized Subsequent to Acquisition (1) Column E Gross Amount Carried at Close of Period (2) Column F Column G Column H Location City, State Encumbrances Land Building & Improvements Land, Buildings & Improvements Land Building & Improvements Total Accumulated Depreciation Total Date Acquired Life on Which Depreciation is Computed Net Lease Portfolio Smyrna, GA $ — $ 825 $ 9,175 $ (5,730) $ 825 $ 3,445 $ 4,270 $ 1,561 $ 2,709 Dec-13 40 years Bohemia, NY 23,214 4,258 27,805 160 4,258 27,965 32,223 5,050 27,173 Sep-14 40 years Hauppauge, NY 14,084 2,086 18,495 1,351 2,086 19,846 21,932 3,829 18,103 Sep-14 40 years Islandia, NY 34,670 8,437 37,198 291 8,437 37,489 45,926 6,904 39,022 Sep-14 40 years Westbury, NY 15,334 2,506 19,163 293 2,506 19,456 21,962 3,466 18,496 Sep-14 40 years Bellevue, WA 29,763 13,801 18,208 4,092 13,801 22,300 36,101 5,248 30,853 Jun-15 40 years Dana Point, CA 31,552 6,286 41,199 727 6,286 41,926 48,212 6,891 41,321 Jun-15 40 years Kalamazoo, MI 33,520 4,521 30,870 2,987 4,521 33,857 38,378 7,188 31,190 Jun-15 40 years Oklahoma City, OK 2,890 3,104 6,119 1,477 3,104 7,596 10,700 2,765 7,935 Jun-15 40 years Palm Desert, CA 19,901 5,365 38,889 2,981 5,365 41,870 47,235 8,422 38,813 Jun-15 40 years Sarasota, FL 72,029 12,845 64,403 4,985 12,845 69,388 82,233 13,326 68,907 Jun-15 40 years Seniors Housing Operating Portfolio Milford, OH 18,760 1,160 14,440 1,767 1,160 16,207 17,367 3,869 13,498 Dec-13 40 years Milford, OH — 700 — 5,603 700 5,603 6,303 384 5,919 Jul-17 40 years Denver, CO 20,189 4,300 27,200 (10,248) 4,300 16,952 21,252 7,409 13,843 Jan-14 40 years Frisco, TX 18,770 3,100 35,874 2,646 3,100 38,520 41,620 7,440 34,180 Feb-14 40 years Alexandria, VA 43,679 7,950 41,124 2,800 7,950 43,924 51,874 7,516 44,358 Jun-15 40 years Crystal Lake, IL 26,657 6,580 28,210 (894) 6,580 27,316 33,896 5,483 28,413 Jun-15 40 years Independence, MO 15,051 1,280 17,090 (1,692) 1,280 15,398 16,678 3,649 13,029 Jun-15 40 years Millbrook, NY 23,951 6,610 20,854 (2,123) 6,610 18,731 25,341 5,198 20,143 Jun-15 40 years St. Petersburg, FL 39,375 8,920 44,137 (19,577) 8,920 24,560 33,480 9,305 24,175 Jun-15 40 years Tarboro, NC 21,854 2,400 17,800 1,749 2,400 19,549 21,949 4,512 17,437 Jun-15 40 years Tuckahoe, NY 35,846 4,870 26,980 1,627 4,870 28,607 33,477 4,746 28,731 Jun-15 40 years Tucson, AZ 63,978 7,370 60,719 5,990 7,370 66,709 74,079 11,931 62,148 Jun-15 40 years Apple Valley, CA 20,956 1,168 24,625 (7,482) 1,168 17,143 18,311 3,815 14,496 Mar-16 40 years Auburn, CA 23,675 1,694 18,438 1,233 1,694 19,671 21,365 3,407 17,958 Mar-16 40 years Austin, TX 26,068 4,020 19,417 2,435 4,020 21,852 25,872 3,724 22,148 Mar-16 40 years Bakersfield, CA 16,543 1,831 21,006 1,319 1,831 22,325 24,156 3,761 20,395 Mar-16 40 years Bangor, ME 21,130 2,463 23,205 952 2,463 24,157 26,620 3,978 22,642 Mar-16 40 years Bellingham, WA 23,462 2,242 18,807 1,566 2,242 20,373 22,615 3,443 19,172 Mar-16 40 years Clovis, CA 18,464 1,821 21,721 715 1,821 22,436 24,257 3,644 20,613 Mar-16 40 years Columbia, MO 22,340 1,621 23,521 870 1,621 24,391 26,012 3,914 22,098 Mar-16 40 years Corpus Christi, TX 18,278 2,263 20,142 (5,447) 2,263 14,695 16,958 3,466 13,492 Mar-16 40 years East Amherst, NY 18,207 2,873 18,279 648 2,873 18,927 21,800 3,099 18,701 Mar-16 40 years El Cajon, CA 20,655 2,357 14,733 923 2,357 15,656 18,013 2,830 15,183 Mar-16 40 years El Paso, TX 11,998 1,610 14,103 1,124 1,610 15,227 16,837 2,571 14,266 Mar-16 40 years Fairport, NY 16,260 1,452 19,427 1,077 1,452 20,504 21,956 3,049 18,907 Mar-16 40 years Fenton, MO 24,162 2,410 22,216 999 2,410 23,215 25,625 3,849 21,776 Mar-16 40 years Grand Junction, CO 19,148 2,525 26,446 715 2,525 27,161 29,686 4,402 25,284 Mar-16 40 years Grand Junction, CO 9,796 1,147 12,523 913 1,147 13,436 14,583 2,449 12,134 Mar-16 40 years Grapevine, TX 21,947 1,852 18,143 (9,710) 1,852 8,433 10,285 3,145 7,140 Mar-16 40 years Groton, CT 17,292 3,673 21,879 (9,371) 3,673 12,508 16,181 3,986 12,195 Mar-16 40 years Guilford, CT 23,877 6,725 27,488 (23,109) 6,725 4,379 11,104 4,010 7,094 Mar-16 40 years Joliet, IL 14,675 1,473 23,427 (7,175) 1,473 16,252 17,725 3,559 14,166 Mar-16 40 years Kennewick, WA 7,543 1,168 18,933 820 1,168 19,753 20,921 3,215 17,706 Mar-16 40 years Las Cruces, NM 10,992 1,568 15,091 1,399 1,568 16,490 18,058 2,739 15,319 Mar-16 40 years Lees Summit, MO 26,716 1,263 20,500 1,084 1,263 21,584 22,847 3,742 19,105 Mar-16 40 years Lodi, CA 19,792 2,863 21,152 1,029 2,863 22,181 25,044 3,728 21,316 Mar-16 40 years Normandy Park, WA 15,972 2,031 16,407 987 2,031 17,394 19,425 2,948 16,477 Mar-16 40 years Column A Column B Column C Initial Cost Column D Capitalized Subsequent to Acquisition (1) Column E Gross Amount Carried at Close of Period (2) Column F Column G Column H Location City, State Encumbrances Land Building & Improvements Land, Buildings & Improvements Land Building & Improvements Total Accumulated Depreciation Total Date Acquired Life on Which Depreciation is Computed Palatine, IL 19,761 1,221 26,993 (12,068) 1,221 14,925 16,146 4,755 11,391 Mar-16 40 years Plano, TX 15,811 2,200 14,860 (6,201) 2,200 8,659 10,859 2,837 8,022 Mar-16 40 years Renton, WA 18,743 2,642 20,469 952 2,642 21,421 24,063 3,631 20,432 Mar-16 40 years Sandy, UT 15,523 2,810 19,132 (6,021) 2,810 13,111 15,921 3,167 12,754 Mar-16 40 years Santa Rosa, CA 27,457 5,409 26,183 1,697 5,409 27,880 33,289 4,652 28,637 Mar-16 40 years Sun City West, AZ 25,230 2,684 29,056 (6,820) 2,684 22,236 24,920 5,004 19,916 Mar-16 40 years Tacoma, WA 29,572 7,974 32,435 2,352 7,977 34,784 42,761 5,947 36,814 Mar-16 40 years Frisco, TX — 1,130 — 12,595 1,130 12,595 13,725 1,634 12,091 Oct-16 40 years Albany, OR 8,650 958 6,625 (3,606) 758 3,219 3,977 1,055 2,922 Feb-17 40 years Port Townsend, WA 16,537 1,613 21,460 658 996 22,735 23,731 2,999 20,732 Feb-17 40 years Roseburg, OR 12,236 699 11,589 645 459 12,474 12,933 1,639 11,294 Feb-17 40 years Sandy, OR 13,956 1,611 16,697 772 1,233 17,847 19,080 2,205 16,875 Feb-17 40 years Santa Barbara, CA 3,914 2,408 15,674 343 2,408 16,017 18,425 1,734 16,691 Feb-17 40 years Wenatchee, WA 19,048 2,540 28,971 865 1,534 30,842 32,376 3,559 28,817 Feb-17 40 years Churchville, NY 6,575 296 7,712 479 296 8,191 8,487 1,134 7,353 Aug-17 35 years Greece, NY — 534 18,158 (11,126) 533 7,033 7,566 1,431 6,135 Aug-17 49 years Greece, NY 26,833 1,007 31,960 1,477 1,007 33,437 34,444 3,762 30,682 Aug-17 41 years Henrietta, NY 11,881 1,153 16,812 930 1,152 17,743 18,895 2,561 16,334 Aug-17 36 years Penfield, NY 12,502 781 20,273 (8,440) 781 11,833 12,614 2,692 9,922 Aug-17 30 years Penfield, NY 10,918 516 9,898 490 515 10,389 10,904 1,406 9,498 Aug-17 35 years Rochester, NY 19,907 2,426 31,861 1,708 2,425 33,570 35,995 3,885 32,110 Aug-17 39 years Rochester, NY 5,341 297 12,484 (9,263) 296 3,222 3,518 1,778 1,740 Aug-17 37 years Victor, NY 27,174 1,060 33,246 1,910 1,059 35,157 36,216 3,842 32,374 Aug-17 41 years Victor, NY 12,800 557 13,570 17 556 13,588 14,144 1,167 12,977 Nov-17 41 years Undeveloped Land Bellevue, WA — 14,200 — — 14,200 — 14,200 — 14,200 Jun-15 (3) Kalamazoo, MI — 100 — — 100 — 100 — 100 Jun-15 (3) Crystal Lake, IL — 810 — — 810 — 810 — 810 Jun-15 (3) Millbrook, NY — 1,050 — — 1,050 — 1,050 — 1,050 Jun-15 (3) Rochester, NY — 544 — — 544 — 544 — 544 Aug-17 (3) Penfield, NY — 534 — — 534 — 534 — 534 Aug-17 (3) Subtotal $ 1,435,384 $ 237,151 $ 1,613,699 $ (75,879) $ 234,706 $ 1,540,265 $ 1,774,971 $ 291,041 $ 1,483,930 Held for Sale Leawood, KS — — — 3,000 3,000 — 3,000 Oct-13 (3) Spring Hill, KS — — — 2,000 2,000 — 2,000 Oct-13 (3) Total $ 1,435,384 $ 237,151 $ 1,613,699 $ (75,879) $ 234,706 $ 1,545,265 $ 1,779,971 $ 291,041 $ 1,488,930 ______________________________________ (1) Negative amount represents impairment of operating real estate. (2) The aggregate cost for federal income tax purposes is approximately $2.2 billion. (3) Depreciation is not recorded on land or assets held for sale. NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES SCHEDULE III - REAL ESTATE AND ACCUMULATED DEPRECIATION December 31, 2020 (Dollars in Thousands) The following table presents changes in the Company’s operating real estate portfolio for the years ended December 31, 2020, 2019 and 2018 (dollars in thousands): Year Ended December 31, 2020 2019 2018 Balance at beginning of year $ 1,931,032 $ 1,949,997 $ 1,966,352 Dispositions — (16,645) (15,240) Improvements 17,036 24,701 35,889 Impairment (165,246) (27,021) (33,494) Subtotal 1,782,822 1,931,032 1,953,507 Classified as held for sale (1) (7,851) — (3,510) Balance at end of year (2) $ 1,774,971 $ 1,931,032 $ 1,949,997 _____________________________ (1) Amounts classified as held for sale during the year and remain as held for sale at the end of the year. (2) The aggregate cost of the properties are approximately $427.2 million higher for federal income tax purposes as of December 31, 2019. The following table presents changes in accumulated depreciation as of December 31, 2020, 2019 and 2018 (dollars in thousands): Year Ended December 31, 2020 2019 2018 Balance at beginning of year $ 230,814 $ 171,083 $ 113,924 Depreciation expense 63,078 62,798 60,028 Property dispositions — (3,067) (1,542) Subtotal 293,892 230,814 172,410 Classified as held for sale (2,851) — (1,327) Balance at end of year $ 291,041 $ 230,814 $ 171,083

Schedule IV - Mortgage Loans on

Schedule IV - Mortgage Loans on Real Estate	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
Schedule IV - Mortgage Loans on Real Estate	SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE December 31, 2020 (Dollars in Thousands) Asset Type: Location / Description Count Fixed Rate Maturity Date (1) Periodic Payment Terms (2) Prior Liens (3) Principal Amount Carrying Value (4) Principal Amount of Loans Subject to Delinquent Principal or Interest Espresso Mezzanine Loan Various / SNF / ALF 1 10.0 % Jan-22 I/O $ 681,526 $ 74,182 $ 55,864 $ — _______________________________________ (1) Reflects the initial maturity date of the investment and does not consider any options to extend beyond such date. (2) Interest Only, or I/O; principal amount due in full at maturity. (3) Represents only third-party liens. (4) The federal income tax basis is approximately $74.2 million. Reconciliation of Carrying Value of Real Estate Debt (dollars in thousands): Year Ended December 31, 2020 2019 2018 Balance at beginning of year $ 55,468 $ 58,600 $ 74,650 Deductions: Reclassification (1) 271 (2,427) (16,151) Repayment of principal — (818) — Amortization of acquisition costs, fees, premiums and discounts 125 113 101 Balance at end of year $ 55,864 $ 55,468 $ 58,600 _______________________________________ (1) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero as of December 31, 2018. The Company has recorded the excess equity in losses related to its unconsolidated venture as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Accounting	Basis of Accounting The accompanying consolidated financial statements and related notes of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).
Reclassifications	Reclassifications Certain prior period amounts have been reclassified on the consolidated statements of cash flows from the supplemental disclosure of non-cash investing and financing activities to adjustments to reconcile net income (loss) to net cash provided by operating activities to conform to current period presentation.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company, the Operating Partnership and their consolidated subsidiaries. The Company consolidates entities in which it has a controlling financial interest by first considering if an entity meets the definition of a variable interest entity (“VIE”) for which the Company is deemed to be the primary beneficiary or if the Company has the power to control an entity through majority voting interest or other arrangements. All significant intercompany balances are eliminated in consolidation.
Variable Interest Entities	Variable Interest Entities A VIE is an entity that lacks one or more of the characteristics of a voting interest entity. A VIE is defined as an entity in which equity investors do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. The determination of whether an entity is a VIE includes both a qualitative and quantitative analysis. The Company bases its qualitative analysis on its review of the design of the entity, its organizational structure including decision-making ability and relevant financial agreements and the quantitative analysis on the forecasted cash flow of the entity. The Company reassesses its initial evaluation of an entity as a VIE upon the occurrence of certain reconsideration events. A VIE must be consolidated only by its primary beneficiary, which is defined as the party who, along with its affiliates and agents, has both the: (i) power to direct the activities that most significantly impact the VIE’s economic performance; and (ii) obligation to absorb the losses of the VIE or the right to receive the benefits from the VIE, which could be significant to the VIE. The Company determines whether it is the primary beneficiary of a VIE by considering qualitative and quantitative factors, including, but not limited to: which activities most significantly impact the VIE’s economic performance and which party controls such activities; the amount and characteristics of its investment; the obligation or likelihood for the Company or other interests to provide financial support; consideration of the VIE’s purpose and design, including the risks the VIE was designed to create and pass through to its variable interest holders and the similarity with and significance to the business activities of the Company and the other interests. The Company reassesses its determination of whether it is the primary beneficiary of a VIE each reporting period. Judgments related to these determinations include estimates about the current and future fair value and performance of investments held by these VIEs and general market conditions. The Company evaluates its investments and financings, including investments in unconsolidated ventures and securitization financing transactions to determine whether each investment or financing is a VIE. The Company analyzes new investments and financings, as well as reconsideration events for existing investments and financings, which vary depending on type of investment or financing. As of December 31, 2020, the Company has identified certain consolidated and unconsolidated VIEs. Assets of each of the VIEs, other than the Operating Partnership, may only be used to settle obligations of the respective VIE. Creditors of each of the VIEs have no recourse to the general credit of the Company. Consolidated VIEs The most significant consolidated VIEs are the Operating Partnership and certain properties that have non-controlling interests. These entities are VIEs because the non-controlling interests do not have substantive kick-out or participating rights. The Operating Partnership consolidates certain properties that have non-controlling interests. Included in operating real estate, net on the Company’s consolidated balance sheets as of December 31, 2020 is $494.3 million related to such consolidated VIEs. Included in mortgage and other notes payable, net on the Company’s consolidated balance sheet as of December 31, 2020 is $459.4 million, collateralized by the real estate assets of the related consolidated VIEs. Investing VIEs The Company’s investment in a securitization financing entity (“Investing VIE”) consisted of subordinate first-loss certificates in a securitization trust, generally referred to as Class B certificates, which represents interests in such VIE. Investing VIEs are structured as pass through entities that receive principal and interest payments from the underlying debt collateral assets and distribute those payments to the securitization trust’s certificate holders, including the Class B certificates. A securitization trust will name a directing certificate holder, who is generally afforded the unilateral right to terminate and appoint a replacement for the special servicer, and as such may qualify as the primary beneficiary of the trust. The Company held Class B certificates in an Investing VIE for which the Company had determined it was the primary beneficiary because it had the power to direct the activities that most significantly impacted the economic performance of the securitization trust. As a result, all of the assets, liabilities (obligations to the certificate holders of the securitization trust, less the Company’s retained interest from the Class B certificates of the securitization), income and expense of the entire Investing VIE were presented in the consolidated financial statements of the Company as required by U.S. GAAP. The Company’s Class B certificates, which represented the retained interest and related interest income, were eliminated in consolidation. Regardless of the presentation, the Company’s consolidated financial statements of operations ultimately reflect the net income attributable to its retained interest in the Class B certificates. In March 2018, the Company sold the Class B certificates of its consolidated Investing VIE, relinquishing its rights as directing certificate holder. As a result, the Company was no longer deemed the primary beneficiary of the securitization trust and, accordingly, did not present the assets or liabilities of the securitization trust on its consolidated balance sheets as of December 31, 2019 and December 31, 2018. The Company has presented the income and expenses of the securitization trust on its consolidated statements of operations for the periods that the Company owned the Class B certificates and was considered the primary beneficiary in 2018. Unconsolidated VIEs
Voting Interest Entities	Voting Interest Entities A voting interest entity is an entity in which the total equity investment at risk is sufficient to enable it to finance its activities independently and the equity holders have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the losses of the entity and the right to receive the residual returns of the entity. The usual condition for a controlling financial interest in a voting interest entity is ownership of a majority voting interest. If the Company has a majority voting interest in a voting interest entity, the entity will generally be consolidated. The Company does not consolidate a voting interest entity if there are substantive participating rights by other parties and/or kick-out rights by a single party or through a simple majority vote. The Company performs on-going reassessments of whether entities previously evaluated under the voting interest framework have become VIEs, based on certain events, and therefore subject to the VIE consolidation framework.
Investments in Unconsolidated Ventures	Investments in Unconsolidated Ventures A non-controlling, unconsolidated ownership interest in an entity may be accounted for using the equity method or the Company may elect the fair value option. The Company will account for an investment under the equity method of accounting if it has the ability to exercise significant influence over the operating and financial policies of an entity, but does not have a controlling financial interest. Under the equity method, the investment is adjusted each period for capital contributions and distributions and its share of the entity’s net income (loss). Capital contributions, distributions and net income (loss) of such entities are recorded in accordance with the terms of the governing documents. An allocation of net income (loss) may differ from the stated ownership percentage interest in such entity as a result of preferred returns and allocation formulas, if any, as described in such governing documents. Equity method investments are recognized using a cost accumulation model, in which the investment is recognized based on the cost to the investor, which includes acquisition fees. The Company records as an expense certain acquisition costs and fees associated with consolidated investments deemed to be business combinations and capitalizes these costs for investments deemed to be acquisitions of an asset, including an equity method investment.
Non-controlling Interests	Non-controlling Interests A non-controlling interest in a consolidated subsidiary is defined as the portion of the equity (net assets) in a subsidiary not attributable, directly or indirectly, to the Company. A non-controlling interest is required to be presented as a separate component of equity on the consolidated balance sheets and presented separately as net income (loss) and comprehensive income (loss) attributable to controlling and non-controlling interests. An allocation to a non-controlling interest may differ from the stated ownership percentage interest in such entity as a result of a preferred return and allocation formula, if any, as described in such governing documents.
Estimates	Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 as reflected and or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Annual Report on Form 10-K. Such estimates may change and the impact of which could be material.
Comprehensive Income (Loss)	Comprehensive Income (Loss)
Fair Value Option	Fair Value Option The fair value option provides an election that allows a company to irrevocably elect to record certain financial assets and liabilities at fair value on an instrument-by-instrument basis at initial recognition. The Company may elect to apply the fair value option for certain investments due to the nature of the instrument. Any change in fair value for assets and liabilities for which the election is made is recognized in earnings.
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash The Company considers all highly-liquid investments with an original maturity date of three months or less to be cash equivalents. Cash, including amounts restricted, may at times exceed the Federal Deposit Insurance Corporation deposit insurance limit of $250,000 per institution. The Company mitigates credit risk by placing cash and cash equivalents with major financial institutions. To date, the Company has not experienced any losses on cash and cash equivalents.
Operating Real Estate	Operating real estate is carried at historical cost less accumulated depreciation. Major replacements and betterments which improve or extend the life of the asset are capitalized and depreciated over their useful life. Ordinary repairs and maintenance are expensed as incurred. Operating real estate is depreciated using the straight-line method over the estimated useful life of the assets, summarized as follows: Category: Term: Building 30 to 50 years Building improvements Lesser of the useful life or remaining life of the building Land improvements 9 to 15 years Tenant improvements Lesser of the useful life or remaining term of the lease Furniture, fixtures and equipment 5 to 14 years
Lessee Accounting	Lessee Accounting A leasing arrangement, a right to control the use of an identified asset for a period of time in exchange for consideration, is classified by the lessee either as a finance lease, which represents a financed purchase of the leased asset, or as an operating lease. For leases with terms greater than 12 months, a lease asset and a lease liability are recognized on the balance sheet at commencement date based on the present value of lease payments over the lease term. Lease renewal or termination options are included in the lease asset and lease liability only if it is reasonably certain that the option to extend would be exercised or the option to terminate would not be exercised. As the implicit rate in most leases are not readily determinable, the Company’s incremental borrowing rate for each lease at commencement date is used to determine the present value of lease payments. Consideration is given to the Company’s recent debt financing transactions, as well as publicly available data for instruments with similar characteristics, adjusted for the respective lease term, when estimating incremental borrowing rates. Lease expense is recognized over the lease term based on an effective interest method for finance leases and on a straight-line basis for operating leases. Right of Use (“ROU”) - Finance Assets
Assets Held for Sale	Assets Held For SaleThe Company classifies certain long-lived assets as held for sale once the criteria, as defined by U.S. GAAP, have been met and are expected to sell within one year. Long-lived assets to be disposed of are reported at the lower of their carrying amount or fair value minus cost to sell, with any write-down recorded to impairment loss on the consolidated statements of operations. Depreciation and amortization is not recorded for assets classified as held for sale.
Real Estate Debt Investments	Real Estate Debt InvestmentsReal estate debt investments are generally intended to be held to maturity and, accordingly, are carried at cost, net of unamortized loan fees, premium, discount and unfunded commitments. Debt investments where the Company does not have the intent to hold the loan for the foreseeable future or until its expected payoff are classified as held for sale and recorded at the lower of cost or estimated fair value.
Deferred Costs	Deferred CostsDeferred costs primarily include deferred financing costs and deferred lease costs. Deferred financing costs represent commitment fees, legal and other third-party costs associated with obtaining financing. These costs are recorded against the carrying value of such financing and are amortized to interest expense over the term of the financing using the effective interest method. Unamortized deferred financing costs are expensed to realized gain (loss) on investments and other, when the associated borrowing is repaid before maturity. Costs incurred in seeking financing transactions which do not close are expensed in the period in which it is determined that the financing will not occur. Deferred lease costs consist of fees incurred to initiate and renew operating leases, which are amortized on a straight-line basis over the remaining lease term and are recorded to depreciation and amortization in the consolidated statements of operations.
Identified Intangibles	Identified Intangibles The Company records acquired identified intangibles, such as the value of in-place leases, goodwill and other intangibles, based on estimated fair value at the acquisition date. The value allocated to the identified intangibles is amortized over the remaining lease term. In-place leases are amortized into depreciation and amortization expense. Impairment analysis for identified intangible assets is performed in connection with the impairment assessment of the related operating real estate. An impairment establishes a new basis for the identified intangible asset and any impairment loss recognized is not subject to subsequent reversal. Refer to “—Credit Losses and Impairment on Investments - Operating Real Estate” for additional information. Goodwill represents the excess of the purchase price over the fair value of net tangible and intangible assets acquired in a business combination and is not amortized. The Company performs an annual impairment test for goodwill and evaluates the recoverability whenever events or changes in circumstances indicate that the carrying value of goodwill may not be fully recoverable. In making such assessment, qualitative factors are used to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the estimated fair value of the reporting unit is less than its carrying value, then an impairment charge is recorded. During the year ended December 31, 2020, the Company tested its goodwill for impairment. The accounting guidance under ASC 350-20 requires that any assets in the reporting unit of goodwill that are subject to impairment testing be evaluated prior to testing the goodwill of the reporting unit for impairment. As a result of impairment recorded on the operating real estate of the reporting unit during the year ended December 31, 2020, the Company concluded that the fair value of its goodwill reporting unit remains greater than its carrying value and goodwill was not impaired as of December 31, 2020. The Company utilized future net cash flows expected to be generated by the properties in a discounted cash flow analysis using terminal capitalization rates ranging from 6.50% to 7.75% and discount rates ranging from 7.75% to 9.25%. The Company concluded that the fair value of the goodwill reporting unit was less than 10% in excess of its carrying value as of December 31, 2020. If a general economic downturn resulting from efforts to contain COVID-19 persists over an extended period of time, this could have a prolonged negative impact on the performance of the Company's operating real estate. At this time, as the extent and duration of the increasingly broad effects of COVID-19 on the global economy remain unclear, it is difficult for the Company to assess and estimate the impact with any meaningful precision.
Acquisition Fees and Expenses	Acquisition Fees and Expenses The total of all acquisition fees and expenses for an investment, including acquisition fees to the Advisor, cannot exceed, in the aggregate, 6.0% of the contract purchase price of such investment unless such excess is approved by a majority of the Company’s directors, including a majority of its independent directors. Effective January 1, 2018, the Advisor no longer receives an acquisition fee in connection with the Company’s acquisitions of real estate properties or debt investments. For the year ended December 31, 2020, the Company did not incur any acquisition fees or expenses to the Advisor or third parties. The Company records as an expense for certain acquisition costs and fees associated with transactions deemed to be business combinations in which it consolidates the asset and capitalizes these costs for transactions deemed to be acquisitions of an asset, including an equity investment.
Revenue Recognition	Revenue Recognition Operating Real Estate Rental income from operating real estate is derived from leasing of space to healthcare operators, including rent received from the Company’s net lease properties and rent, ancillary service fees and other related revenue earned from ILF residents. Rental revenue recognition commences when the operator takes legal possession of the leased space and the leased space is substantially ready for its intended use. The leases are for fixed terms of varying length and generally provide for rentals and expense reimbursements to be paid in monthly installments. Rental income from leases is recognized on a straight-line basis over the term of the respective leases. ILF resident agreements are generally short-term in nature and may allow for termination with 30 days’ notice. The excess of rents recognized over amounts contractually due pursuant to the underlying leases are included in receivables, net on the consolidated balance sheets. The Company amortizes any operator inducements as a reduction of revenue utilizing the straight-line method over the term of the lease. The Company also generates operating income from operating healthcare properties. Revenue related to operating healthcare properties includes resident room and care charges, ancillary fees and other resident service charges. Rent is charged and revenue is recognized when such services are provided, generally defined per the resident agreement as of the date upon which a resident occupies a room or uses the services. Resident agreements are generally short-term in nature and may allow for termination with 30 days’ notice. Income derived from our ALFs, MCFs and CCRCs is recorded in resident fee income in the consolidated statements of operations. Lease income from operators and residents is recognized at lease commencement only to the extent collection is expected to be probable in consideration of operators’ and residents’ creditworthiness. This assessment is based on several qualitative and quantitative factors, including and as appropriate, the payment history, ability to satisfy its lease obligations, the value of the underlying collateral or deposit, if any, and current economic conditions. If collection is assessed to not be probable thereafter, lease income recognized is limited to lease payments collected, with the reversal of any income recognized to date in excess of amounts received. If collection is subsequently reassessed to be probable, lease income is adjusted to reflect the amount of income that would have been recognized had collection always been assessed as probable. For the year ended December 31, 2020, the operator of the Smyrna (formerly Peregrine) portfolio failed to remit rental payments and accordingly no rental income was recognized. Further, the Company continues to monitor the operator for the Arbors portfolio, which is currently in lease default as a result of the operators’ failure to remit rent timely and satisfy other conditions under its lease. As of December 31, 2020, the Company expects rent collection to be probable for the Arbors portfolio. For the years ended December 31, 2020 and 2019, total property and other revenues includes variable lease revenues of $14.4 million and $16.2 million, respectively. Variable lease income includes ancillary services provided to operator/residents, as well as non-recurring services and fees at the Company’s operating facilities. In addition, during the year ended December 31, 2020, the Company recognized $1.8 million in grant income received from the Provider Relief Fund administered by the U.S Department of Health & Human Services (“DHHS”). The grant income is classified as other income in the consolidated statements of operations. Lease Concessions Related to COVID-19 As a result of the COVID-19 crisis, the Company continues to engage with affected operators on a case-by-case basis to evaluate and respond to the current environment and assess the potential for flexible payment terms. For lease concessions resulting directly from the impact of COVID-19 that do not result in a substantial increase in the rights of the lessor or the obligations of the lessee, for example, where total payments required by the modified contract will be substantially the same as or less than the original contract, the Company made a policy election to account for the concessions as though the enforceable rights and obligations for those concessions existed in the lease contracts, under a relief provided by the Financial Accounting Standards Board (“FASB”). Under the relief, the concessions will not be treated as lease modifications that are accounted for over the remaining term of the respective leases, as the Company believes this would not accurately reflect the temporary economic effect of the concessions. Instead, (i) rent deferrals that meet the criteria will be treated as if no changes were made to the lease contract, with continued recognition of lease income and receivable under the original terms of the contract; and (ii) rent forgiveness that meets the criteria will be accounted for as variable lease payments in the affected periods. Effective June 1, 2020, the Company granted a lease concession to the operator of its Fountains net lease portfolio. The concession allowed the operator to defer a portion of contractual rent payments for a 90-day period, with full contractual rent to be repaid over the 12 months following the concession period. The lease concession provided the operator relief consistent with the debt forbearance received from the lender of the properties in the portfolio. The amount of the deferred rental payments under the lease concession totaled $3.9 million. The lease concession period ended on August 31, 2020 and the operator has resumed remitting contractual rent payments, including amounts related to deferred rent granted under the lease concession. As there were no substantive changes to the original lease or changes in total cash flows, the concession was not treated as a lease modification and the Company continues to recognize lease income and receivables under the original terms of the lease. Real Estate Debt Investments Interest income is recognized on an accrual basis and any related premium, discount, origination costs and fees are amortized over the life of the investment using the effective interest method. The amortization is reflected as an adjustment to interest income in the consolidated statements of operations. The amortization of a premium or accretion of a discount is discontinued if such investment is reclassified to held for sale.
Impairment on Operating Real Estate and Investments in Unconsolidated Ventures	Impairment on Operating Real Estate and Investments in Unconsolidated Ventures Due to uncertainties over the extent and duration of the economic fallout from COVID-19, at this time. It is difficult for the Company to assess and estimate the future economic effects of COVID-19 with any meaningful precision. As the actual impact of COVID-19 will depend on many factors beyond the Company’s control and knowledge, the resulting effect on impairment of the Company's real estate held for investment and held for sale and investments in unconsolidated ventures may materially differ from the Company's current expectations and further impairment charges may be recorded in future periods. Operating Real Estate The Company’s real estate portfolio is reviewed on a quarterly basis, or more frequently as necessary, to assess whether there are any indicators that the value of its operating real estate may be impaired or that its carrying value may not be recoverable. A property’s value is considered impaired if the Company’s estimate of the aggregate expected future undiscounted cash flow generated by the property is less than the carrying value. In conducting this review, the Company considers U.S. macroeconomic factors, real estate and healthcare sector conditions, together with asset specific and other factors. To the extent an impairment has occurred, the loss is measured as the excess of the carrying value of the property over the estimated fair value and recorded in impairment loss in the consolidated statements of operations. Real estate held for sale is stated at the lower of its carrying amount or estimated fair value less disposal cost, with any write-down to disposal cost recorded as an impairment loss. For any increase in fair value less disposal cost subsequent to classification as held for sale, the impairment may be reversed, but only up to the amount of cumulative loss previously recognized. The Company considered the potential impact of the COVID-19 pandemic on the future net operating income of its healthcare real estate held for investment as an indicator of impairment. Fair values were estimated based upon the income capitalization approach, using net operating income for each property and applying indicative capitalization rates.
Credit Losses on Real Estate Debt Investments and Receivables	Credit Losses on Real Estate Debt Investments and Receivables The current expected credit loss (“CECL”) model, in estimating expected credit losses over the life of a financial instrument at the time of origination or acquisition, considers historical loss experiences, current conditions and the effects of reasonable and supportable expectations of changes in future macroeconomic conditions. The Company assesses the estimate of expected credit losses on a quarterly basis or more frequently as necessary. The Company considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. The Company measures expected credit losses of real estate debt investments and other receivables (“Financial Assets”) on a collective basis when similar risk characteristics exist. If the Company determines that a particular Financial Asset does not share risk characteristics with its other Financial Assets, the Company evaluates the Financial Asset for expected credit losses on an individual basis. When developing an estimate of expected credit losses on Financial Assets, the Company considers available information relevant to assessing the collectability of cash flows. This information may include internal information, external information, or a combination of both relating to past events, current conditions, and reasonable and supportable forecasts. The Company considers relevant qualitative and quantitative factors that relate to the environment in which the Company operates and are specific to the borrower.
Foreign Currency	Foreign Currency Assets and liabilities denominated in a foreign currency for which the functional currency is a foreign currency are translated using the currency exchange rate in effect at the end of the period presented and the results of operations for such entities are translated into U.S. dollars using the average currency exchange rate in effect during the period. The resulting foreign currency translation adjustment is recorded as a component of accumulated OCI in the consolidated statements of equity. Assets and liabilities denominated in a foreign currency for which the functional currency is the U.S. dollar are remeasured using the currency exchange rate in effect at the end of the period presented and the results of operations for such entities are remeasured into U.S. dollars using the average currency exchange rate in effect during the period. As of December 31, 2020 and December 31, 2019, the Company had exposure to foreign currency through an investment in an unconsolidated venture, the effects of which are reflected as a component of accumulated OCI in the consolidated statements of equity and in equity in earnings (losses) in the consolidated statements of operations.
Equity-Based Compensation	Equity-Based Compensation The Company accounts for equity-based compensation awards using the fair value method, which requires an estimate of fair value of the award at the time of grant. All fixed equity-based awards to directors, which have no vesting conditions other than time of service, are amortized to compensation expense over the awards’ vesting period on a straight-line basis. Equity-based compensation is classified within general and administrative expenses in the consolidated statements of operations.
Income Taxes	Income Taxes The Company elected to be taxed as a REIT and to comply with the related provisions of the Internal Revenue Code beginning in its taxable year ended December 31, 2013. Accordingly, the Company will generally not be subject to U.S. federal income tax to the extent of its distributions to stockholders as long as certain asset, gross income and share ownership tests are met. To maintain its qualification as a REIT, the Company must annually distribute dividends equal to at least 90.0% of its REIT taxable income (with certain adjustments) to its stockholders and meet certain other requirements. The Company believes that all of the criteria to maintain the Company’s REIT qualification have been met for the applicable periods, but there can be no assurance that these criteria will continue to be met in subsequent periods. If the Company were to fail to meet these requirements, it would be subject to U.S. federal income tax and potential interest and penalties, which could have a material adverse impact on its results of operations and amounts available for distributions to its stockholders. The Company’s accounting policy with respect to interest and penalties is to classify these amounts as a component of income tax expense, where applicable. The Company has assessed its tax positions for all open tax years, which include 2017 to 2020, and concluded there were no material uncertainties to be recognized. The Company may also be subject to certain state, local and franchise taxes. Under certain circumstances, federal income and excise taxes may be due on its undistributed taxable income. The Company made a joint election to treat certain subsidiaries as taxable REIT subsidiaries (“TRS”) which may be subject to U.S. federal, state and local income taxes. In general, a TRS of the Company may perform services for managers/operators/residents of the Company, hold assets that the Company cannot hold directly and may engage in any real estate or non-real estate related business.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting Standards Adopted in 2020 Credit Losses— In June 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments- Credit Losses , followed by subsequent amendments, which modifies the credit impairment model for financial instruments. ASU No. 2016-13 was codified as Accounting Standards Codification (“ASC”) Topic 326. Pursuant to ASC Topic 326, the multiple existing incurred loss models have been replaced with the CECL model for off-balance sheet credit exposures that are not unconditionally cancellable by the lender and financial instruments carried at amortized cost, such as loans, loan commitments, held-to-maturity debt securities, financial guarantees, net investment in sales-type and direct financing leases, reinsurance and trade receivables. Targeted changes are also made to the impairment model of available-for-sale (“AFS”) debt securities which are not within the scope of CECL. The CECL model, in estimating expected credit losses over the life of a financial instrument at the time of origination or acquisition, considers historical loss experience, current conditions and the effects of a reasonable and supportable expectation of changes in future macroeconomic conditions. Recognition of allowance for credit losses under the CECL model will generally be accelerated as it encompasses credit losses over the full remaining expected life of the affected financial instruments. For collateralized financial assets, measurement of credit losses under CECL is based on fair value of the collateral if foreclosure is probable or if the collateral-dependent practical expedient is elected for financial assets expected to be repaid substantially through operation or sale of the collateral when the borrower is experiencing financial difficulty. The accounting model for purchased credit-impaired loans and debt securities will be simplified to be consistent with the CECL model for originated and purchased non-credit-impaired assets. For AFS debt securities, unrealized credit losses will be recognized as allowances rather than reductions in amortized cost basis and elimination of the other-than-temporary impairment concept will result in more frequent estimation of credit losses. ASC 326 also requires expanded disclosures on credit risk, including credit quality indicators by vintage of financing receivables. The Company adopted the new standard on January 1, 2020. The Company has identified its mezzanine loan debt investment to be within the scope of ASU No. 2016-13. The Company has developed the policies, systems and controls required for the implementation and ongoing management of CECL. ASU 2016-13 specifies that an allowance for credit losses should be based on relevant information about past events, including historical loss experience, current portfolio and market conditions, and reasonable and supportable forecasts for the duration of each respective loan. Based on its analysis, the Company has not recorded any credit loss allowance for its mezzanine loan upon the adoption of this standard. Refer to Note 5, “Real Estate Debt Investments” for additional information. The Company had no debt securities with unrealized loss in accumulated other comprehensive income as of December 31, 2019 and accordingly, there was no impact upon adoption of the new standard. As it relates to the Company’s other accounts receivable that are subject to CECL, there was no impact from adoption of the new standard. Related Party Guidance for VIEs— In November 2018, the FASB issued ASU No. 2018-17, Targeted Improvements to Related Party Guidance for Variable Interest Entities . The ASU amends the VIE guidance to align, throughout the VIE model, the evaluation of a decision maker's or service provider’s fee held by a related party, whether or not they are under common control, in both the assessment of whether the fee qualifies as a variable interest and the determination of a primary beneficiary. Specifically, a decision maker or service provider considers interests in a VIE held by a related party under common control only if it has a direct interest in that related party under common control and considers such indirect interest in the VIE held by the related party under common control on a proportionate basis, rather than in its entirety. Transition is generally on a modified retrospective basis, with the cumulative effect adjusted to retained earnings at the beginning of the earliest period presented. The Company adopted ASU No. 2018-17 on January 1, 2020, with no transitional impact upon adoption. Future Application of Accounting Standards Income Tax Accounting— In December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes . The ASU simplifies accounting for income taxes by eliminating certain exceptions to the general approach in ASC 740, Income Taxes, and clarifies certain aspects of the guidance for more consistent application. The simplifications relate to intraperiod tax allocations when there is a loss in continuing operations and a gain outside of continuing operations, accounting for tax law or tax rate changes and year-to-date losses in interim periods, recognition of deferred tax liability for outside basis difference when investment ownership changes, and accounting for franchise taxes that are partially based on income. The ASU also provides new guidance that clarifies the accounting for transactions resulting in a step-up in tax basis of goodwill, among other changes. Transition is generally prospective, other than the provision related to outside basis difference which is on a modified retrospective basis with cumulative effect adjusted to retained earnings at the beginning of the period adopted, and franchise tax provision which is on either full or modified retrospective. ASU No. 2019-12 is effective January 1, 2021, with early adoption permitted in an interim period, to be applied to all provisions. The Company is currently evaluating the impact of this new guidance. Accounting for Certain Equity Investments— In January 2020, the FASB issued ASU No. 2020-01, Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 . The ASU clarifies that if as a result of an observable transaction, an equity investment under the measurement alternative is transitioned into equity method and vice versa, an equity method investment is transitioned into measurement alternative, the investment is to be remeasured immediately before and after the transaction, respectively. The ASU also clarifies that certain forward contracts or purchased options to acquire equity securities that are not deemed to be derivatives or in-substance common stock will generally be measured using the fair value principles of ASC 321 before settlement or exercise, and that an entity should not be considering how it will account for the resulting investments upon eventual settlement or exercise. ASU No. 2020-01 is to be applied prospectively, effective January 1, 2021, with early adoption permitted in an interim period. The Company is currently evaluating the impact of this new guidance. Reference Rate Reform— In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting . The guidance in Topic 848 is optional, the election of which provides temporary relief for the accounting effects on contracts, hedging relationships and other transactions impacted by the transition from interbank offered rates (such as London Interbank Offered Rate (“LIBOR”)) that are expected to be discontinued by the end of 2021 to alternative reference rates (such as Secured Overnight Financing Rate). Modification of contractual terms to effect the reference rate reform transition on debt, leases, derivatives and other contracts is eligible for relief from modification accounting and accounted for as a continuation of the existing contract. Topic 848 is effective upon issuance through December 31, 2022, and may be applied retrospectively to January 1, 2020. The Company may elect practical expedients or exceptions as applicable over time as reference rate reform activities occur.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Reconciliation of Cash, Cash Equivalents and Restricted Cash	The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported on the consolidated balance sheets to the total of such amounts as reported on the consolidated statements of cash flows (dollars in thousands): Year Ended December 31, 2020 2019 2018 Cash and cash equivalents $ 65,995 $ 41,884 $ 73,811 Restricted cash 27,575 16,936 20,697 Total cash, cash equivalents and restricted cash $ 93,570 $ 58,820 $ 94,508
Reconciliation of Cash, Cash Equivalents and Restricted Cash	The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported on the consolidated balance sheets to the total of such amounts as reported on the consolidated statements of cash flows (dollars in thousands): Year Ended December 31, 2020 2019 2018 Cash and cash equivalents $ 65,995 $ 41,884 $ 73,811 Restricted cash 27,575 16,936 20,697 Total cash, cash equivalents and restricted cash $ 93,570 $ 58,820 $ 94,508
Schedule of Operating Real Estate Estimated Useful Life	Operating real estate is depreciated using the straight-line method over the estimated useful life of the assets, summarized as follows: Category: Term: Building 30 to 50 years Building improvements Lesser of the useful life or remaining life of the building Land improvements 9 to 15 years Tenant improvements Lesser of the useful life or remaining term of the lease Furniture, fixtures and equipment 5 to 14 years
Schedule of Future Minimum Lease Payments for Capital Leases	The following table presents the future minimum lease payments under finance leases and the present value of the minimum lease payments, which are included in other liabilities on the Company’s consolidated balance sheets (dollars in thousands): Years Ending December 31: 2021 $ 670 2022 577 2023 155 2024 59 2025 17 Thereafter 9 Total minimum lease payments $ 1,487 Less: Amount representing interest $ (112) Present value of minimum lease payments $ 1,375
Summary of Deferred Costs and Intangible Assets	The following table presents deferred costs and intangible assets, net (dollars in thousands): December 31, 2020 December 31, 2019 Goodwill and intangible assets, net: In-place lease value, net $ 4,635 $ 6,437 Goodwill 21,387 21,387 Certificate of need intangible assets 380 380 Subtotal intangible assets 26,402 28,204 Deferred costs, net 81 151 Total $ 26,483 $ 28,355
Schedule of Deferred Costs and Intangible Assets, Future Amortization Expense	The following table presents future amortization of in-place lease value and deferred costs (dollars in thousands): Years Ending December 31: 2021 $ 1,871 2022 593 2023 337 2024 337 2025 337 Thereafter 1,241 Total $ 4,716
Schedule of Other Assets	The following table presents a summary of other assets (dollars in thousands): December 31, 2020 December 31, 2019 Other assets: Healthcare facility regulatory reserve deposit (1) $ — $ 6,000 Remainder interest in condominium units (2) 2,327 2,327 Prepaid expenses 3,798 3,841 Lease / rent inducements, net 2,246 1,636 Utility deposits 447 317 Other 863 368 Total $ 9,681 $ 14,489 _______________________________________ (1) As of December 31, 2020, the Company is in possession of the regulatory reserve deposit and, accordingly, the amount totaling $6.0 million has been reclassified to restricted cash. (2) Represents future interests in property subject to life estates.

Operating Real Estate (Tables)

Operating Real Estate (Tables)	12 Months Ended
	Dec. 31, 2020
Real Estate [Abstract]
Schedule of Operating Real Estate	The following table presents operating real estate, net (dollars in thousands): December 31, 2020 December 31, 2019 Land $ 234,706 $ 236,036 Land improvements 23,797 23,287 Buildings and improvements 1,389,706 1,551,113 Tenant improvements 16,172 14,642 Construction in progress 2,535 4,956 Furniture, fixtures and equipment 108,055 100,998 Subtotal $ 1,774,971 $ 1,931,032 Less: Accumulated depreciation (291,041) (230,814) Operating real estate, net $ 1,483,930 $ 1,700,218
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity	The following table presents approximate future minimum rental income under noncancelable operating leases to be received over the next five years and thereafter as of December 31, 2020 (dollars in thousands): Years Ending December 31: (1) 2021 $ 34,183 2022 14,659 2023 10,919 2024 11,192 2025 11,472 Thereafter 45,604 Total $ 128,029 _______________________________________ (1) Excludes rental income from residents at ILFs that are subject to short-term leases.

Investments in Unconsolidated_2

Investments in Unconsolidated Ventures (Tables)	12 Months Ended
	Dec. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	The following tables present the Company’s investments in unconsolidated ventures (dollars in thousands): Carrying Value Portfolio Acquisition Date Ownership December 31, 2020 December 31, 2019 (1) Eclipse May-2014 5.6 % $ 5,624 $ 9,483 Envoy (2) Sep-2014 11.4 % 2 399 Diversified US/UK Dec-2014 14.3 % 89,651 125,597 Espresso (3) Jul-2015 36.7 % — — Trilogy (4) Dec-2015 23.2 % 133,896 133,361 Subtotal $ 229,173 $ 268,840 Operator Platform (5) Jul-2017 20.0 % — 54 Total $ 229,173 $ 268,894 _______________________________________ (1) Includes $1.3 million, $13.4 million, $7.6 million and $9.8 million of capitalized acquisition costs for the Company’s investments in the Eclipse, Diversified US/UK (formerly Griffin-American), Espresso and Trilogy joint ventures, respectively. (2) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. The Company’s carrying value for its investment in the Envoy joint venture represents additional proceeds to be received upon satisfaction of certain conditions under the sale. (3) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero in the fourth quarter of 2018. The Company has recorded the excess equity in losses related to its unconsolidated venture as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture. (4) In October 2018, the Company sold 20.0% of its ownership interest in the Trilogy joint venture, which generated gross proceeds of $48.0 million and reduced the Company’s ownership interest in the joint venture from approximately 29% to 23%. (5) Represents investment in Solstice Senior Living, LLC (“Solstice”), the manager of the Winterfell portfolio. Solstice is a joint venture between affiliates of Integral Senior Living, LLC (“ISL”), a management company of ILF, ALF and MCF founded in 2000, which owns 80.0%, and the Company, which owns 20.0%. As a result of losses recorded by the joint venture, the Company’s carrying value of its Solstice unconsolidated investment was reduced to zero in the third quarter of 2020. Year Ended December 31, 2020 Year Ended December 31, 2019 Portfolio Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Eclipse $ (3,774) $ (4,769) $ 86 $ 435 $ (987) $ 2,717 Envoy (7) — 390 20 (892) 4,339 (4) Diversified US/UK (Formerly Griffin-American) (35,396) (47,177) 1,487 (4,540) (16,359) 23,061 Espresso 270 (9,415) — (2,426) (8,530) — Trilogy (2) 4,495 (13,617) 3,960 3,003 (13,797) 5,805 Subtotal $ (34,412) $ (74,978) $ 5,923 $ (3,508) $ (40,565) $ 35,922 Operator Platform (3) (54) — — (37) — — Total $ (34,466) $ (74,978) $ 5,923 $ (3,545) $ (40,565) $ 35,922 _______________________________________ (1) Represents the net amount of the Company’s proportionate share of select revenues and expenses, including: straight-line rental income (expense), (above)/below market lease and in-place lease amortization, (above)/below market debt and deferred financing costs amortization, depreciation and amortization expense, acquisition fees and transaction costs, loan loss reserves, liability extinguishment gains, debt extinguishment losses, impairment, as well as unrealized and realized gain (loss) from sales of real estate and investments. (2) The Trilogy joint venture received and recognized federal COVID-19 provider relief funds totaling $53.9 million, of which the Company’s proportionate share totaled $12.5 million, and is included in equity in earnings for the year ended December 31, 2020. (3) Represents the Company’s investment in Solstice. During the year ended December 31, 2020, the Company's unconsolidated investment in Solstice was reduced to zero. As such, the Company did not recognize its proportionate share of losses from the joint venture of approximately $3,000 for the year ended December 31, 2020. (4) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. Summarized Financial Data The combined balance sheets as of December 31, 2020 and 2019 and combined statements of operations for the years ended December 31, 2020, 2019 and 2018 for the Company’s unconsolidated ventures are as follows (dollars in thousands): December 31, 2020 December 31, 2019 Year Ended December 31, 2020 2019 2018 Assets Operating real estate, net $ 4,500,319 $ 4,821,757 Total revenues $ 1,562,284 $ 1,575,758 $ 1,514,098 Other assets 1,261,678 1,199,552 Net income (loss) $ (294,501) $ (17,689) $ (150,170) Total assets $ 5,761,997 $ 6,021,309 Liabilities and equity Total liabilities $ 4,626,761 $ 4,578,905 Equity 1,135,236 1,442,404 Total liabilities and equity $ 5,761,997 $ 6,021,309 The below table indicates the Company’s investments for which Colony Capital is also an equity partner in the joint venture. Each investment was approved by the Company’s board of directors, including all of its independent directors. Refer to Note 4, “Investments in Unconsolidated Ventures” for further discussion of these investments: Portfolio Partner(s) Acquisition Date Ownership Eclipse Colony Capital/Formation Capital, LLC May 2014 5.6% Diversified US/UK (Formerly Griffin-American) Colony Capital December 2014 14.3%

Real Estate Debt Investments (T

Real Estate Debt Investments (Tables)	12 Months Ended
	Dec. 31, 2020
Real Estate [Abstract]
Schedule of the Company's Real Estate Debt Investments	The following table presents the Company’s one debt investment (dollars in thousands): Carrying Value (1) Asset Type: Principal Amount December 31, 2020 December 31, 2019 Fixed Rate Final Maturity Date Mezzanine loan (1) $ 74,182 $ 55,864 $ 55,468 10.0 % Jan 2022 _______________________________________ (1) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero in the fourth quarter of 2018. The Company has recorded the excess equity in losses related to its unconsolidated investment as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture. As of December 31, 2020 and December 31, 2019, the cumulative excess equity in losses included in the mezzanine loan carrying value were $18.3 million and $18.6 million, respectively.

Borrowings (Tables)

Borrowings (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Summary of Borrowings	The following table presents the Company’s mortgage and other notes payable (dollars in thousands): December 31, 2020 December 31, 2019 Recourse vs. Non-Recourse Final Maturity (1) Contractual Interest Rate (2) Principal Amount (3) Carrying Value (3) Principal (3) Carrying (3) Mortgage notes payable, net Watermark Aqua Portfolio Denver, CO Non-recourse Feb 2021 LIBOR + 2.92% $ 20,189 $ 20,183 $ 20,547 $ 20,500 Frisco, TX Non-recourse Mar 2021 LIBOR + 3.04% 18,770 18,764 19,170 19,127 Milford, OH Non-recourse Sep 2026 LIBOR + 2.68% 18,760 18,423 18,760 18,357 Rochester Portfolio Rochester, NY Non-recourse Feb 2025 4.25% 19,907 19,830 20,228 20,131 Rochester, NY (4) Non-recourse Aug 2027 LIBOR + 2.34% 101,224 100,378 101,224 100,267 Rochester, NY Non-recourse Aug 2021 LIBOR + 2.90% 12,800 12,584 12,800 12,232 Arbors Portfolio (5) Various locations Non-recourse Feb 2025 3.99% 87,302 86,521 89,026 88,020 Watermark Fountains Portfolio (6) Various locations Non-recourse Jun 2022 3.92% 386,607 385,606 392,269 390,508 Various locations Non-recourse Jun 2022 5.56% 73,439 73,180 74,208 73,750 Winterfell Portfolio (7) Various locations Non-recourse Jun 2025 4.17% 622,045 607,526 632,024 614,415 Avamere Portfolio (8) Various locations Non-recourse Feb 2027 4.66% 70,427 69,962 71,464 70,922 Subtotal mortgage notes payable, net $ 1,431,470 $ 1,412,957 $ 1,451,720 $ 1,428,229 Other notes payable Oak Cottage Santa Barbara, CA Non-recourse Feb 2022 6.00% 3,914 3,914 3,693 3,693 Subtotal other notes payable, net $ 3,914 $ 3,914 $ 3,693 $ 3,693 Total mortgage and other notes payable, net $ 1,435,384 $ 1,416,871 $ 1,455,413 $ 1,431,922 _______________________________________ (1) Refer to Note 15, “Subsequent Events” for additional information regarding the final maturity dates for two of the mortgage notes payable in the Watermark Aqua Portfolio. (2) Floating rate borrowings are comprised of $171.7 million principal amount at one-month LIBOR. (3) The difference between principal amount and carrying value of mortgage notes payable is attributable to deferred financing costs, net for all borrowings, other than the Winterfell portfolio which is attributable to below market debt intangibles. (4) Comprised of seven individual mortgage notes payable secured by seven healthcare real estate properties, cross-collateralized and subject to cross-default. (5) Comprised of four individual mortgage notes payable secured by four healthcare real estate properties, cross-collateralized and subject to cross-default. (6) Includes $386.6 million principal amount of fixed rate borrowings, secured by 14 healthcare real estate properties, cross-collateralized and subject to cross-default, as well as a supplemental financing totaling $73.4 million of principal, secured by seven healthcare real estate properties, cross-collateralized and subject to cross-default. (7) Comprised of 32 individual mortgage notes payable secured by 32 healthcare real estate properties, cross-collateralized and subject to cross-default. (8) Comprised of five individual mortgage notes payable secured by five healthcare real estate properties, cross-collateralized and subject to cross-default.
Schedule of Principal on Borrowings based on Final Maturity	The following table presents future scheduled principal payments on mortgage and other notes payable based on final maturity (dollars in thousands): Years Ending December 31: 2021 $ 79,696 2022 467,008 2023 19,696 2024 20,406 2025 670,302 Thereafter 178,276 Total $ 1,435,384 The following table presents the Company’s borrowings under the Sponsor line of credit as of December 31, 2020 (dollars in thousands): Capacity Principal Outstanding Contractual Interest Rate Maturity Date Sponsor Line of Credit $ 35,000 $ 35,000 LIBOR + 3.50% Dec 2022

Related Party Arrangements (Tab

Related Party Arrangements (Tables)	12 Months Ended
	Dec. 31, 2020
Related Party Transactions [Abstract]
Schedule of the Fees and Reimbursements Incurred to the Advisor and Dealer Manager	The following tables present the fees and reimbursements incurred and paid to the Advisor (dollars in thousands): Type of Fee or Reimbursement Due to Related Party as of December 31, 2019 Year Ended December 31, 2020 Due to Related Party as of December 31, 2020 Financial Statement Location Incurred Paid Fees to Advisor Entities (1) Asset management (2) Asset management and other fees-related party $ 1,477 $ 17,170 $ (17,724) (2) $ 923 Reimbursements to Advisor Entities Operating costs (3) General and administrative expenses 4,303 14,682 (11,590) 7,395 Total $ 5,780 $ 31,852 $ (29,314) $ 8,318 _______________________________________ (1) Effective June 30, 2020, our Advisor no longer has the potential to receive a disposition fee in connection with the sale of real estate properties or debt investments. The Company did not incur any disposition fees during the year ended December 31, 2020, nor were any such fees outstanding as of December 31, 2020. (2) Includes $9.7 million paid in shares of the Company’s common stock and a $0.3 million gain recognized on the settlement of the share-based payment. (3) As of December 31, 2020, the Advisor did not have any unreimbursed operating costs which remained eligible to be allocated to the Company. Type of Fee or Reimbursement Due to Related Party as of December 31, 2018 Year Ended December 31, 2019 Due to Related Party as of December 31, 2019 Financial Statement Location Incurred Paid Fees to Advisor Entities (1) Asset management (2) Asset management and other fees-related party $ 1,665 $ 19,789 $ (19,977) (2) $ 1,477 Reimbursements to Advisor Entities Operating costs (3) General and administrative expenses 4,010 11,892 (11,599) 4,303 Total $ 5,675 $ 31,681 $ (31,576) $ 5,780 _______________________________________ (1) The Company did not incur any disposition fees during the year ended December 31, 2019, nor were any such fees outstanding as of December 31, 2019. (2) Includes $9.9 million paid in shares of the Company’s common stock and a $0.1 million gain recognized on the settlement of the share-based payment. (3) As of December 31, 2019, the Advisor did not have any unreimbursed operating costs which remained eligible to be allocated to the Company.
Schedule of Joint Ventures	The following tables present the Company’s investments in unconsolidated ventures (dollars in thousands): Carrying Value Portfolio Acquisition Date Ownership December 31, 2020 December 31, 2019 (1) Eclipse May-2014 5.6 % $ 5,624 $ 9,483 Envoy (2) Sep-2014 11.4 % 2 399 Diversified US/UK Dec-2014 14.3 % 89,651 125,597 Espresso (3) Jul-2015 36.7 % — — Trilogy (4) Dec-2015 23.2 % 133,896 133,361 Subtotal $ 229,173 $ 268,840 Operator Platform (5) Jul-2017 20.0 % — 54 Total $ 229,173 $ 268,894 _______________________________________ (1) Includes $1.3 million, $13.4 million, $7.6 million and $9.8 million of capitalized acquisition costs for the Company’s investments in the Eclipse, Diversified US/UK (formerly Griffin-American), Espresso and Trilogy joint ventures, respectively. (2) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. The Company’s carrying value for its investment in the Envoy joint venture represents additional proceeds to be received upon satisfaction of certain conditions under the sale. (3) As a result of impairments and other non-cash reserves recorded by the joint venture, the Company’s carrying value of its Espresso unconsolidated investment was reduced to zero in the fourth quarter of 2018. The Company has recorded the excess equity in losses related to its unconsolidated venture as a reduction to the carrying value of its mezzanine loan, which was originated to a subsidiary of the Espresso joint venture. (4) In October 2018, the Company sold 20.0% of its ownership interest in the Trilogy joint venture, which generated gross proceeds of $48.0 million and reduced the Company’s ownership interest in the joint venture from approximately 29% to 23%. (5) Represents investment in Solstice Senior Living, LLC (“Solstice”), the manager of the Winterfell portfolio. Solstice is a joint venture between affiliates of Integral Senior Living, LLC (“ISL”), a management company of ILF, ALF and MCF founded in 2000, which owns 80.0%, and the Company, which owns 20.0%. As a result of losses recorded by the joint venture, the Company’s carrying value of its Solstice unconsolidated investment was reduced to zero in the third quarter of 2020. Year Ended December 31, 2020 Year Ended December 31, 2019 Portfolio Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Equity in Earnings (Losses) Select Revenues and (Expenses), net (1) Cash Distributions Eclipse $ (3,774) $ (4,769) $ 86 $ 435 $ (987) $ 2,717 Envoy (7) — 390 20 (892) 4,339 (4) Diversified US/UK (Formerly Griffin-American) (35,396) (47,177) 1,487 (4,540) (16,359) 23,061 Espresso 270 (9,415) — (2,426) (8,530) — Trilogy (2) 4,495 (13,617) 3,960 3,003 (13,797) 5,805 Subtotal $ (34,412) $ (74,978) $ 5,923 $ (3,508) $ (40,565) $ 35,922 Operator Platform (3) (54) — — (37) — — Total $ (34,466) $ (74,978) $ 5,923 $ (3,545) $ (40,565) $ 35,922 _______________________________________ (1) Represents the net amount of the Company’s proportionate share of select revenues and expenses, including: straight-line rental income (expense), (above)/below market lease and in-place lease amortization, (above)/below market debt and deferred financing costs amortization, depreciation and amortization expense, acquisition fees and transaction costs, loan loss reserves, liability extinguishment gains, debt extinguishment losses, impairment, as well as unrealized and realized gain (loss) from sales of real estate and investments. (2) The Trilogy joint venture received and recognized federal COVID-19 provider relief funds totaling $53.9 million, of which the Company’s proportionate share totaled $12.5 million, and is included in equity in earnings for the year ended December 31, 2020. (3) Represents the Company’s investment in Solstice. During the year ended December 31, 2020, the Company's unconsolidated investment in Solstice was reduced to zero. As such, the Company did not recognize its proportionate share of losses from the joint venture of approximately $3,000 for the year ended December 31, 2020. (4) In March 2019, the Envoy joint venture completed the sale of its remaining 11 properties for a sales price of $118.0 million, which generated net proceeds to the Company totaling $4.3 million. Summarized Financial Data The combined balance sheets as of December 31, 2020 and 2019 and combined statements of operations for the years ended December 31, 2020, 2019 and 2018 for the Company’s unconsolidated ventures are as follows (dollars in thousands): December 31, 2020 December 31, 2019 Year Ended December 31, 2020 2019 2018 Assets Operating real estate, net $ 4,500,319 $ 4,821,757 Total revenues $ 1,562,284 $ 1,575,758 $ 1,514,098 Other assets 1,261,678 1,199,552 Net income (loss) $ (294,501) $ (17,689) $ (150,170) Total assets $ 5,761,997 $ 6,021,309 Liabilities and equity Total liabilities $ 4,626,761 $ 4,578,905 Equity 1,135,236 1,442,404 Total liabilities and equity $ 5,761,997 $ 6,021,309 The below table indicates the Company’s investments for which Colony Capital is also an equity partner in the joint venture. Each investment was approved by the Company’s board of directors, including all of its independent directors. Refer to Note 4, “Investments in Unconsolidated Ventures” for further discussion of these investments: Portfolio Partner(s) Acquisition Date Ownership Eclipse Colony Capital/Formation Capital, LLC May 2014 5.6% Diversified US/UK (Formerly Griffin-American) Colony Capital December 2014 14.3%

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Schedule of Dividend Investment Estimated Value per Share	The following table presents the price at which dividends were invested based on when the price became effective: Effective Date Estimated Value per Share Valuation Date April 2016 $ 8.63 12/31/2015 December 2016 9.10 6/30/2016 December 2017 8.50 6/30/2017 December 2018 7.10 6/30/2018 December 2019 6.25 6/30/2019 December 2020 3.89 6/30/2020
Dividends Declared	The following table presents distributions declared for the years ended December 31, 2019 and 2018 (dollars in thousands): Distributions (1) Period Cash DRP Total 2019 First Quarter $ 2,991 $ 2,422 $ 5,413 Second Quarter — — — Third Quarter — — — Fourth Quarter — — — Total $ 2,991 $ 2,422 $ 5,413 2018 First Quarter $ 7,684 $ 7,876 $ 15,560 Second Quarter 8,028 7,722 15,750 Third Quarter 8,374 7,567 15,941 Fourth Quarter 8,653 7,352 16,005 Total $ 32,739 $ 30,517 $ 63,256 _______________________________________

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of the Principal Amount, Carrying Value and Fair Value of Certain Financial Assets and Liabilities	The following table presents the principal amount, carrying value and fair value of certain financial assets and liabilities (dollars in thousands): December 31, 2020 December 31, 2019 Principal Amount Carrying Value Fair Value Principal Amount Carrying Value Fair Value Financial assets: (1) Real estate debt investments, net $ 74,182 $ 55,864 $ 74,182 $ 74,182 $ 55,468 $ 74,182 Financial liabilities: (1) Mortgage and other notes payable, net $ 1,435,384 $ 1,416,871 $ 1,354,832 $ 1,455,413 $ 1,431,922 $ 1,450,876 Line of credit - related party 35,000 35,000 35,000 — — — _______________________________________ (1) The fair value of other financial instruments not included in this table is estimated to approximate their carrying value. The following table summarizes the fair value, measured at the time of impairment, of Level 3 assets which have been measured at fair value on a nonrecurring basis during the periods presented and the associated impairment losses (dollars in thousands): Year Ended December 31, 2020 2019 2018 Fair Value Impairment Losses Fair Value Impairment Losses Fair Value Impairment Losses Operating real estate, net $ 234,650 $ 164,215 $ 58,804 $ 27,021 $ 47,955 $ 31,000 Assets held for sale 5,000 1,753 1,649 533 2,183 2,494

Quarterly Financial Informati_2

Quarterly Financial Information (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	The following tables present select quarterly information for the years ended December 31, 2020 and 2019 (dollars in thousands, except per share data): Three Months Ended December 31, September 30, June 30, March 31, 2020 2020 2020 2020 Property and other revenues $ 66,841 $ 67,755 $ 69,308 $ 72,891 Net interest income 1,936 1,927 1,906 1,905 Real estate properties - operating expenses 46,648 46,501 45,328 45,701 Impairment loss 74,531 — 91,437 — Expenses 165,333 86,782 176,432 86,336 Equity in earnings (losses) of unconsolidated ventures 2,333 (1,043) (34,763) (993) Net income (loss) (93,538) (18,158) (139,995) (12,547) Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders (91,709) (17,987) (139,281) (12,481) Net income (loss) per share of common stock, basic/diluted (1) $ (0.48) $ (0.09) $ (0.74) $ (0.07) _______________________________________ (1) The total for the year may differ from the sum of the quarters as a result of weighting. Three Months Ended December 31, September 30, June 30, March 31, 2019 2019 2019 2019 Property and other revenues $ 72,907 $ 72,778 $ 74,972 $ 72,521 Net interest income 1,932 1,946 1,923 1,902 Real estate properties - operating expenses 46,001 45,359 44,636 45,218 Impairment loss 17,408 — 10,146 — Expenses 106,235 86,571 95,420 93,099 Equity in earnings (losses) of unconsolidated ventures 4,121 (3,037) (4,405) (224) Net income (loss) (26,924) (14,697) (17,460) (18,669) Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders (26,573) (14,624) (17,146) (18,617) Net income (loss) per share of common stock, basic/diluted (1) $ (0.13) $ (0.08) $ (0.09) $ (0.10) _______________________________________ (1) The total for the year may differ from the sum of the quarters as a result of weighting.

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2020
Segment Reporting [Abstract]
Schedule of Real Estate Properties	The following table presents the operators and managers of the Company’s properties, excluding properties owned through unconsolidated joint ventures (dollars in thousands): Year Ended December 31, 2020 Operator / Manager Properties Under Management Units Under Management (1) Property and Other Revenues (2) % of Total Property and Other Revenues Watermark Retirement Communities 30 5,265 $ 138,708 50.3 % Solstice Senior Living (3) 32 4,000 101,054 36.7 % Avamere Health Services 5 453 17,367 6.3 % Arcadia Management 4 572 10,615 3.9 % Integral Senior Living (4) 1 44 7,405 2.7 % Senior Lifestyle Corporation (5) 1 63 — — % Other (6) — — 199 0.1 % Total 73 10,397 $ 275,348 100.0 % ______________________________________ (1) Represents rooms for ALFs and ILFs and beds for MCFs and SNFs, based on predominant type. (2) Includes rental income received from the Company’s net lease properties as well as rental income, ancillary service fees and other related revenue earned from ILF residents and resident fee income derived from the Company’s ALFs, MCFs and CCRCs, which includes resident room and care charges, ancillary fees and other resident service charges. (3) Solstice is a joint venture of which affiliates of ISL own 80%. (4) Property count and units excludes two ISL properties designated as held for sale as of December 31, 2020. (5) Operator has failed to remit rental payments during the year ended December 31, 2020.
Summary of Segment Reporting	The following tables present segment reporting (dollars in thousands): Direct Investments Year Ended December 31, 2020 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total Property and other revenues $ 32,899 $ 242,250 $ — $ — $ 199 $ 275,348 Interest income on debt investments — — — 7,674 — 7,674 Real estate properties - operating expenses (13) (184,165) — — — (184,178) Interest expense (11,832) (53,210) — — (949) (65,991) Transaction costs (58) (7) — — — (65) Asset management and other fees - related party — — — — (17,170) (17,170) General and administrative expenses (804) (296) — (19) (15,386) (16,505) Depreciation and amortization (14,940) (50,066) — — — (65,006) Impairment loss (722) (165,246) — — — (165,968) Other income — 1,840 — — — 1,840 Realized gain (loss) on investments and other — (13) — — 315 302 Equity in earnings (losses) of unconsolidated ventures — — (34,466) — — (34,466) Income tax expense — (53) — — — (53) Net income (loss) $ 4,530 $ (208,966) $ (34,466) $ 7,655 $ (32,991) $ (264,238) Direct Investments Year Ended December 31, 2019 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total Property and other revenues $ 33,424 $ 259,033 $ — $ 35 $ 686 $ 293,178 Interest income on debt investments — — — 7,703 — 7,703 Real estate properties - operating expenses (11) (181,203) — — — (181,214) Interest expense (12,434) (56,360) — — (102) (68,896) Transaction costs — (122) — — — (122) Asset management and other fees - related party — — — — (19,789) (19,789) General and administrative expenses (268) (42) — (38) (12,413) (12,761) Depreciation and amortization (14,329) (56,660) — — — (70,989) Impairment loss (4,132) (23,422) — — — (27,554) Realized gain (loss) on investments and other 5,872 719 — — (277) 6,314 Equity in earnings (losses) of unconsolidated ventures — — (3,545) — — (3,545) Income tax benefit (expense) — (75) — — — (75) Net income (loss) $ 8,122 $ (58,132) $ (3,545) $ 7,700 $ (31,895) $ (77,750) _______________________________________ (1) Includes unallocated asset management fee-related party and general and administrative expenses. Direct Investments Year Ended December 31, 2018 Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Subtotal Investing VIE (2) Total Property and other revenues $ 34,276 $ 258,779 $ — $ 375 $ 841 $ 294,271 $ — $ 294,271 Net interest income — — — 8,534 (314) (3) 8,220 811 9,031 Real estate properties - operating expenses (1,346) (187,415) — — — (188,761) — (188,761) Interest expense (13,326) (56,595) — — (275) (70,196) — (70,196) Other expenses related to securitization trust — — — — — — (811) (811) Transaction costs (60) (828) — — — (888) — (888) Asset management and other fees - related party — — — — (23,478) (23,478) — (23,478) General and administrative expenses (183) (856) (2) (46) (13,303) (14,390) — (14,390) Depreciation and amortization (13,694) (93,439) — — — (107,133) — (107,133) Impairment loss (5,094) (31,183) — — — (36,277) — (36,277) Unrealized gain (loss) on mortgage loans held in securitization trust, net — — — (314) 314 (3) — — — Realized gain (loss) on investments and other — 2,525 14,086 3,495 137 20,243 — 20,243 Equity in earnings (losses) of unconsolidated ventures — — (33,517) — — (33,517) — (33,517) Income tax benefit (expense) — (114) — — — (114) — (114) Net income (loss) $ 573 $ (109,126) $ (19,433) $ 12,044 $ (36,078) $ (152,020) $ — $ (152,020) _______________________________________ (1) Includes unallocated asset management fee-related party and general and administrative expenses. (2) Investing VIEs are not considered to be a segment that the Company conducts its business through, however U.S. GAAP requires the Company, as the primary beneficiary, to present the assets and liabilities of the securitization trust on its consolidated balance sheets and recognize the related interest income and interest expense, as net interest income on the consolidated statements of operations. Though U.S. GAAP requires this presentation, the Company views its investment in the securitization trust as a net investment in debt and securities. (3) Represents income earned from the healthcare-related securities purchased at a discount, recognized using the effective interest method had the transaction been recorded as an available for sale security, at amortized cost. During the year ended December 31, 2018, $0.3 million was attributable to discount accretion income and was eliminated in consolidation in the corporate segment.
Summary of Assets by Segment	The following table presents total assets by segment (dollars in thousands): Direct Investments Total Assets: Net Lease Operating Unconsolidated Investments Debt and Securities Corporate (1) Total December 31, 2020 $ 348,688 $ 1,223,045 $ 229,170 $ 56,502 $ 61,031 $ 1,918,436 December 31, 2019 365,789 1,420,023 268,892 56,099 30,404 2,141,207 ______________________________________

Business and Organization (Deta

Business and Organization (Details)	12 Months Ended	71 Months Ended
	Dec. 31, 2020USD ($)employee$ / sharesshares	Dec. 31, 2020USD ($)employee$ / sharesshares	Dec. 31, 2019$ / sharesshares
Class of Stock [Line Items]
Common stock, shares authorized (in shares) | shares	400,000,000	400,000,000	400,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.01	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares) | shares	50,000,000	50,000,000	50,000,000
Preferred stock, par value (in dollars per share) | $ / shares	$ 0.01	$ 0.01	$ 0.01
Number of employees | employee	0	0
Net proceeds from issuance of common stock		$ 2,000,000,000
Dividend Reinvestment Plan
Class of Stock [Line Items]
Net proceeds from issuance of common stock		$ 232,600,000
Advisor
Class of Stock [Line Items]
Non-controlling interest investment in operating partnership	$ 1,000
Special Unit Holder
Class of Stock [Line Items]
Non-controlling interest investment in operating partnership	$ 1,000
Primary Beneficiary
Class of Stock [Line Items]
Limited partnership interest in operating partnership	99.99%

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	Dec. 31, 2020USD ($)dproperty	Dec. 31, 2019USD ($)property	Dec. 31, 2020USD ($)d	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2020USD ($)d	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Variable Interest Entities
Operating real estate, net	$ 1,483,930,000	$ 1,700,218,000	$ 1,483,930,000				$ 1,700,218,000				$ 1,483,930,000	$ 1,700,218,000
Mortgage and other notes payable, net	1,416,871,000	$ 1,431,922,000	1,416,871,000				1,431,922,000				1,416,871,000	1,431,922,000
Finance Lease Obligations
Finance leases for equipment	$ 3,500,000		$ 3,500,000								3,500,000
Payments of finance lease obligations											$ 700,000	700,000
Weighted average interest rate (percent)	6.20%		6.20%								6.20%
Remaining lease term (years)	2 years 4 months 24 days		2 years 4 months 24 days								2 years 4 months 24 days
Number of properties held for sale | property	2	1
Identified Intangibles
Amortization expense for in-place leases and deferred costs											$ 1,900,000	8,300,000
Acquisition Fees and Expenses
Acquisition fee and expense cap	6.00%		6.00%								6.00%
Days notice required for lease termination | d	30		30								30
Variable lease revenues											$ 14,400,000	16,200,000
Other income											$ 1,840,000	0	$ 0
Concession period (days)											90 days
Repayment period (months)											12 months
Payments deferred	$ 3,900,000		$ 3,900,000								$ 3,900,000
Impairment loss			74,531,000	$ 0	$ 91,437,000	$ 0	$ 17,408,000	$ 0	$ 10,146,000	$ 0	165,968,000	27,554,000	36,277,000
Investments in Unconsolidated Ventures
Impairment recognized											0
Impairment of affiliate properties											38,200,000
Income Taxes
Deferred tax asset	$ 18,200,000		$ 18,200,000								18,200,000
Income tax expense											53,000	$ 75,000	$ 114,000
Diversified US/UK (formerly Griffin-American)
Acquisition Fees and Expenses
Impairment loss											$ 508,800,000
Minimum | Terminal capitalization rate
Identified Intangibles
Goodwill impairment measurement input	6.50%		6.50%								6.50%
Minimum | Discount rate
Identified Intangibles
Goodwill impairment measurement input	7.75%		7.75%								7.75%
Maximum | Terminal capitalization rate
Identified Intangibles
Goodwill impairment measurement input	7.75%		7.75%								7.75%
Maximum | Discount rate
Identified Intangibles
Goodwill impairment measurement input	9.25%		9.25%								9.25%
Winterfell
Acquisition Fees and Expenses
Impairment loss											$ 84,900,000
Aqua
Acquisition Fees and Expenses
Impairment loss											19,900,000
Fountains Portfolio
Acquisition Fees and Expenses
Impairment loss											42,700,000
Rochester Portfolio
Acquisition Fees and Expenses
Impairment loss											12,500,000
Avamere Portfolio
Acquisition Fees and Expenses
Impairment loss											4,200,000
Properties Sold or Designated as Held for Sale
Acquisition Fees and Expenses
Impairment loss											1,800,000
Diversified US/UK (formerly Griffin-American)
Investments in Unconsolidated Ventures
Impairment of affiliate properties											34,400,000
Eclipse
Investments in Unconsolidated Ventures
Impairment of affiliate properties											3,200,000
Trilogy
Investments in Unconsolidated Ventures
Impairment of affiliate properties											600,000
Leases, Acquired-in-Place
Identified Intangibles
In-place lease value, gross	$ 130,000,000		$ 130,000,000								130,000,000
In-place lease value, accumulated amortization	125,400,000		125,400,000								125,400,000
Variable Interest Entity, Primary Beneficiary
Variable Interest Entities
Operating real estate, net	494,300,000		494,300,000								494,300,000
Mortgage and other notes payable, net	459,400,000		459,400,000								459,400,000
Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entities
VIE carrying value	$ 229,200,000		$ 229,200,000								$ 229,200,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Cash and cash equivalents	$ 65,995	$ 41,884	$ 73,811
Restricted cash	27,575	16,936	20,697
Total cash, cash equivalents and restricted cash	$ 93,570	$ 58,820	$ 94,508	$ 80,488

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Estimated Useful Lives (Details)	12 Months Ended
	Dec. 31, 2020
Building | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	30 years
Building | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	50 years
Land improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	9 years
Land improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	15 years
Furniture and fixtures | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	5 years
Furniture and fixtures | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life (in years)	14 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Future Minimum Lease Payments from Capital Leases (Details) $ in Thousands	Dec. 31, 2020USD ($)
Accounting Policies [Abstract]
2021	$ 670
2022	577
2023	155
2024	59
2025	17
Thereafter	9
Total minimum lease payments	1,487
Less: Amount representing interest	(112)
Present value of minimum lease payments	$ 1,375

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Deferred Costs and Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Goodwill and intangible assets, net:
In-place lease value, net	$ 4,635	$ 6,437
Goodwill	21,387	21,387
Certificate of need intangible assets	380	380
Subtotal intangible assets	26,402	28,204
Deferred costs, net	81	151
Total	$ 26,483	$ 28,355

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Schedule of Future Amortization Expense (Details) $ in Thousands	Dec. 31, 2020USD ($)
Accounting Policies [Abstract]
2021	$ 1,871
2022	593
2023	337
2024	337
2025	337
Thereafter	1,241
Total	$ 4,716

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Other Assets and Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Other assets:
Healthcare facility regulatory reserve deposit	$ 0	$ 6,000
Remainder interest in condominium units	2,327	2,327
Prepaid expenses	3,798	3,841
Lease / rent inducements, net	2,246	1,636
Utility deposits	447	317
Other	863	368
Total	9,681	14,489
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	27,575	$ 16,936	$ 20,697
Regulatory Reserve Deposit
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted cash	$ 6,000

Operating Real Estate - Identif

Operating Real Estate - Identifiable Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Real Estate [Abstract]
Land	$ 234,706	$ 236,036
Land improvements	23,797	23,287
Buildings and improvements	1,389,706	1,551,113
Tenant improvements	16,172	14,642
Construction in progress	2,535	4,956
Furniture, fixtures and equipment	108,055	100,998
Subtotal	1,774,971	1,931,032
Less: Accumulated depreciation	(291,041)	(230,814)
Operating real estate, net	$ 1,483,930	$ 1,700,218

Operating Real Estate - Narrati

Operating Real Estate - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Real Estate [Line Items]
Depreciation	$ 63.1	$ 62.8	$ 60
Impairment loss	166	27.6
Building and Building Improvements
Real Estate [Line Items]
Accumulated impairment	$ 213.9	$ 58

Operating Real Estate - Minimum

Operating Real Estate - Minimum Future Rents (Details) $ in Thousands	Dec. 31, 2020USD ($)
Real Estate [Abstract]
2021	$ 34,183
2022	14,659
2023	10,919
2024	11,192
2025	11,472
Thereafter	45,604
Total	$ 128,029

Investments in Unconsolidated_3

Investments in Unconsolidated Ventures - Changes in Carrying Value (Details)	1 Months Ended		3 Months Ended								12 Months Ended
	Mar. 31, 2019USD ($)facility	Oct. 31, 2018USD ($)	Dec. 31, 2020USD ($)	Sep. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Jun. 30, 2019USD ($)	Mar. 31, 2019USD ($)facility	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018
Schedule of Equity Method Investments [Line Items]
Carrying Value			$ 229,173,000				$ 268,894,000				$ 229,173,000	$ 268,894,000
Number of properties sold | facility	11									11
Proceeds from sale of held-for-sale property	$ 118,000,000
Proceeds from sale of held-for-sale property, net	$ 4,300,000
Sale of ownership interest in unconsolidated ventures											0	0	$ 47,813,000
Equity in earnings (losses) of unconsolidated ventures			2,333,000	$ (1,043,000)	$ (34,763,000)	$ (993,000)	4,121,000	$ (3,037,000)	$ (4,405,000)	$ (224,000)	(34,466,000)	(3,545,000)	(33,517,000)
Select Revenues and (Expenses), net											(74,978,000)	(40,565,000)
Cash Distributions											5,923,000	35,922,000
Trilogy
Schedule of Equity Method Investments [Line Items]
Federal COVID-19 provider relief funds received											53,900,000
Eclipse, Envoy, Griffin-American, Espresso, Trilogy
Schedule of Equity Method Investments [Line Items]
Carrying Value			$ 229,173,000				268,840,000				229,173,000	268,840,000
Equity in earnings (losses) of unconsolidated ventures											(34,412,000)	(3,508,000)
Select Revenues and (Expenses), net											(74,978,000)	(40,565,000)
Cash Distributions											$ 5,923,000	35,922,000
Eclipse
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			5.60%								5.60%
Carrying Value			$ 5,624,000				9,483,000				$ 5,624,000	9,483,000
Capitalized acquisition costs							1,300,000					1,300,000
Equity in earnings (losses) of unconsolidated ventures											(3,774,000)	435,000
Select Revenues and (Expenses), net											(4,769,000)	(987,000)
Cash Distributions											$ 86,000	2,717,000
Envoy
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			11.40%								11.40%
Carrying Value			$ 2,000				399,000				$ 2,000	399,000
Equity in earnings (losses) of unconsolidated ventures											(7,000)	20,000
Select Revenues and (Expenses), net											0	(892,000)
Cash Distributions											$ 390,000	4,339,000
Diversified US/UK (formerly Griffin-American)
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			14.30%								14.30%
Carrying Value			$ 89,651,000				125,597,000				$ 89,651,000	125,597,000
Capitalized acquisition costs							13,400,000					13,400,000
Equity in earnings (losses) of unconsolidated ventures											(35,396,000)	(4,540,000)
Select Revenues and (Expenses), net											(47,177,000)	(16,359,000)
Cash Distributions											$ 1,487,000	23,061,000
Espresso
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			36.70%								36.70%
Carrying Value			$ 0				0				$ 0	0
Capitalized acquisition costs							7,600,000					7,600,000
Equity in earnings (losses) of unconsolidated ventures											270,000	(2,426,000)
Select Revenues and (Expenses), net											(9,415,000)	(8,530,000)
Cash Distributions											$ 0	0
Espresso | Mezzanine loans
Schedule of Equity Method Investments [Line Items]
Carrying Value													$ 0
Trilogy
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)		23.00%	23.20%								23.20%			29.00%
Carrying Value			$ 133,896,000				133,361,000				$ 133,896,000	133,361,000
Capitalized acquisition costs							9,800,000					9,800,000
Ownership interest sold (as a percentage)		20.00%
Sale of ownership interest in unconsolidated ventures		$ 48,000,000
Equity in earnings (losses) of unconsolidated ventures											4,495,000	3,003,000
Select Revenues and (Expenses), net											(13,617,000)	(13,797,000)
Cash Distributions											3,960,000	5,805,000
Federal COVID-19 provider relief funds received											$ 12,500,000
Operator Platform
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			20.00%								20.00%
Carrying Value			$ 0				$ 54,000				$ 0	54,000
Equity in earnings (losses) of unconsolidated ventures											(54,000)	(37,000)
Select Revenues and (Expenses), net											0	0
Cash Distributions											$ 0	$ 0
Solstice Senior Living
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			0.00%								0.00%
Equity in earnings (losses) of unconsolidated ventures											$ 3,000,000
Winterfell | Solstice Senior Living
Schedule of Equity Method Investments [Line Items]
Ownership interest (as a percentage)			20.00%								20.00%
Carrying Value				$ 0
Winterfell | Solstice Senior Living
Schedule of Equity Method Investments [Line Items]
Noncontrolling interest, ownership percentage by parent (as a percentage)			80.00%								80.00%

Investments in Unconsolidated_4

Investments in Unconsolidated Ventures - Assets and Liabilities (Details) - USD ($) $ in Thousands		3 Months Ended								12 Months Ended
		Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule of Equity Method Investments [Line Items]
Operating real estate, net		$ 1,483,930				$ 1,700,218				$ 1,483,930	$ 1,700,218
Other assets		9,681				14,489				9,681	14,489
Total assets	[1]	1,918,436				2,141,207				1,918,436	2,141,207
Total liabilities	[1]	1,506,374				1,473,703				1,506,374	1,473,703
Equity		412,062				667,504				412,062	667,504	$ 744,374	$ 944,799
Total liabilities and equity		1,918,436				2,141,207				1,918,436	2,141,207
Total revenues		66,841	$ 67,755	$ 69,308	$ 72,891	72,907	$ 72,778	$ 74,972	$ 72,521	275,348	293,178	294,271
Net income (loss)		(93,538)	$ (18,158)	$ (139,995)	$ (12,547)	(26,924)	$ (14,697)	$ (17,460)	$ (18,669)	(264,238)	(77,750)	(152,020)
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Schedule of Equity Method Investments [Line Items]
Operating real estate, net		4,500,319				4,821,757				4,500,319	4,821,757
Other assets		1,261,678				1,199,552				1,261,678	1,199,552
Total assets		5,761,997				6,021,309				5,761,997	6,021,309
Total liabilities		4,626,761				4,578,905				4,626,761	4,578,905
Equity		1,135,236				1,442,404				1,135,236	1,442,404
Total liabilities and equity		$ 5,761,997				$ 6,021,309				5,761,997	6,021,309
Total revenues										1,562,284	1,575,758	1,514,098
Net income (loss)										$ (294,501)	$ (17,689)	$ (150,170)
[1]	Represents the consolidated assets and liabilities of NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Operating Partnership is a consolidated variable interest entity (“VIE”), of which the Company is the sole general partner and owns approximately 99.99%. As of December 31, 2020, the Operating Partnership includes $0.5 billion and $0.5 billion of assets and liabilities, respectively, of certain VIEs that are consolidated by the Operating Partnership. Refer to Note 2, “Summary of Significant Accounting Policies.”

Real Estate Debt Investments -

Real Estate Debt Investments - Schedule of the Company's Real Estate Debt Investment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 55,864,000	$ 55,468,000
Carrying value	229,173,000	268,894,000
Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying value	0	0
Mezzanine loans | Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Principal Amount	74,182,000
Carrying Value	55,864,000	55,468,000
Carrying value			$ 0
Cumulative excess equity in losses included in mezzanine loan carrying value	$ 18,300,000	$ 18,600,000
Mezzanine loans | Weighted Average | Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Fixed Rate	10.00%

Real Estate Debt Investments _2

Real Estate Debt Investments - Narrative (Details) $ in Thousands	Dec. 31, 2020	Jan. 31, 2021USD ($)	Dec. 31, 2020USD ($)Investment	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repayment of real estate debt investment			$ 0	$ 818	$ 0
Amended and Restated Loan Agreement
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Fixed Rate	14.00%
Amended and Restated Loan Agreement | Subsequent event
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Repayment of real estate debt investment		$ 5,000
Mezzanine loans
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Number of debt instruments | Investment			1
Percent of interest income contributed by investment			100.00%

Borrowings - Schedule of Borrow

Borrowings - Schedule of Borrowings (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)propertydebt_instrument	Dec. 31, 2019USD ($)
Debt Instrument [Line Items]
Carrying Value	$ 1,435,384
Watermark Fountains Portfolio
Debt Instrument [Line Items]
Number of healthcare real estate properties | property	14
Winterfell
Debt Instrument [Line Items]
Number of healthcare real estate properties | property	32
Mortgage notes payable, net
Debt Instrument [Line Items]
Principal Amount	$ 1,435,384	$ 1,455,413
Mortgage notes payable, net | Rochester Portfolio
Debt Instrument [Line Items]
Number of debt instruments | debt_instrument	7
Number of healthcare real estate properties | property	7
Mortgage notes payable, net | Arbors Portfolio
Debt Instrument [Line Items]
Number of debt instruments | debt_instrument	4
Number of healthcare real estate properties | property	4
Mortgage notes payable, net | Winterfell
Debt Instrument [Line Items]
Number of debt instruments | debt_instrument	32
Mortgage notes payable, net | Avamere Portfolio
Debt Instrument [Line Items]
Number of debt instruments | debt_instrument	5
Number of healthcare real estate properties | property	5
Mortgage notes payable, net | Denver, CO Non-recourse | Denver, CO
Debt Instrument [Line Items]
Principal Amount	$ 20,189	20,547
Carrying Value	$ 20,183	20,500
Mortgage notes payable, net | Denver, CO Non-recourse | Denver, CO | LIBOR
Debt Instrument [Line Items]
Interest rate (percentage)	2.92%
Mortgage notes payable, net | Frisco, TX Non-recourse | Frisco, TX
Debt Instrument [Line Items]
Principal Amount	$ 18,770	19,170
Carrying Value	$ 18,764	19,127
Mortgage notes payable, net | Frisco, TX Non-recourse | Frisco, TX | LIBOR
Debt Instrument [Line Items]
Interest rate (percentage)	3.04%
Mortgage notes payable, net | Milford, OH Non-recourse | Milford, OH
Debt Instrument [Line Items]
Principal Amount	$ 18,760	18,760
Carrying Value	$ 18,423	18,357
Mortgage notes payable, net | Milford, OH Non-recourse | Milford, OH | LIBOR
Debt Instrument [Line Items]
Interest rate (percentage)	2.68%
Mortgage notes payable, net | Rochester, NY Non-recourse, February 2025 | Rochester, NY
Debt Instrument [Line Items]
Contractual Interest Rate	4.25%
Principal Amount	$ 19,907	20,228
Carrying Value	19,830	20,131
Mortgage notes payable, net | Rochester, NY Non-recourse, August 2027 | Rochester, NY
Debt Instrument [Line Items]
Principal Amount	101,224	101,224
Carrying Value	$ 100,378	100,267
Mortgage notes payable, net | Rochester, NY Non-recourse, August 2027 | Rochester, NY | LIBOR
Debt Instrument [Line Items]
Interest rate (percentage)	2.34%
Mortgage notes payable, net | Rochester, NY Non-recourse, August 2021 | Rochester Portfolio
Debt Instrument [Line Items]
Principal Amount	$ 12,800	12,800
Carrying Value	$ 12,584	12,232
Mortgage notes payable, net | Rochester, NY Non-recourse, August 2021 | Rochester Portfolio | LIBOR
Debt Instrument [Line Items]
Interest rate (percentage)	2.90%
Mortgage notes payable, net | Non-Recourse
Debt Instrument [Line Items]
Principal Amount	$ 1,431,470	1,451,720
Carrying Value	$ 1,412,957	1,428,229
Mortgage notes payable, net | Non-Recourse | Arbors Portfolio
Debt Instrument [Line Items]
Contractual Interest Rate	3.99%
Principal Amount	$ 87,302	89,026
Carrying Value	$ 86,521	88,020
Mortgage notes payable, net | Non-Recourse | Watermark Fountains Portfolio
Debt Instrument [Line Items]
Contractual Interest Rate	3.92%
Principal Amount	$ 386,607	392,269
Carrying Value	$ 385,606	390,508
Mortgage notes payable, net | Non-Recourse | Watermark Fountains Portfolio 2
Debt Instrument [Line Items]
Contractual Interest Rate	5.56%
Principal Amount	$ 73,439	74,208
Carrying Value	$ 73,180	73,750
Number of healthcare real estate properties | property	7
Mortgage notes payable, net | Non-Recourse | Winterfell
Debt Instrument [Line Items]
Contractual Interest Rate	4.17%
Principal Amount	$ 622,045	632,024
Carrying Value	$ 607,526	614,415
Mortgage notes payable, net | Non-Recourse | Avamere Portfolio
Debt Instrument [Line Items]
Contractual Interest Rate	4.66%
Principal Amount	$ 70,427	71,464
Carrying Value	69,962	70,922
Mortgage notes payable, net | One-Month LIBOR
Debt Instrument [Line Items]
Principal Amount	171,700
Other notes payable | Non-Recourse
Debt Instrument [Line Items]
Principal Amount	3,914	3,693
Carrying Value	$ 3,914	3,693
Other notes payable | Non-Recourse | Oak Cottage
Debt Instrument [Line Items]
Contractual Interest Rate	6.00%
Principal Amount	$ 3,914	3,693
Carrying Value	3,914	3,693
Mortgages and other notes payable
Debt Instrument [Line Items]
Principal Amount	1,435,384	1,455,413
Carrying Value	$ 1,416,871	$ 1,431,922

Borrowings - Maturity Schedule

Borrowings - Maturity Schedule (Details) $ in Thousands	Dec. 31, 2020USD ($)
Debt Disclosure [Abstract]
2021	$ 79,696
2022	467,008
2023	19,696
2024	20,406
2025	670,302
Thereafter	178,276
Total	$ 1,435,384

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($)	Jul. 01, 2020	May 01, 2020	Apr. 30, 2020	Oct. 31, 2017	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Nov. 30, 2017
Line of Credit Facility [Line Items]
Forbearance period (days)		90 days
Principal amount of debt deferred					$ 1,300,000,000
Forbearance repayment period (months)					12 months
Interest expense					$ 65,991,000	$ 68,896,000	$ 70,196,000
Mortgage notes payable, net
Line of Credit Facility [Line Items]
Principal amount of mortgage note payable					1,435,384,000	$ 1,455,413,000
Rochester, NY | Mortgage notes payable, net
Line of Credit Facility [Line Items]
Maximum days of interest deferred	90 days
Maximum duration of principal payments to be deferred	120 days
Colony NorthStar, Inc. | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 15,000,000	35,000,000			$ 35,000,000
Expiration term (in years)				1 year
Line of credit extension term (in months)				6 months
Proceeds drawn under line of credit			$ 35,000,000
Interest expense					$ 900,000
LIBOR | Colony NorthStar, Inc. | Line of Credit
Line of Credit Facility [Line Items]
Contractual Interest Rate					3.50%

Borrowings - Schedule of Sponso

Borrowings - Schedule of Sponsor Line of Credit (Details) - Line of Credit - Colony NorthStar, Inc. - USD ($)	12 Months Ended
	Dec. 31, 2020	Nov. 30, 2017	Oct. 31, 2017
Debt Instrument [Line Items]
Capacity	$ 35,000,000	$ 35,000,000	$ 15,000,000
Principal Outstanding	$ 35,000,000
LIBOR
Debt Instrument [Line Items]
Contractual Interest Rate	3.50%

Related Party Arrangements - Ad

Related Party Arrangements - Advisor (Narrative) (Details)	1 Months Ended
	Jun. 30, 2020
Advisor
Related Party Transaction [Line Items]
Term of renewal (in years)	1 year

Related Party Arrangements - Fe

Related Party Arrangements - Fees to Advisor (Narrative) (Details) - USD ($) $ in Thousands	Jan. 01, 2018	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Due to related party		$ 8,318	$ 5,780	$ 5,675
Advisor | Asset Management Fees
Related Party Transaction [Line Items]
Monthly asset management fees as a percentage of investment amount	0.125%
Due to related party		$ 2,500
Share repurchase program period (in years)		2 years
Advisor | Incentive Fee
Related Party Transaction [Line Items]
Incentive fee distributions, percent of net cash flows		15.00%
Incentive fee distributions, minimum non-compounded annual pre-tax return on invested capital		6.75%
Advisor | Asset Disposition Fee
Related Party Transaction [Line Items]
Asset disposition fee as a percentage of contract sales price of property sold		2.00%
Asset disposition fee as a percentage of contract sales price of debt investment sold		1.00%
Asset disposition fee as a percentage of the debt investment prior to such transaction		1.00%

Related Party Arrangements - Re

Related Party Arrangements - Reimbursements to Advisor (Narrative) (Details) - Advisor - Operating Costs	12 Months Ended
	Dec. 31, 2020USD ($)quarter
Related Party Transaction [Line Items]
Reimbursement of personnel costs related to executive officers and other personnel involved in activities for which the Advisor receives an acquisition fee or disposition fee | $	$ 0
Number of preceding fiscal quarters | quarter	4
Percentage of average invested assets reimbursable as operating costs	2.00%
Expense reimbursement period (months)	12 months
Maximum
Related Party Transaction [Line Items]
Percentage of net income, without reduction for any additions to reserves for depreciation, loan losses or other similar non-cash reserves and excluding any gain from the sale of the company's assets	25.00%

Related Party Arrangements - Su

Related Party Arrangements - Summary of Fees and Reimbursements (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Related Party Transaction, Due to Related Parties [Roll Forward]
Due to related party, beginning balance	$ 5,780	$ 5,675
Incurred	31,852	31,681
Paid	(29,314)	(31,576)
Due to related party, ending balance	8,318	5,780
Issuance of common stock as payment for asset management fees	9,700	9,900
Gain on settlement of share based payment	300	100
Advisor | Asset management
Related Party Transaction, Due to Related Parties [Roll Forward]
Due to related party, ending balance	2,500
Advisor | Asset management | Asset management and other fees-related party
Related Party Transaction, Due to Related Parties [Roll Forward]
Due to related party, beginning balance	1,477	1,665
Incurred	17,170	19,789
Paid	(17,724)	(19,977)
Due to related party, ending balance	923	1,477
Advisor | Operating costs | General and administrative expenses
Related Party Transaction, Due to Related Parties [Roll Forward]
Due to related party, beginning balance	4,303	4,010
Incurred	14,682	11,892
Paid	(11,590)	(11,599)
Due to related party, ending balance	$ 7,395	$ 4,303

Related Party Arrangements - Is

Related Party Arrangements - Issuance of Common Stock to the Advisor (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Related Party Transaction [Line Items]
Share-based payment of advisor asset management fees (in shares)	1,600,000
Issuance of common stock as payment for asset management fees	$ 9,700	$ 9,900
Common stock (in shares)	190,409,341	189,111,561
Common stock	$ 1,904	$ 1,891
The Advisor, the Sponsor, and affiliates
Related Party Transaction [Line Items]
Common stock (in shares)	4,700,000
Common stock	$ 18,300
Common stock, outstanding (percentage)	2.10%

Related Party Arrangements - In

Related Party Arrangements - Investments in Joint Ventures (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Oct. 31, 2018	Dec. 31, 2015	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2018
Related Party Transaction [Line Items]
Investment portfolio			$ 1,483,930	$ 1,700,218
Payments to acquire interest in joint venture			0	39,801	$ 4,470
Sale of ownership interest in unconsolidated ventures			$ 0	$ 0	$ 47,813
Solstice Senior Living
Related Party Transaction [Line Items]
Ownership interest (as a percentage)			0.00%
American Healthcare Investors, LLC | Sponsor
Related Party Transaction [Line Items]
Ownership interest (as a percentage)			43.00%
The Trilogy Portfolio
Related Party Transaction [Line Items]
Ownership interest (as a percentage)	23.00%	29.00%				29.00%
Investment portfolio		$ 1,200,000
Payments to acquire interest in joint venture		$ 201,700
Ownership interest sold (as a percentage)	20.00%
Sale of ownership interest in unconsolidated ventures	$ 48,000
Winterfell | Solstice Senior Living
Related Party Transaction [Line Items]
Ownership interest (as a percentage)			20.00%
Winterfell | Solstice Senior Living
Related Party Transaction [Line Items]
Noncontrolling interest, ownership percentage by parent (as a percentage)			80.00%
Property management fee expense paid to joint venture			$ 5,000

Related Party Arrangements - Sc

Related Party Arrangements - Schedule of Joint Ventures (Details) - Colony NorthStar, Inc.	Dec. 31, 2020
Eclipse
Related Party Transaction [Line Items]
Ownership interest (as a percentage)	5.60%
Diversified US/UK (formerly Griffin-American)
Related Party Transaction [Line Items]
Ownership interest (as a percentage)	14.30%

Related Party Arrangements - Or

Related Party Arrangements - Origination of Mezzanine Loan (Narrative) (Details) - Variable Interest Entity, Not Primary Beneficiary - USD ($) $ in Millions	Dec. 31, 2020	Jul. 31, 2015
Related Party Transaction [Line Items]
VIE carrying value	$ 229.2
Mezzanine loans
Related Party Transaction [Line Items]
VIE carrying value		$ 75

Related Party Arrangements - Li

Related Party Arrangements - Line of Credit - Related Party (Narrative) (Details) - Line of Credit - Colony NorthStar, Inc. - USD ($)	12 Months Ended
	Dec. 31, 2020	Nov. 30, 2017	Oct. 31, 2017
Related Party Transaction [Line Items]
Maximum borrowing capacity	$ 35,000,000	$ 35,000,000	$ 15,000,000
LIBOR
Related Party Transaction [Line Items]
Contractual Interest Rate	3.50%

Equity-Based Compensation (Deta

Equity-Based Compensation (Details) - USD ($) $ in Millions	Dec. 31, 2014	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Equity-based compensation
Equity-based compensation expense		$ 0.2	$ 0.2	$ 0.2
Unrecognized equity-based compensation		$ 0.2	$ 0.2
Restricted stock
Equity-based compensation
Number of shares authorized		2,000,000
Restricted common shares grant vesting period	4 years	2 years
Unvested shares (in shares)		30,403	25,360
Independent Directors | Restricted stock
Equity-based compensation
Number of shares granted to independent directors (in shares)		159,932
Aggregate value for restricted common shares granted to independent directors		$ 1.3

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock (Details) - USD ($) shares in Millions, $ in Billions	1 Months Ended	71 Months Ended
	Jan. 19, 2016	Dec. 31, 2020
Class of Stock [Line Items]
Value of common stock issued		$ 2
Common Stock
Class of Stock [Line Items]
Number of shares issued (in shares)	173.4
Value of common stock issued	$ 1.7

Stockholders' Equity - Distribu

Stockholders' Equity - Distribution Reinvestment Plan (Details) - USD ($) $ / shares in Units, shares in Millions	1 Months Ended	12 Months Ended	60 Months Ended	71 Months Ended
	Jan. 19, 2016	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Apr. 30, 2016
Class of Stock [Line Items]
Value of common stock issued				$ 2,000,000,000
Common Stock
Class of Stock [Line Items]
Number of shares issued (in shares)	173.4
Value of common stock issued	$ 1,700,000,000
Dividend Reinvestment Plan
Class of Stock [Line Items]
Share price (in dollars per share)		$ 3.89	$ 3.89	$ 3.89	$ 6.25	$ 7.10	$ 8.50	$ 9.10	$ 8.63
Selling commissions or dealer manager fees paid		$ 0
Notice period served by board of directors to amend or terminate DRP (in days)		10 days
Dividend Reinvestment Plan | Common Stock
Class of Stock [Line Items]
Number of shares issued (in shares)			25.7
Value of common stock issued			$ 232,600,000
Initial Distribution Support Agreement | Dividend Reinvestment Plan
Class of Stock [Line Items]
Share price (in dollars per share)		$ 9.50	$ 9.50	9.50
Follow-on Distribution Reinvestment Plan
Class of Stock [Line Items]
Share price (in dollars per share)		$ 10.20	$ 10.20	$ 10.20
Percentage of offering price		95.00%	95.00%	95.00%
Follow-on Distribution Reinvestment Plan | Dividend Reinvestment Plan
Class of Stock [Line Items]
Share price (in dollars per share)		$ 9.69	$ 9.69	$ 9.69

Stockholders' Equity - Distri_2

Stockholders' Equity - Distributions (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended	24 Months Ended
	Jan. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019
Equity [Abstract]
Daily amount of distribution accrued per share (in dollars per share)	$ 0.000924658	$ 0.000924658	$ 0.00184932
Annualized distribution (in dollars per share)		$ 0.3375	$ 0.675
Operating loss carryforwards				$ 86

Stockholder's Equity - Dividend

Stockholder's Equity - Dividends Declared (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018
Distributions
Cash	$ 0	$ 0	$ 0	$ 2,991	$ 8,653	$ 8,374	$ 8,028	$ 7,684	$ 2,991	$ 32,739
DRP	0	0	0	2,422	7,352	7,567	7,722	7,876	2,422	30,517
Total	$ 0	$ 0	$ 0	$ 5,413	$ 16,005	$ 15,941	$ 15,750	$ 15,560	$ 5,413	$ 63,256

Stockholders' Equity - Share Re

Stockholders' Equity - Share Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Shares repurchased during period (in shares)	0.3	1.5
Value of shares repurchased during period	$ 2.1	$ 10.7
Average price per share (in dollars per share)	$ 6.29	$ 7.10

Non-controlling Interests (Deta

Non-controlling Interests (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Noncontrolling Interest [Abstract]
Comprehensive (income) loss attributable to non-controlling interests	$ 2,780	$ 790	$ 442

Fair Value - Schedule of the Pr

Fair Value - Schedule of the Principal Amount, Carrying Value and Fair Value of Certain Financial Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Financial Assets
Carrying Value	$ 55,864	$ 55,468
Financial Liabilities
Carrying Value	1,416,871	1,431,922
Carrying Value	8,318	5,780	$ 5,675
Mortgage and other notes payable, net
Financial Liabilities
Principal Amount	1,435,384	1,455,413
Carrying Value	1,416,871	1,431,922
Fair Value	1,354,832	1,450,876
Line of Credit
Financial Liabilities
Principal Amount	35,000	0
Carrying Value	35,000	0
Fair Value	35,000	0
Real estate debt investments, net
Financial Assets
Principal Amount	74,182	74,182
Carrying Value	55,864	55,468
Fair Value	$ 74,182	$ 74,182

Fair Value - Nonrecurring Fair

Fair Value - Nonrecurring Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Operating real estate, net	$ 1,483,930	$ 1,700,218
Assets held for sale	5,000	1,649
Impairment loss	166,000	27,600
Nonrecurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Operating real estate, net	234,650	58,804	$ 47,955
Assets held for sale	5,000	1,649	2,183
Nonrecurring | Level 3 | Operating Real Estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment loss	164,215	27,021	31,000
Nonrecurring | Level 3 | Assets Held-For-Sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment loss	$ 1,753	$ 533	$ 2,494

Fair Value - Narrative (Details

Fair Value - Narrative (Details) - Discounted cash flow method - Real estate investment - Nonrecurring	Dec. 31, 2020
Minimum | Terminal capitalization rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input (percentage)	0.0600
Minimum | Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input (percentage)	0.070
Maximum | Terminal capitalization rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input (percentage)	0.0775
Maximum | Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input (percentage)	0.0875

Quarterly Financial Informati_3

Quarterly Financial Information (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Property and other revenues	$ 66,841	$ 67,755	$ 69,308	$ 72,891	$ 72,907	$ 72,778	$ 74,972	$ 72,521	$ 275,348	$ 293,178	$ 294,271
Net interest income	1,936	1,927	1,906	1,905	1,932	1,946	1,923	1,902
Real estate properties - operating expenses	46,648	46,501	45,328	45,701	46,001	45,359	44,636	45,218	184,178	181,214	188,761
Impairment loss	74,531	0	91,437	0	17,408	0	10,146	0	165,968	27,554	36,277
Expenses	165,333	86,782	176,432	86,336	106,235	86,571	95,420	93,099	514,883	381,325	441,934
Equity in earnings (losses) of unconsolidated ventures	2,333	(1,043)	(34,763)	(993)	4,121	(3,037)	(4,405)	(224)	(34,466)	(3,545)	(33,517)
Net income (loss)	(93,538)	(18,158)	(139,995)	(12,547)	(26,924)	(14,697)	(17,460)	(18,669)	(264,238)	(77,750)	(152,020)
Net income (loss) attributable to NorthStar Healthcare Income, Inc. common stockholders	$ (91,709)	$ (17,987)	$ (139,281)	$ (12,481)	$ (26,573)	$ (14,624)	$ (17,146)	$ (18,617)	$ (261,458)	$ (76,960)	$ (151,578)
Net income (loss) per share of common stock, basic/diluted (in dollars per share)	$ (0.48)	$ (0.09)	$ (0.74)	$ (0.07)	$ (0.13)	$ (0.08)	$ (0.09)	$ (0.10)	$ (1.38)	$ (0.41)	$ (0.81)

Segment Reporting - Narrative (

Segment Reporting - Narrative (Details)	12 Months Ended
	Dec. 31, 2020segment
Segment Reporting [Abstract]
Number of segments	5

Segment Reporting - Schedule of

Segment Reporting - Schedule of Properties (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)unitproperty
Real Estate Properties [Line Items]
Properties Under Management | property	73
Units Under Management | unit	10,397
Property and Other Revenues | $	$ 275,348
Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	100.00%
Watermark Retirement Communities
Real Estate Properties [Line Items]
Properties Under Management | property	30
Units Under Management | unit	5,265
Property and Other Revenues | $	$ 138,708
Watermark Retirement Communities | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	50.30%
Solstice Senior Living
Real Estate Properties [Line Items]
Properties Under Management | property	32
Units Under Management | unit	4,000
Property and Other Revenues | $	$ 101,054
Solstice Senior Living | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	36.70%
Avamere Health Services
Real Estate Properties [Line Items]
Properties Under Management | property	5
Units Under Management | unit	453
Property and Other Revenues | $	$ 17,367
Avamere Health Services | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	6.30%
Arcadia Management
Real Estate Properties [Line Items]
Properties Under Management | property	4
Units Under Management | unit	572
Property and Other Revenues | $	$ 10,615
Arcadia Management | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	3.90%
Integral Senior Living
Real Estate Properties [Line Items]
Properties Under Management | property	1
Units Under Management | unit	44
Property and Other Revenues | $	$ 7,405
Integral Senior Living | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	2.70%
Senior Lifestyle Corporation
Real Estate Properties [Line Items]
Properties Under Management | property	1
Units Under Management | unit	63
Property and Other Revenues | $	$ 0
Senior Lifestyle Corporation | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	0.00%
Other
Real Estate Properties [Line Items]
Properties Under Management | property	0
Units Under Management | unit	0
Property and Other Revenues | $	$ 199
Other | Revenue
Real Estate Properties [Line Items]
Percentage of Total Property and Other Revenues	0.10%
Winterfell | Solstice Senior Living
Real Estate Properties [Line Items]
Noncontrolling interest, ownership percentage by parent (as a percentage)	80.00%

Segment Reporting - Segment Sta

Segment Reporting - Segment Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Segment Reporting Information [Line Items]
Property and other revenues									$ 275,348	$ 293,178	$ 294,271
Net interest income									7,674	7,703	9,031
Real estate properties - operating expenses	$ (46,648)	$ (46,501)	$ (45,328)	$ (45,701)	$ (46,001)	$ (45,359)	$ (44,636)	$ (45,218)	(184,178)	(181,214)	(188,761)
Interest expense									(65,991)	(68,896)	(70,196)
Other expenses related to securitization trust									0	0	(811)
Transaction costs									(65)	(122)	(888)
Asset management and other fees - related party									(17,170)	(19,789)	(23,478)
General and administrative expenses									(16,505)	(12,761)	(14,390)
Depreciation and amortization									(65,006)	(70,989)	(107,133)
Impairment loss	(74,531)	0	(91,437)	0	(17,408)	0	(10,146)	0	(165,968)	(27,554)	(36,277)
Other income									1,840	0	0
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other									302	6,314	20,243
Equity in earnings (losses) of unconsolidated ventures	2,333	(1,043)	(34,763)	(993)	4,121	(3,037)	(4,405)	(224)	(34,466)	(3,545)	(33,517)
Income tax expense									(53)	(75)	(114)
Net income (loss)	$ (93,538)	$ (18,158)	$ (139,995)	$ (12,547)	$ (26,924)	$ (14,697)	$ (17,460)	$ (18,669)	(264,238)	(77,750)	(152,020)
Discount accretion income									125	113	101
Direct Investments - Net Lease Segment
Segment Reporting Information [Line Items]
Property and other revenues									32,899	33,424
Net interest income									0	0
Real estate properties - operating expenses									(13)	(11)
Interest expense									(11,832)	(12,434)
Transaction costs									(58)	0
Asset management and other fees - related party									0	0
General and administrative expenses									(804)	(268)
Depreciation and amortization									(14,940)	(14,329)
Impairment loss									(722)	(4,132)
Other income									0
Realized gain (loss) on investments and other									0	5,872
Equity in earnings (losses) of unconsolidated ventures									0	0
Income tax expense									0	0
Net income (loss)									4,530	8,122
Direct Investments - Operating Segment
Segment Reporting Information [Line Items]
Property and other revenues									242,250	259,033
Net interest income									0	0
Real estate properties - operating expenses									(184,165)	(181,203)
Interest expense									(53,210)	(56,360)
Transaction costs									(7)	(122)
Asset management and other fees - related party									0	0
General and administrative expenses									(296)	(42)
Depreciation and amortization									(50,066)	(56,660)
Impairment loss									(165,246)	(23,422)
Other income									1,840
Realized gain (loss) on investments and other									(13)	719
Equity in earnings (losses) of unconsolidated ventures									0	0
Income tax expense									(53)	(75)
Net income (loss)									(208,966)	(58,132)
Unconsolidated Investments
Segment Reporting Information [Line Items]
Property and other revenues									0	0
Net interest income									0	0
Real estate properties - operating expenses									0	0
Interest expense									0	0
Transaction costs									0	0
Asset management and other fees - related party									0	0
General and administrative expenses									0	0
Depreciation and amortization									0	0
Impairment loss									0	0
Other income									0
Realized gain (loss) on investments and other									0	0
Equity in earnings (losses) of unconsolidated ventures									(34,466)	(3,545)
Income tax expense									0	0
Net income (loss)									(34,466)	(3,545)
Debt and Securities
Segment Reporting Information [Line Items]
Property and other revenues									0	35
Net interest income									7,674	7,703
Real estate properties - operating expenses									0	0
Interest expense									0	0
Transaction costs									0	0
Asset management and other fees - related party									0	0
General and administrative expenses									(19)	(38)
Depreciation and amortization									0	0
Impairment loss									0	0
Other income									0
Realized gain (loss) on investments and other									0	0
Equity in earnings (losses) of unconsolidated ventures									0	0
Income tax expense									0	0
Net income (loss)									7,655	7,700
Corporate
Segment Reporting Information [Line Items]
Property and other revenues									199	686
Net interest income									0	0
Real estate properties - operating expenses									0	0
Interest expense									(949)	(102)
Transaction costs									0	0
Asset management and other fees - related party									(17,170)	(19,789)
General and administrative expenses									(15,386)	(12,413)
Depreciation and amortization									0	0
Impairment loss									0	0
Other income									0
Realized gain (loss) on investments and other									315	(277)
Equity in earnings (losses) of unconsolidated ventures									0	0
Income tax expense									0	0
Net income (loss)									$ (32,991)	$ (31,895)
Operating Segments
Segment Reporting Information [Line Items]
Property and other revenues											294,271
Net interest income											8,220
Real estate properties - operating expenses											(188,761)
Interest expense											(70,196)
Other expenses related to securitization trust											0
Transaction costs											(888)
Asset management and other fees - related party											(23,478)
General and administrative expenses											(14,390)
Depreciation and amortization											(107,133)
Impairment loss											(36,277)
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other											20,243
Equity in earnings (losses) of unconsolidated ventures											(33,517)
Income tax expense											(114)
Net income (loss)											(152,020)
Operating Segments | Direct Investments - Net Lease Segment
Segment Reporting Information [Line Items]
Property and other revenues											34,276
Net interest income											0
Real estate properties - operating expenses											(1,346)
Interest expense											(13,326)
Other expenses related to securitization trust											0
Transaction costs											(60)
Asset management and other fees - related party											0
General and administrative expenses											(183)
Depreciation and amortization											(13,694)
Impairment loss											(5,094)
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other											0
Equity in earnings (losses) of unconsolidated ventures											0
Income tax expense											0
Net income (loss)											573
Operating Segments | Direct Investments - Operating Segment
Segment Reporting Information [Line Items]
Property and other revenues											258,779
Net interest income											0
Real estate properties - operating expenses											(187,415)
Interest expense											(56,595)
Other expenses related to securitization trust											0
Transaction costs											(828)
Asset management and other fees - related party											0
General and administrative expenses											(856)
Depreciation and amortization											(93,439)
Impairment loss											(31,183)
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other											2,525
Equity in earnings (losses) of unconsolidated ventures											0
Income tax expense											(114)
Net income (loss)											(109,126)
Operating Segments | Unconsolidated Investments
Segment Reporting Information [Line Items]
Property and other revenues											0
Net interest income											0
Real estate properties - operating expenses											0
Interest expense											0
Other expenses related to securitization trust											0
Transaction costs											0
Asset management and other fees - related party											0
General and administrative expenses											(2)
Depreciation and amortization											0
Impairment loss											0
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other											14,086
Equity in earnings (losses) of unconsolidated ventures											(33,517)
Income tax expense											0
Net income (loss)											(19,433)
Operating Segments | Debt and Securities
Segment Reporting Information [Line Items]
Property and other revenues											375
Net interest income											8,534
Real estate properties - operating expenses											0
Interest expense											0
Other expenses related to securitization trust											0
Transaction costs											0
Asset management and other fees - related party											0
General and administrative expenses											(46)
Depreciation and amortization											0
Impairment loss											0
Unrealized gain (loss) on mortgage loans held in securitization trust, net											(314)
Realized gain (loss) on investments and other											3,495
Equity in earnings (losses) of unconsolidated ventures											0
Income tax expense											0
Net income (loss)											12,044
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Property and other revenues											841
Net interest income											(314)
Real estate properties - operating expenses											0
Interest expense											(275)
Other expenses related to securitization trust											0
Transaction costs											0
Asset management and other fees - related party											(23,478)
General and administrative expenses											(13,303)
Depreciation and amortization											0
Impairment loss											0
Unrealized gain (loss) on mortgage loans held in securitization trust, net											314
Realized gain (loss) on investments and other											137
Equity in earnings (losses) of unconsolidated ventures											0
Income tax expense											0
Net income (loss)											(36,078)
Discount accretion income											300
Investing VIE
Segment Reporting Information [Line Items]
Property and other revenues											0
Net interest income											811
Real estate properties - operating expenses											0
Interest expense											0
Other expenses related to securitization trust											(811)
Transaction costs											0
Asset management and other fees - related party											0
General and administrative expenses											0
Depreciation and amortization											0
Impairment loss											0
Unrealized gain (loss) on mortgage loans held in securitization trust, net											0
Realized gain (loss) on investments and other											0
Equity in earnings (losses) of unconsolidated ventures											0
Income tax expense											0
Net income (loss)											$ 0

Segment Reporting - Summary of

Segment Reporting - Summary of Assets by Segment (Details) - USD ($) $ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Assets	[1]	$ 1,918,436	$ 2,141,207
Direct Investments - Net Lease Segment
Segment Reporting Information [Line Items]
Assets		348,688	365,789
Direct Investments - Operating Segment
Segment Reporting Information [Line Items]
Assets		1,223,045	1,420,023
Unconsolidated Investments
Segment Reporting Information [Line Items]
Assets		229,170	268,892
Debt and Securities
Segment Reporting Information [Line Items]
Assets		56,502	56,099
Corporate
Segment Reporting Information [Line Items]
Assets		$ 61,031	$ 30,404
[1]	Represents the consolidated assets and liabilities of NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Operating Partnership is a consolidated variable interest entity (“VIE”), of which the Company is the sole general partner and owns approximately 99.99%. As of December 31, 2020, the Operating Partnership includes $0.5 billion and $0.5 billion of assets and liabilities, respectively, of certain VIEs that are consolidated by the Operating Partnership. Refer to Note 2, “Summary of Significant Accounting Policies.”

Subsequent Events - Narrative (

Subsequent Events - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Jan. 31, 2021	Mar. 18, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Subsequent Event [Line Items]
Repayment of real estate debt investment			$ 0	$ 818	$ 0
Mortgage notes payable, net
Subsequent Event [Line Items]
Principal amount of mortgage note payable			1,435,384	1,455,413
Denver, CO | Denver, CO Non-recourse | Mortgage notes payable, net
Subsequent Event [Line Items]
Principal amount of mortgage note payable			$ 20,189	$ 20,547
Subsequent event
Subsequent Event [Line Items]
Proceeds from government assistance	$ 6,800
Subsequent event | Watermark Aqua Portfolio | Mortgage notes payable, net
Subsequent Event [Line Items]
Refinanced amount	18,700
Principal amount of mortgage note payable	$ 26,000
Contractual Interest Rate	3.00%
Subsequent event | Mezzanine loans
Subsequent Event [Line Items]
Repayment of real estate debt investment		$ 24,900

Schedule III - Real Estate an_2

Schedule III - Real Estate and Accumulated Depreciation - Schedule of Real Estate Properties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Gross amount carried at close of period, total	$ 1,774,971	$ 1,931,032	$ 1,949,997	$ 1,966,352
Accumulated depreciation	291,041	$ 230,814	$ 171,083	$ 113,924
Federal income tax basis over cost basis	2,200,000
Smyrna, GA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	825
Initial cost of buildings and improvements	9,175
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(5,730)
Gross amount carried at close of period, land	825
Gross amount carried at close of period, buildings and improvements	3,445
Gross amount carried at close of period, total	4,270
Accumulated depreciation	1,561
Total	$ 2,709
Life on which depreciation is computed (in years)	40 years
Bohemia, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 23,214
Initial cost of land	4,258
Initial cost of buildings and improvements	27,805
Costs capitalized subsequent to acquisition, land, buildings, and improvements	160
Gross amount carried at close of period, land	4,258
Gross amount carried at close of period, buildings and improvements	27,965
Gross amount carried at close of period, total	32,223
Accumulated depreciation	5,050
Total	$ 27,173
Life on which depreciation is computed (in years)	40 years
Hauppauge, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 14,084
Initial cost of land	2,086
Initial cost of buildings and improvements	18,495
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,351
Gross amount carried at close of period, land	2,086
Gross amount carried at close of period, buildings and improvements	19,846
Gross amount carried at close of period, total	21,932
Accumulated depreciation	3,829
Total	$ 18,103
Life on which depreciation is computed (in years)	40 years
Islandia, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 34,670
Initial cost of land	8,437
Initial cost of buildings and improvements	37,198
Costs capitalized subsequent to acquisition, land, buildings, and improvements	291
Gross amount carried at close of period, land	8,437
Gross amount carried at close of period, buildings and improvements	37,489
Gross amount carried at close of period, total	45,926
Accumulated depreciation	6,904
Total	$ 39,022
Life on which depreciation is computed (in years)	40 years
Westbury, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 15,334
Initial cost of land	2,506
Initial cost of buildings and improvements	19,163
Costs capitalized subsequent to acquisition, land, buildings, and improvements	293
Gross amount carried at close of period, land	2,506
Gross amount carried at close of period, buildings and improvements	19,456
Gross amount carried at close of period, total	21,962
Accumulated depreciation	3,466
Total	$ 18,496
Life on which depreciation is computed (in years)	40 years
Bellevue, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 29,763
Initial cost of land	13,801
Initial cost of buildings and improvements	18,208
Costs capitalized subsequent to acquisition, land, buildings, and improvements	4,092
Gross amount carried at close of period, land	13,801
Gross amount carried at close of period, buildings and improvements	22,300
Gross amount carried at close of period, total	36,101
Accumulated depreciation	5,248
Total	$ 30,853
Life on which depreciation is computed (in years)	40 years
Dana Point, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 31,552
Initial cost of land	6,286
Initial cost of buildings and improvements	41,199
Costs capitalized subsequent to acquisition, land, buildings, and improvements	727
Gross amount carried at close of period, land	6,286
Gross amount carried at close of period, buildings and improvements	41,926
Gross amount carried at close of period, total	48,212
Accumulated depreciation	6,891
Total	$ 41,321
Life on which depreciation is computed (in years)	40 years
Kalamazoo, MI
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 33,520
Initial cost of land	4,521
Initial cost of buildings and improvements	30,870
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,987
Gross amount carried at close of period, land	4,521
Gross amount carried at close of period, buildings and improvements	33,857
Gross amount carried at close of period, total	38,378
Accumulated depreciation	7,188
Total	$ 31,190
Life on which depreciation is computed (in years)	40 years
Oklahoma City, OK
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 2,890
Initial cost of land	3,104
Initial cost of buildings and improvements	6,119
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,477
Gross amount carried at close of period, land	3,104
Gross amount carried at close of period, buildings and improvements	7,596
Gross amount carried at close of period, total	10,700
Accumulated depreciation	2,765
Total	$ 7,935
Life on which depreciation is computed (in years)	40 years
Palm Desert, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,901
Initial cost of land	5,365
Initial cost of buildings and improvements	38,889
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,981
Gross amount carried at close of period, land	5,365
Gross amount carried at close of period, buildings and improvements	41,870
Gross amount carried at close of period, total	47,235
Accumulated depreciation	8,422
Total	$ 38,813
Life on which depreciation is computed (in years)	40 years
Sarasota, FL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 72,029
Initial cost of land	12,845
Initial cost of buildings and improvements	64,403
Costs capitalized subsequent to acquisition, land, buildings, and improvements	4,985
Gross amount carried at close of period, land	12,845
Gross amount carried at close of period, buildings and improvements	69,388
Gross amount carried at close of period, total	82,233
Accumulated depreciation	13,326
Total	$ 68,907
Life on which depreciation is computed (in years)	40 years
Milford, OH
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,760
Initial cost of land	1,160
Initial cost of buildings and improvements	14,440
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,767
Gross amount carried at close of period, land	1,160
Gross amount carried at close of period, buildings and improvements	16,207
Gross amount carried at close of period, total	17,367
Accumulated depreciation	3,869
Total	$ 13,498
Life on which depreciation is computed (in years)	40 years
Milford, OH
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 0
Initial cost of land	700
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	5,603
Gross amount carried at close of period, land	700
Gross amount carried at close of period, buildings and improvements	5,603
Gross amount carried at close of period, total	6,303
Accumulated depreciation	384
Total	$ 5,919
Life on which depreciation is computed (in years)	40 years
Denver, CO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 20,189
Initial cost of land	4,300
Initial cost of buildings and improvements	27,200
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(10,248)
Gross amount carried at close of period, land	4,300
Gross amount carried at close of period, buildings and improvements	16,952
Gross amount carried at close of period, total	21,252
Accumulated depreciation	7,409
Total	$ 13,843
Life on which depreciation is computed (in years)	40 years
Frisco, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,770
Initial cost of land	3,100
Initial cost of buildings and improvements	35,874
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,646
Gross amount carried at close of period, land	3,100
Gross amount carried at close of period, buildings and improvements	38,520
Gross amount carried at close of period, total	41,620
Accumulated depreciation	7,440
Total	$ 34,180
Life on which depreciation is computed (in years)	40 years
Alexandria, VA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 43,679
Initial cost of land	7,950
Initial cost of buildings and improvements	41,124
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,800
Gross amount carried at close of period, land	7,950
Gross amount carried at close of period, buildings and improvements	43,924
Gross amount carried at close of period, total	51,874
Accumulated depreciation	7,516
Total	$ 44,358
Life on which depreciation is computed (in years)	40 years
Crystal Lake, IL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 26,657
Initial cost of land	6,580
Initial cost of buildings and improvements	28,210
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(894)
Gross amount carried at close of period, land	6,580
Gross amount carried at close of period, buildings and improvements	27,316
Gross amount carried at close of period, total	33,896
Accumulated depreciation	5,483
Total	$ 28,413
Life on which depreciation is computed (in years)	40 years
Independence, MO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 15,051
Initial cost of land	1,280
Initial cost of buildings and improvements	17,090
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(1,692)
Gross amount carried at close of period, land	1,280
Gross amount carried at close of period, buildings and improvements	15,398
Gross amount carried at close of period, total	16,678
Accumulated depreciation	3,649
Total	$ 13,029
Life on which depreciation is computed (in years)	40 years
Millbrook, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 23,951
Initial cost of land	6,610
Initial cost of buildings and improvements	20,854
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(2,123)
Gross amount carried at close of period, land	6,610
Gross amount carried at close of period, buildings and improvements	18,731
Gross amount carried at close of period, total	25,341
Accumulated depreciation	5,198
Total	$ 20,143
Life on which depreciation is computed (in years)	40 years
St. Petersburg, FL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 39,375
Initial cost of land	8,920
Initial cost of buildings and improvements	44,137
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(19,577)
Gross amount carried at close of period, land	8,920
Gross amount carried at close of period, buildings and improvements	24,560
Gross amount carried at close of period, total	33,480
Accumulated depreciation	9,305
Total	$ 24,175
Life on which depreciation is computed (in years)	40 years
Tarboro, NC
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 21,854
Initial cost of land	2,400
Initial cost of buildings and improvements	17,800
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,749
Gross amount carried at close of period, land	2,400
Gross amount carried at close of period, buildings and improvements	19,549
Gross amount carried at close of period, total	21,949
Accumulated depreciation	4,512
Total	$ 17,437
Life on which depreciation is computed (in years)	40 years
Tuckahoe, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 35,846
Initial cost of land	4,870
Initial cost of buildings and improvements	26,980
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,627
Gross amount carried at close of period, land	4,870
Gross amount carried at close of period, buildings and improvements	28,607
Gross amount carried at close of period, total	33,477
Accumulated depreciation	4,746
Total	$ 28,731
Life on which depreciation is computed (in years)	40 years
Tucson, AZ
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 63,978
Initial cost of land	7,370
Initial cost of buildings and improvements	60,719
Costs capitalized subsequent to acquisition, land, buildings, and improvements	5,990
Gross amount carried at close of period, land	7,370
Gross amount carried at close of period, buildings and improvements	66,709
Gross amount carried at close of period, total	74,079
Accumulated depreciation	11,931
Total	$ 62,148
Life on which depreciation is computed (in years)	40 years
Apple Valley, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 20,956
Initial cost of land	1,168
Initial cost of buildings and improvements	24,625
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(7,482)
Gross amount carried at close of period, land	1,168
Gross amount carried at close of period, buildings and improvements	17,143
Gross amount carried at close of period, total	18,311
Accumulated depreciation	3,815
Total	$ 14,496
Life on which depreciation is computed (in years)	40 years
Auburn, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 23,675
Initial cost of land	1,694
Initial cost of buildings and improvements	18,438
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,233
Gross amount carried at close of period, land	1,694
Gross amount carried at close of period, buildings and improvements	19,671
Gross amount carried at close of period, total	21,365
Accumulated depreciation	3,407
Total	$ 17,958
Life on which depreciation is computed (in years)	40 years
Austin, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 26,068
Initial cost of land	4,020
Initial cost of buildings and improvements	19,417
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,435
Gross amount carried at close of period, land	4,020
Gross amount carried at close of period, buildings and improvements	21,852
Gross amount carried at close of period, total	25,872
Accumulated depreciation	3,724
Total	$ 22,148
Life on which depreciation is computed (in years)	40 years
Bakersfield, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 16,543
Initial cost of land	1,831
Initial cost of buildings and improvements	21,006
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,319
Gross amount carried at close of period, land	1,831
Gross amount carried at close of period, buildings and improvements	22,325
Gross amount carried at close of period, total	24,156
Accumulated depreciation	3,761
Total	$ 20,395
Life on which depreciation is computed (in years)	40 years
Bangor, ME
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 21,130
Initial cost of land	2,463
Initial cost of buildings and improvements	23,205
Costs capitalized subsequent to acquisition, land, buildings, and improvements	952
Gross amount carried at close of period, land	2,463
Gross amount carried at close of period, buildings and improvements	24,157
Gross amount carried at close of period, total	26,620
Accumulated depreciation	3,978
Total	$ 22,642
Life on which depreciation is computed (in years)	40 years
Bellingham, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 23,462
Initial cost of land	2,242
Initial cost of buildings and improvements	18,807
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,566
Gross amount carried at close of period, land	2,242
Gross amount carried at close of period, buildings and improvements	20,373
Gross amount carried at close of period, total	22,615
Accumulated depreciation	3,443
Total	$ 19,172
Life on which depreciation is computed (in years)	40 years
Clovis, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,464
Initial cost of land	1,821
Initial cost of buildings and improvements	21,721
Costs capitalized subsequent to acquisition, land, buildings, and improvements	715
Gross amount carried at close of period, land	1,821
Gross amount carried at close of period, buildings and improvements	22,436
Gross amount carried at close of period, total	24,257
Accumulated depreciation	3,644
Total	$ 20,613
Life on which depreciation is computed (in years)	40 years
Columbia, MO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 22,340
Initial cost of land	1,621
Initial cost of buildings and improvements	23,521
Costs capitalized subsequent to acquisition, land, buildings, and improvements	870
Gross amount carried at close of period, land	1,621
Gross amount carried at close of period, buildings and improvements	24,391
Gross amount carried at close of period, total	26,012
Accumulated depreciation	3,914
Total	$ 22,098
Life on which depreciation is computed (in years)	40 years
Corpus Christi, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,278
Initial cost of land	2,263
Initial cost of buildings and improvements	20,142
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(5,447)
Gross amount carried at close of period, land	2,263
Gross amount carried at close of period, buildings and improvements	14,695
Gross amount carried at close of period, total	16,958
Accumulated depreciation	3,466
Total	$ 13,492
Life on which depreciation is computed (in years)	40 years
East Amherst, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,207
Initial cost of land	2,873
Initial cost of buildings and improvements	18,279
Costs capitalized subsequent to acquisition, land, buildings, and improvements	648
Gross amount carried at close of period, land	2,873
Gross amount carried at close of period, buildings and improvements	18,927
Gross amount carried at close of period, total	21,800
Accumulated depreciation	3,099
Total	$ 18,701
Life on which depreciation is computed (in years)	40 years
El Cajon, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 20,655
Initial cost of land	2,357
Initial cost of buildings and improvements	14,733
Costs capitalized subsequent to acquisition, land, buildings, and improvements	923
Gross amount carried at close of period, land	2,357
Gross amount carried at close of period, buildings and improvements	15,656
Gross amount carried at close of period, total	18,013
Accumulated depreciation	2,830
Total	$ 15,183
Life on which depreciation is computed (in years)	40 years
El Paso, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 11,998
Initial cost of land	1,610
Initial cost of buildings and improvements	14,103
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,124
Gross amount carried at close of period, land	1,610
Gross amount carried at close of period, buildings and improvements	15,227
Gross amount carried at close of period, total	16,837
Accumulated depreciation	2,571
Total	$ 14,266
Life on which depreciation is computed (in years)	40 years
Fairport, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 16,260
Initial cost of land	1,452
Initial cost of buildings and improvements	19,427
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,077
Gross amount carried at close of period, land	1,452
Gross amount carried at close of period, buildings and improvements	20,504
Gross amount carried at close of period, total	21,956
Accumulated depreciation	3,049
Total	$ 18,907
Life on which depreciation is computed (in years)	40 years
Fenton, MO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 24,162
Initial cost of land	2,410
Initial cost of buildings and improvements	22,216
Costs capitalized subsequent to acquisition, land, buildings, and improvements	999
Gross amount carried at close of period, land	2,410
Gross amount carried at close of period, buildings and improvements	23,215
Gross amount carried at close of period, total	25,625
Accumulated depreciation	3,849
Total	$ 21,776
Life on which depreciation is computed (in years)	40 years
Grand Junction, CO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,148
Initial cost of land	2,525
Initial cost of buildings and improvements	26,446
Costs capitalized subsequent to acquisition, land, buildings, and improvements	715
Gross amount carried at close of period, land	2,525
Gross amount carried at close of period, buildings and improvements	27,161
Gross amount carried at close of period, total	29,686
Accumulated depreciation	4,402
Total	$ 25,284
Life on which depreciation is computed (in years)	40 years
Grand Junction, CO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 9,796
Initial cost of land	1,147
Initial cost of buildings and improvements	12,523
Costs capitalized subsequent to acquisition, land, buildings, and improvements	913
Gross amount carried at close of period, land	1,147
Gross amount carried at close of period, buildings and improvements	13,436
Gross amount carried at close of period, total	14,583
Accumulated depreciation	2,449
Total	$ 12,134
Life on which depreciation is computed (in years)	40 years
Grapevine, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 21,947
Initial cost of land	1,852
Initial cost of buildings and improvements	18,143
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(9,710)
Gross amount carried at close of period, land	1,852
Gross amount carried at close of period, buildings and improvements	8,433
Gross amount carried at close of period, total	10,285
Accumulated depreciation	3,145
Total	$ 7,140
Life on which depreciation is computed (in years)	40 years
Groton, CT
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 17,292
Initial cost of land	3,673
Initial cost of buildings and improvements	21,879
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(9,371)
Gross amount carried at close of period, land	3,673
Gross amount carried at close of period, buildings and improvements	12,508
Gross amount carried at close of period, total	16,181
Accumulated depreciation	3,986
Total	$ 12,195
Life on which depreciation is computed (in years)	40 years
Guilford, CT
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 23,877
Initial cost of land	6,725
Initial cost of buildings and improvements	27,488
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(23,109)
Gross amount carried at close of period, land	6,725
Gross amount carried at close of period, buildings and improvements	4,379
Gross amount carried at close of period, total	11,104
Accumulated depreciation	4,010
Total	$ 7,094
Life on which depreciation is computed (in years)	40 years
Joliet, IL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 14,675
Initial cost of land	1,473
Initial cost of buildings and improvements	23,427
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(7,175)
Gross amount carried at close of period, land	1,473
Gross amount carried at close of period, buildings and improvements	16,252
Gross amount carried at close of period, total	17,725
Accumulated depreciation	3,559
Total	$ 14,166
Life on which depreciation is computed (in years)	40 years
Kennewick, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 7,543
Initial cost of land	1,168
Initial cost of buildings and improvements	18,933
Costs capitalized subsequent to acquisition, land, buildings, and improvements	820
Gross amount carried at close of period, land	1,168
Gross amount carried at close of period, buildings and improvements	19,753
Gross amount carried at close of period, total	20,921
Accumulated depreciation	3,215
Total	$ 17,706
Life on which depreciation is computed (in years)	40 years
Las Cruces, NM
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 10,992
Initial cost of land	1,568
Initial cost of buildings and improvements	15,091
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,399
Gross amount carried at close of period, land	1,568
Gross amount carried at close of period, buildings and improvements	16,490
Gross amount carried at close of period, total	18,058
Accumulated depreciation	2,739
Total	$ 15,319
Life on which depreciation is computed (in years)	40 years
Lees Summit, MO
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 26,716
Initial cost of land	1,263
Initial cost of buildings and improvements	20,500
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,084
Gross amount carried at close of period, land	1,263
Gross amount carried at close of period, buildings and improvements	21,584
Gross amount carried at close of period, total	22,847
Accumulated depreciation	3,742
Total	$ 19,105
Life on which depreciation is computed (in years)	40 years
Lodi, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,792
Initial cost of land	2,863
Initial cost of buildings and improvements	21,152
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,029
Gross amount carried at close of period, land	2,863
Gross amount carried at close of period, buildings and improvements	22,181
Gross amount carried at close of period, total	25,044
Accumulated depreciation	3,728
Total	$ 21,316
Life on which depreciation is computed (in years)	40 years
Normandy Park, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 15,972
Initial cost of land	2,031
Initial cost of buildings and improvements	16,407
Costs capitalized subsequent to acquisition, land, buildings, and improvements	987
Gross amount carried at close of period, land	2,031
Gross amount carried at close of period, buildings and improvements	17,394
Gross amount carried at close of period, total	19,425
Accumulated depreciation	2,948
Total	$ 16,477
Life on which depreciation is computed (in years)	40 years
Palatine, IL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,761
Initial cost of land	1,221
Initial cost of buildings and improvements	26,993
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(12,068)
Gross amount carried at close of period, land	1,221
Gross amount carried at close of period, buildings and improvements	14,925
Gross amount carried at close of period, total	16,146
Accumulated depreciation	4,755
Total	$ 11,391
Life on which depreciation is computed (in years)	40 years
Plano, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 15,811
Initial cost of land	2,200
Initial cost of buildings and improvements	14,860
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(6,201)
Gross amount carried at close of period, land	2,200
Gross amount carried at close of period, buildings and improvements	8,659
Gross amount carried at close of period, total	10,859
Accumulated depreciation	2,837
Total	$ 8,022
Life on which depreciation is computed (in years)	40 years
Renton, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 18,743
Initial cost of land	2,642
Initial cost of buildings and improvements	20,469
Costs capitalized subsequent to acquisition, land, buildings, and improvements	952
Gross amount carried at close of period, land	2,642
Gross amount carried at close of period, buildings and improvements	21,421
Gross amount carried at close of period, total	24,063
Accumulated depreciation	3,631
Total	$ 20,432
Life on which depreciation is computed (in years)	40 years
Sandy, UT
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 15,523
Initial cost of land	2,810
Initial cost of buildings and improvements	19,132
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(6,021)
Gross amount carried at close of period, land	2,810
Gross amount carried at close of period, buildings and improvements	13,111
Gross amount carried at close of period, total	15,921
Accumulated depreciation	3,167
Total	$ 12,754
Life on which depreciation is computed (in years)	40 years
Santa Rosa, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 27,457
Initial cost of land	5,409
Initial cost of buildings and improvements	26,183
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,697
Gross amount carried at close of period, land	5,409
Gross amount carried at close of period, buildings and improvements	27,880
Gross amount carried at close of period, total	33,289
Accumulated depreciation	4,652
Total	$ 28,637
Life on which depreciation is computed (in years)	40 years
Sun City West, AZ
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 25,230
Initial cost of land	2,684
Initial cost of buildings and improvements	29,056
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(6,820)
Gross amount carried at close of period, land	2,684
Gross amount carried at close of period, buildings and improvements	22,236
Gross amount carried at close of period, total	24,920
Accumulated depreciation	5,004
Total	$ 19,916
Life on which depreciation is computed (in years)	40 years
Tacoma, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 29,572
Initial cost of land	7,974
Initial cost of buildings and improvements	32,435
Costs capitalized subsequent to acquisition, land, buildings, and improvements	2,352
Gross amount carried at close of period, land	7,977
Gross amount carried at close of period, buildings and improvements	34,784
Gross amount carried at close of period, total	42,761
Accumulated depreciation	5,947
Total	$ 36,814
Life on which depreciation is computed (in years)	40 years
Frisco, TX
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 0
Initial cost of land	1,130
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	12,595
Gross amount carried at close of period, land	1,130
Gross amount carried at close of period, buildings and improvements	12,595
Gross amount carried at close of period, total	13,725
Accumulated depreciation	1,634
Total	$ 12,091
Life on which depreciation is computed (in years)	40 years
Albany, OR
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 8,650
Initial cost of land	958
Initial cost of buildings and improvements	6,625
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(3,606)
Gross amount carried at close of period, land	758
Gross amount carried at close of period, buildings and improvements	3,219
Gross amount carried at close of period, total	3,977
Accumulated depreciation	1,055
Total	$ 2,922
Life on which depreciation is computed (in years)	40 years
Port Townsend, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 16,537
Initial cost of land	1,613
Initial cost of buildings and improvements	21,460
Costs capitalized subsequent to acquisition, land, buildings, and improvements	658
Gross amount carried at close of period, land	996
Gross amount carried at close of period, buildings and improvements	22,735
Gross amount carried at close of period, total	23,731
Accumulated depreciation	2,999
Total	$ 20,732
Life on which depreciation is computed (in years)	40 years
Roseburg, OR
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 12,236
Initial cost of land	699
Initial cost of buildings and improvements	11,589
Costs capitalized subsequent to acquisition, land, buildings, and improvements	645
Gross amount carried at close of period, land	459
Gross amount carried at close of period, buildings and improvements	12,474
Gross amount carried at close of period, total	12,933
Accumulated depreciation	1,639
Total	$ 11,294
Life on which depreciation is computed (in years)	40 years
Sandy, OR
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 13,956
Initial cost of land	1,611
Initial cost of buildings and improvements	16,697
Costs capitalized subsequent to acquisition, land, buildings, and improvements	772
Gross amount carried at close of period, land	1,233
Gross amount carried at close of period, buildings and improvements	17,847
Gross amount carried at close of period, total	19,080
Accumulated depreciation	2,205
Total	$ 16,875
Life on which depreciation is computed (in years)	40 years
Santa Barbara, CA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 3,914
Initial cost of land	2,408
Initial cost of buildings and improvements	15,674
Costs capitalized subsequent to acquisition, land, buildings, and improvements	343
Gross amount carried at close of period, land	2,408
Gross amount carried at close of period, buildings and improvements	16,017
Gross amount carried at close of period, total	18,425
Accumulated depreciation	1,734
Total	$ 16,691
Life on which depreciation is computed (in years)	40 years
Wenatchee, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,048
Initial cost of land	2,540
Initial cost of buildings and improvements	28,971
Costs capitalized subsequent to acquisition, land, buildings, and improvements	865
Gross amount carried at close of period, land	1,534
Gross amount carried at close of period, buildings and improvements	30,842
Gross amount carried at close of period, total	32,376
Accumulated depreciation	3,559
Total	$ 28,817
Life on which depreciation is computed (in years)	40 years
Churchville, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 6,575
Initial cost of land	296
Initial cost of buildings and improvements	7,712
Costs capitalized subsequent to acquisition, land, buildings, and improvements	479
Gross amount carried at close of period, land	296
Gross amount carried at close of period, buildings and improvements	8,191
Gross amount carried at close of period, total	8,487
Accumulated depreciation	1,134
Total	$ 7,353
Life on which depreciation is computed (in years)	35 years
Greece, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 0
Initial cost of land	534
Initial cost of buildings and improvements	18,158
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(11,126)
Gross amount carried at close of period, land	533
Gross amount carried at close of period, buildings and improvements	7,033
Gross amount carried at close of period, total	7,566
Accumulated depreciation	1,431
Total	$ 6,135
Life on which depreciation is computed (in years)	49 years
Greece, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 26,833
Initial cost of land	1,007
Initial cost of buildings and improvements	31,960
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,477
Gross amount carried at close of period, land	1,007
Gross amount carried at close of period, buildings and improvements	33,437
Gross amount carried at close of period, total	34,444
Accumulated depreciation	3,762
Total	$ 30,682
Life on which depreciation is computed (in years)	41 years
Henrietta, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 11,881
Initial cost of land	1,153
Initial cost of buildings and improvements	16,812
Costs capitalized subsequent to acquisition, land, buildings, and improvements	930
Gross amount carried at close of period, land	1,152
Gross amount carried at close of period, buildings and improvements	17,743
Gross amount carried at close of period, total	18,895
Accumulated depreciation	2,561
Total	$ 16,334
Life on which depreciation is computed (in years)	36 years
Penfield, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 12,502
Initial cost of land	781
Initial cost of buildings and improvements	20,273
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(8,440)
Gross amount carried at close of period, land	781
Gross amount carried at close of period, buildings and improvements	11,833
Gross amount carried at close of period, total	12,614
Accumulated depreciation	2,692
Total	$ 9,922
Life on which depreciation is computed (in years)	30 years
Penfield, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 10,918
Initial cost of land	516
Initial cost of buildings and improvements	9,898
Costs capitalized subsequent to acquisition, land, buildings, and improvements	490
Gross amount carried at close of period, land	515
Gross amount carried at close of period, buildings and improvements	10,389
Gross amount carried at close of period, total	10,904
Accumulated depreciation	1,406
Total	$ 9,498
Life on which depreciation is computed (in years)	35 years
Rochester, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 19,907
Initial cost of land	2,426
Initial cost of buildings and improvements	31,861
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,708
Gross amount carried at close of period, land	2,425
Gross amount carried at close of period, buildings and improvements	33,570
Gross amount carried at close of period, total	35,995
Accumulated depreciation	3,885
Total	$ 32,110
Life on which depreciation is computed (in years)	39 years
Rochester, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 5,341
Initial cost of land	297
Initial cost of buildings and improvements	12,484
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(9,263)
Gross amount carried at close of period, land	296
Gross amount carried at close of period, buildings and improvements	3,222
Gross amount carried at close of period, total	3,518
Accumulated depreciation	1,778
Total	$ 1,740
Life on which depreciation is computed (in years)	37 years
Victor, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 27,174
Initial cost of land	1,060
Initial cost of buildings and improvements	33,246
Costs capitalized subsequent to acquisition, land, buildings, and improvements	1,910
Gross amount carried at close of period, land	1,059
Gross amount carried at close of period, buildings and improvements	35,157
Gross amount carried at close of period, total	36,216
Accumulated depreciation	3,842
Total	$ 32,374
Life on which depreciation is computed (in years)	41 years
Penfield, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 12,800
Initial cost of land	557
Initial cost of buildings and improvements	13,570
Costs capitalized subsequent to acquisition, land, buildings, and improvements	17
Gross amount carried at close of period, land	556
Gross amount carried at close of period, buildings and improvements	13,588
Gross amount carried at close of period, total	14,144
Accumulated depreciation	1,167
Total	$ 12,977
Life on which depreciation is computed (in years)	41 years
Undeveloped Land
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	$ 1,435,384
Initial cost of land	237,151
Initial cost of buildings and improvements	1,613,699
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(75,879)
Gross amount carried at close of period, land	234,706
Gross amount carried at close of period, buildings and improvements	1,540,265
Gross amount carried at close of period, total	1,774,971
Accumulated depreciation	291,041
Total	1,483,930
Undeveloped Land | Bellevue, WA
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	14,200
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	14,200
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	14,200
Accumulated depreciation	0
Total	14,200
Undeveloped Land | Kalamazoo, MI
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	100
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	100
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	100
Accumulated depreciation	0
Total	100
Undeveloped Land | Crystal Lake, IL
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	810
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	810
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	810
Accumulated depreciation	0
Total	810
Undeveloped Land | Millbrook, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	1,050
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	1,050
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	1,050
Accumulated depreciation	0
Total	1,050
Undeveloped Land | Rochester, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	544
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	544
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	544
Accumulated depreciation	0
Total	544
Undeveloped Land | Penfield, NY
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land	534
Initial cost of buildings and improvements	0
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	534
Gross amount carried at close of period, buildings and improvements	0
Gross amount carried at close of period, total	534
Accumulated depreciation	0
Total	534
Held-for-sale
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	1,435,384
Initial cost of land	237,151
Initial cost of buildings and improvements	1,613,699
Costs capitalized subsequent to acquisition, land, buildings, and improvements	(75,879)
Gross amount carried at close of period, land	234,706
Gross amount carried at close of period, buildings and improvements	1,545,265
Gross amount carried at close of period, total	1,779,971
Accumulated depreciation	291,041
Total	1,488,930
Held-for-sale | Leawood, KS
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land
Initial cost of buildings and improvements
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	0
Gross amount carried at close of period, buildings and improvements	3,000
Gross amount carried at close of period, total	3,000
Accumulated depreciation	0
Total	3,000
Held-for-sale | Spring Hill, KS
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Encumbrances	0
Initial cost of land
Initial cost of buildings and improvements
Costs capitalized subsequent to acquisition, land, buildings, and improvements	0
Gross amount carried at close of period, land	0
Gross amount carried at close of period, buildings and improvements	2,000
Gross amount carried at close of period, total	2,000
Accumulated depreciation	0
Total	$ 2,000

Schedule III - Real Estate an_3

Schedule III - Real Estate and Accumulated Depreciation - Schedule of Real Estate and Accumulated Depreciation Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate [Roll Forward]
Balance at beginning of year	$ 1,931,032	$ 1,949,997	$ 1,966,352
Dispositions	0	(16,645)	(15,240)
Improvements	17,036	24,701	35,889
Impairment	(165,246)	(27,021)	(33,494)
Subtotal	1,782,822	1,931,032	1,953,507
Classified as held for sale	(7,851)	0	(3,510)
Balance at end of year	1,774,971	1,931,032	1,949,997
Amount of federal income tax basis over cost basis		427,200
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation [Roll Forward]
Balance at beginning of year	230,814	171,083	113,924
Depreciation expense	63,078	62,798	60,028
Property dispositions	0	(3,067)	(1,542)
Subtotal	293,892	230,814	172,410
Classified as held for sale	(2,851)	0	(1,327)
Balance at end of year	$ 291,041	$ 230,814	$ 171,083

Schedule IV - Mortgage Loans _2

Schedule IV - Mortgage Loans on Real Estate - Schedule of Loans (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying value	$ 55,864	$ 55,468	$ 58,600	$ 74,650
Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Federal tax basis of principal amount	$ 74,200
Mezzanine loans | Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Count | loan	1
Fixed Rate	10.00%
Prior Liens	$ 681,526
Principal Amount	74,182
Carrying value	55,864
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0

Schedule IV - Mortgage Loans _3

Schedule IV - Mortgage Loans on Real Estate - Real Estate Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at beginning of year	$ 55,468	$ 58,600	$ 74,650
Deductions:
Reclassification	271	(2,427)	(16,151)
Repayment of principal	0	(818)	0
Amortization of acquisition costs, fees, premiums and discounts	125	113	101
Balance at end of year	55,864	55,468	58,600
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Value	$ 229,173	$ 268,894
Espresso
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Carrying Value			$ 0